
<html lang="en"     class="pb-page"  data-request-id="de0065b4-6e61-4c39-b69c-b8fceee64c35"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b02078;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity" /></meta><meta name="dc.Creator" content="Bala C.  Chenna" /></meta><meta name="dc.Creator" content="Linfeng  Li" /></meta><meta name="dc.Creator" content="Drake M.  Mellott" /></meta><meta name="dc.Creator" content="Xiang  Zhai" /></meta><meta name="dc.Creator" content="Jair L.  Siqueira-Neto" /></meta><meta name="dc.Creator" content="Claudia  Calvet Alvarez" /></meta><meta name="dc.Creator" content="Jean A.  Bernatchez" /></meta><meta name="dc.Creator" content="Emily  Desormeaux" /></meta><meta name="dc.Creator" content="Elizabeth  Alvarez Hernandez" /></meta><meta name="dc.Creator" content="Jana  Gomez" /></meta><meta name="dc.Creator" content="James H.  McKerrow" /></meta><meta name="dc.Creator" content="Jorge  Cruz-Reyes" /></meta><meta name="dc.Creator" content="Thomas D.  Meek" /></meta><meta name="dc.Description" content="Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent..." /></meta><meta name="Description" content="Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 3, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02078" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02078" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02078" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02078" /></link>
        
    
    

<title>Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02078" /></meta><meta property="og:title" content="Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0002.jpeg" /></meta><meta property="og:description" content="Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive “warheads” of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1–0.4 μM). These cruzain inhibitors exhibited moderate to excellent selectivity versus human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1–15 μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5–8 μM). PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compounds to treat Chagas disease and human sleeping sickness." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02078"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02078">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02078&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02078&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02078&amp;href=/doi/10.1021/acs.jmedchem.9b02078" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 3298-3316</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b02063" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02090" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Bala C. Chenna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bala C. Chenna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bala+C.++Chenna">Bala C. Chenna</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2660-5302" title="Orcid link">http://orcid.org/0000-0002-2660-5302</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Linfeng Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linfeng Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linfeng++Li">Linfeng Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6185-4999" title="Orcid link">http://orcid.org/0000-0001-6185-4999</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Drake M. Mellott</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Drake M. Mellott</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Drake+M.++Mellott">Drake M. Mellott</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiang Zhai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiang Zhai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Zhai">Xiang Zhai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jair L. Siqueira-Neto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jair L. Siqueira-Neto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jair+L.++Siqueira-Neto">Jair L. Siqueira-Neto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudia Calvet Alvarez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia Calvet Alvarez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Calvet+Alvarez">Claudia Calvet Alvarez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean A. Bernatchez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean A. Bernatchez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean+A.++Bernatchez">Jean A. Bernatchez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8309-1627" title="Orcid link">http://orcid.org/0000-0002-8309-1627</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emily Desormeaux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emily Desormeaux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Desormeaux">Emily Desormeaux</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth Alvarez Hernandez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth Alvarez Hernandez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Alvarez+Hernandez">Elizabeth Alvarez Hernandez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jana Gomez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Gomez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Gomez">Jana Gomez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James H. McKerrow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James H. McKerrow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+H.++McKerrow">James H. McKerrow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jorge Cruz-Reyes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge Cruz-Reyes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Cruz-Reyes">Jorge Cruz-Reyes</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Thomas D. Meek</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas D. Meek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#b6c2d2dbd3d3ddf6c2d7dbc398d3d2c3"><span class="__cf_email__" data-cfemail="2256464f4747496256434f570c474657">[email protected]</span></a>. Phone: 979-458-9787.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+D.++Meek">Thomas D. Meek</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1931-8073" title="Orcid link">http://orcid.org/0000-0002-1931-8073</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02078&amp;href=/doi/10.1021%2Facs.jmedchem.9b02078" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 3298–3316</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 3, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 December 2019</li><li><span class="item_label"><b>Published</b> online</span>3 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02078" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02078</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3298%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBala%2BC.%2BChenna%252C%2BLinfeng%2BLi%252C%2BDrake%2BM.%2BMellott%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D6%26contentID%3Dacs.jmedchem.9b02078%26title%3DPeptidomimetic%2BVinyl%2BHeterocyclic%2BInhibitors%2Bof%2BCruzain%2BEffect%2BAntitrypanosomal%2BActivity%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3316%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02078"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1190</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02078" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bala&quot;,&quot;last_name&quot;:&quot;C. Chenna&quot;},{&quot;first_name&quot;:&quot;Linfeng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Drake&quot;,&quot;last_name&quot;:&quot;M. Mellott&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Zhai&quot;},{&quot;first_name&quot;:&quot;Jair&quot;,&quot;last_name&quot;:&quot;L. Siqueira-Neto&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Calvet Alvarez&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;A. Bernatchez&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Desormeaux&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Alvarez Hernandez&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Gomez&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;H. McKerrow&quot;},{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Cruz-Reyes&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;D. Meek&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;3298-3316&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02078&quot;},&quot;abstract&quot;:&quot;Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive “warheads” of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1–0.4 μM). These cruzain inhibitors exhibited moderate to excellent selectivity versus human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1–15 μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5–8 μM). PVHIs represent a new class of cruzain inhibitors that could &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02078&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02078" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02078&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02078" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02078&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02078" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02078&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02078&amp;href=/doi/10.1021/acs.jmedchem.9b02078" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02078" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02078" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02078%26sid%3Dliteratum%253Aachs%26pmid%3D32125159%26genre%3Darticle%26aulast%3DChenna%26date%3D2020%26atitle%3DPeptidomimetic%2BVinyl%2BHeterocyclic%2BInhibitors%2Bof%2BCruzain%2BEffect%2BAntitrypanosomal%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D6%26spage%3D3298%26epage%3D3316%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292547" title="Adducts">Adducts</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291612" title="Vinyl">Vinyl</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/jmcmar.2020.63.issue-6/20200326/jmcmar.2020.63.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cruzain, an essential cysteine protease of the parasitic protozoan, <i>Trypanosoma cruzi</i>, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive “warheads” of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(<i>N</i>-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (<i>K</i><sub>i</sub>* = 0.1–0.4 μM). These cruzain inhibitors exhibited moderate to excellent selectivity versus human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of <i>Trypanosoma brucei brucei</i> (EC<sub>50</sub> = 1–15 μM) and eliminated <i>T. cruzi</i> in infected murine cardiomyoblasts (EC<sub>50</sub> = 5–8 μM). PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compounds to treat Chagas disease and human sleeping sickness.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03275" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03275" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chagas disease, caused by the American parasitic protozoan <i>Trypanosoma cruzi</i> (<i>T. cruzi</i>), affects nearly 8 million people in Mexico and Central and South America, resulting in 50,000 annual deaths.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> It is estimated that more than 300,000 U.S. residents are infected with <i>T. cruzi</i>, and cases have been reported in California, Texas, and other parts of the Southwestern U.S. in which the infections were acquired locally.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Approximately 20–30% of people infected with <i>T. cruzi</i> will develop debilitating and potentially fatal heart dilation, arrhythmias, apical aneurysms,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and/or a dilated colon and esophagus.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The related African trypanosomes <i>Trypanosoma brucei rhodesiense</i> (<i>T. b. rhodesiense</i>) and <i>Trypanosoma brucei gambiense</i> (<i>T. b. gambiense</i>)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> cause human sleeping sickness. Sleeping sickness is endemic in 36 African countries, threatening an estimated 60 million people, with more than 60,000 reported cases.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> With the absence of vaccines, the standard treatment for Chagas disease is limited to nifurtimox and benznidazole, which are so replete with side effects that abandonment of treatment is common.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a></div><div class="NLM_p">Cysteine proteases of the papain family are of similar structures<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and substrate specificities<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> and are implicated in numerous human diseases including cancer (cathepsin L),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> chronic obstructive pulmonary disorder (cathepsins C<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and S<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>) and osteoporosis (cathepsin K<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>). Likewise, the highly homologous, cathepsin L-like cysteine proteases, cruzain (E.C. 3.4.22.51; UniProt ID: <a href="https://P25779" class="ext-link">P25779</a>),<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> rhodesain,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and brucipain (TbCatL),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> found in the respective parasitic species <i>T. cruzi</i>, <i>T. b. rhodesiense</i>, and <i>T. b. brucei</i>, are essential to the establishment and maintenance of host infection by trypanosomes.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24">(20−24)</a> The roles of protozoal cysteine proteases in disease include the scavenging of iron from metalloproteins<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the evasion of immune surveillance by proteolysis of NF-κB.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Gene deletion of cruzain demonstrated its role in undermining the prophylactic role of macrophages during infection.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The work of McKerrow and colleagues demonstrated the biochemical essentiality of cruzain in the pathology of <i>T. cruzi</i>.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30">(26−30)</a> They first expressed and characterized cruzain,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> including its crystal structure,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and identified the drug candidate <b>K11777</b>, a dipeptide vinyl sulfone (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which undergoes irreversible thia-Michael addition to active site Cys<sub>25</sub>.<a onclick="showRef(event, 'ref20 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref20 ref31 ref32 ref33">(20,31−33)</a> The progression of <b>K11777</b> to human trials includes demonstration of a cure of <i>T. cruzi</i><i>-</i>infected mammalian cells in the culture<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and also elimination of parasites from acutely infected mice.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, <b>K11777</b> has stalled in preclinical evaluation due to liver toxicity, possibly arising from its irreversible mechanism.<a onclick="showRef(event, 'ref13 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref13 ref34 ref35">(13,34,35)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>K11777</b>, <b>GSK2793660</b>, and Cbz-Phe-Phe-vinyl-2Pyrmd <b>7</b> with thia-Michael addition of Cys<sub>25</sub> to the vinyl groups in these compounds, including the putative adduct <b>7a</b>, which reverts to the fully conjugated <b>7</b> upon the reverse of adduct formation. The common bioisosteric atoms of <b>K11777</b>, <b>GSK2793660</b>, and <b>7</b> are highlighted in red. X is an electron-donating or electron-withdrawing substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inactivators that form reversible covalent adducts with cysteine groups on enzymes have received recent attention.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> Such reversible covalent inactivators demonstrate time-dependent inactivation, like irreversible inactivators, but may exert greater selectivity for the intended target rather than homologous “off-target” enzymes. This is because while the initial–collision complexes of irreversible inactivators with a panel of related enzymes may have variable affinities, over time, the establishment of permanent covalent bonds may render this initial selectivity inconsequential. However, in the case of a reversible covalent inhibitor, their residence times on these enzymes are likely to be variable,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> leading ultimately to “relief” from covalent inactivation for off-targets.</div><div class="NLM_p last">The design of dipeptide vinyl heterocyclic inhibitors is predicated on existing irreversible covalent inactivators of cysteine proteases such as the vinyl sulfone of <b>K11777</b> and the acrylamide of <b>GSK2793660</b>, an inactivator of human cathepsin C that reached phase I clinical trials.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Both compounds form irreversible covalent adducts with the active site cysteines of the respective enzymes via a thia-Michael reaction (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), and both have encountered either toxicity issues or adverse events in, respectively, either animals<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> or humans.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Accordingly, we sought replacements of the vinyl sulfone and acrylamide “warheads” with less electrophilic moieties that would undergo reversible thia-Michael addition, to develop inactivators of high potency for cruzain, but also with suitable selectivity for trypanosomal over human cysteine proteases. One approach is the replacement of the vinyl sulfone and carboxamide group of the acrylamide with a bioisosteric heterocyclic group, which is conjugated to the reactive vinyl group. A vinyl-2-pyrimidine is one such bioisosteric replacement (<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) in which one of the ring nitrogens mimics the amide carbonyl and sulfone oxygen while the other substitutes for the amide nitrogen (red atoms in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). As the pyrimidine is conjugated to the vinyl group, the expected addition of the thiol group of the cysteine to the β-carbon of the vinyl group and attending protonation of the α-carbon would eliminate this conjugation. Subsequent re-establishment of conjugation via reversal of the thia-Michael reaction would provide reversible covalent inactivation of the enzyme. Another feature afforded by this vinyl heterocycle is the ability to modify the reactivity of the vinyl group by the substitution of the heterocycle with electron-donating or electron-withdrawing groups. In this study, we designed, synthesized, and evaluated a panel of dipeptide compounds containing a vinyl group replacing the scissile amide group of the substrate, which is conjugated to a phenyl group or a collection of heterocycles. For some, we investigated the ability of glutathione to form covalent adducts with their vinyl groups to explore the electronic nature of the heterocycle required for facile addition of thiols. Many of these compounds displayed potent, time-dependent inhibition of cruzain and antitrypanosomal activity in cell cultures.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Evaluation of Dipeptide Substrates</h3><div class="NLM_p">We previously conducted a detailed investigation of the catalytic mechanism of cruzain utilizing three dipeptide substrates and by using solvent kinetic isotope effects in both presteady-state and steady-state kinetic modes.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> As with other cysteine proteases, our kinetic studies supported a double-displacement chemical mechanism in which a thioester intermediate of Cys<sub>25</sub> and substrate is first formed (enzyme acylation) concurrent with the release of the amine product. This half-reaction is followed by enzyme-catalyzed hydrolysis of the thioester (enzyme deacylation) to afford the carboxylate product. We determined that for Cbz-Phe-Arg-AMC (<b>S1</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), the most optimal substrate in terms of values of <i>k</i><sub>cat</sub> and <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>, and Cbz-Arg-Arg-AMC (<b>S6</b>), enzyme-catalyzed deacylation comprised the slow steps of the reaction (<i>k</i><sub>cat</sub> = <i>k</i><sub>dac</sub>), while the rates of the acylation of active site Cys<sub>25</sub> (described by <i>k</i><sub>ac</sub>) were 10-fold and 4-fold, respectively, more rapid than <i>k</i><sub>cat</sub>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The parameter <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> contains the individual rate constants found in the expression for <i>k</i><sub>ac</sub> and therefore reports on the rates of substrate binding and catalysis up to and including the acylation of active site Cys<sub>25</sub>. Accordingly, this kinetic parameter comprises a useful guide for the selection of optimal dipeptide scaffolds to be incorporated into inhibitors that are meant to form reversible covalent complexes with Cys<sub>25</sub> upon binding, a reaction that chemically mimics acylation. If our dipeptidic vinyl heterocyclic inhibitors do indeed inhibit cruzain by the addition of the thiolate of Cys<sub>25</sub> to their olefinic replacements for the scissile amide bond, then the values of <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> (the specificity constants) for the fluorogenic substrates should provide an approximate linear correlation with values of <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> (which is the “specificity constant” of inactivation).<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinetic Parameters of Peptide Substances for Cruzain<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">substrate</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>cat</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>m</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> (μM<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>cat</sub>/<i>K</i><sub>m rel</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>cat rel</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S1</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Arg-AMC</td><td class="colsep0 rowsep0" align="char" char="±">9.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.89 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S2</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.26 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">8 ± 2</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S3</b></td><td class="colsep0 rowsep0" align="left">Cbz-Leu-hPhe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S4</b></td><td class="colsep0 rowsep0" align="left">Cbz-Leu-Arg-AMC</td><td class="colsep0 rowsep0" align="char" char="±">8.4 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S5</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-(4-Pyr)Ala-AMC</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S6</b></td><td class="colsep0 rowsep0" align="left">Cbz-Arg-Arg-AMC<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S7</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S8</b></td><td class="colsep0 rowsep0" align="left">Cbz-(4-Pyr)Ala-hPhe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.6 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S9</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">0.26 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S10</b></td><td class="colsep0 rowsep0" align="left">Cbz-Arg-hPhe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">4.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">6.8 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S11</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-Phe-AMC</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S12</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Ala-AMC<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.89 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.023 ± 0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data obtained at pH 7.5, 25 °C, and 10% DMSO (v/v).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data obtained at 2% DMSO (v/v) from ref <a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a>.</p></div></div></div><div class="NLM_p">We have kinetically characterized 12 dipeptide fluorogenic substrates of cruzain, which are of the form Cbz/NMePip-P<sub>2</sub>-P<sub>1</sub>-AMC, for which Cbz is benzyloxycarbonyl; NMePip is <i>N</i>-methyl-piperazinyl; P<sub>2</sub> = Phe, Leu, Arg, or 4-pyridyl-alanine ((4-Pyr)Ala); P<sub>1</sub> = Phe, hPhe (homoPhe), Arg, Ala, and (4-Pyr)Ala; and AMC is 7-amino-4-methylcoumarin (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The largest specificity constant (<i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>) measured was that of Cbz-Phe-Arg-AMC (11 μM<sup>–1</sup> s<sup>–1</sup>, relative <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> = 1.0). Substrates <b>S2</b>–<b>S4</b> have values of <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>, which are 73–35% of that of Cbz-Phe-Arg-AMC, indicating that Cbz-Phe-hPhe-AMC, Cbz-Leu-hPhe-AMC, and Cbz-Leu-Arg-AMC all comprise highly competent substrates likely effecting rapid acylation of cruzain. The poorest substrate, Cbz-Phe-Ala-AMC (<b>S12</b>), demonstrated that a small side chain in the P<sub>1</sub> position is less preferable than more bulky hydrophobic moieties. Conversely, the dipeptide Cbz-Phe-hPhe-AMC (<b>S2</b>) exhibited a value of <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> = 8 μM<sup>–1</sup> s<sup>–1</sup>, indicating that a peptide substrate with the same P<sub>2</sub> and P<sub>1</sub> amino acids as <b>K11777</b> is an excellent substrate of cruzain and likely involves rapid acylation. Interestingly, when the Cbz group of substrate <b>S2</b> is replaced with NMePip (<b>S7</b>), a substrate mimic of <b>K11777</b>, <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> is 8-fold lower (1.3 μM<sup>–1</sup> s<sup>–1</sup>). However, its value of <i>k</i><sub>cat</sub> exceeded that of Cbz-Phe-hPhe-AMC (<b>S2</b>), suggesting that the NMePip N-terminus of <b>S7</b> acts to retard cruzain acylation in comparison to the Cbz group of <b>S2</b>. While Cbz-Phe-Phe-AMC (<b>S9</b>) had a value of <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> that was only 7% of Cbz-Phe-Arg-AMC, its <i>K</i><sub>m</sub> value of 0.34 μM indicated potent binding, albeit with slow turnover. This may indicate that a P<sub>1</sub> Phe substitution leads to favorable binding, but this side chain impedes either the acylation or deacylation step in catalysis. This was observed for dipeptide–AMC substrates for the papain-like protease, human cathepsin C.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p last">We explored the viability of the (4-Pyr)Ala residue as a potential mimic of both Phe and Arg, for the latter residue when the pyridine is protonated. Cbz-Phe-(4-Pyr)Ala-AMC (<b>S5</b>) was found to be a good substrate (relative <i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub> = 0.10) but with a higher value of <i>K</i><sub>m</sub> (3.7 μM) compared to substrates containing Phe and hPhe in the P<sub>1</sub> residue. To leverage the ability of cruzain to tolerate both charged basic and hydrophobic residues in the P<sub>2</sub> position, we prepared Cbz-(4-Pyr)Ala-hPhe-AMC and Cbz-Arg-hPhe-AMC (<b>S8</b> and <b>S10</b>). These substrates displayed efficient turnover numbers (<i>k</i><sub>cat</sub> = 5.3 and 4.9 s<sup>–1</sup><i>,</i> respectively) but poor values of <i>K</i><sub>m</sub> (4.6 and 6.8 μM) in comparison to Cbz-Phe-Phe/hPhe-AMC (0.26−0.34 μM). This demonstrates that the enzyme has a strong preference for substrates that contain a hydrophobic P<sub>2</sub> residue. Together, these results indicated that dipeptide scaffolds in which P<sub>2</sub> = Cbz-Phe or NMePip-Phe and P<sub>1</sub> = Arg, hPhe, or (4-Pyr)Ala may be among the best to incorporate into the vinyl heterocyclic framework. Accordingly, for our new peptidomimetic vinyl heterocyclic inhibitors, we have primarily utilized the Cbz-Phe-Phe and NMePip/Cbz-Phe-hPhe dipeptide scaffolds.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Computer-Assisted Inhibitor Design</h3><div class="NLM_p">To aid in the rational design of our vinyl heterocyclic inhibitors, we employed molecular docking of these compounds to a model constructed from the crystal structure of <b>K11777</b>-cruzain (PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZ2">2OZ2</a>), which contains a covalent bond between the inactivator and Cys<sub>25</sub>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Owing to our hypothesis that the vinyl heterocyclic inhibitors have the ability to undergo a reversible thia-Michael addition with the active site Cys<sub>25</sub> of cruzain, it is necessary to consider scenarios of both noncovalent and covalent binding. To this end, we first predicted the binding patterns for NMePip-Phe-hPhe-vinyl-2Pyrmd (<b>9</b>), which has the same scaffold as <b>K11777</b> using Glide<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44−46)</a> and CovDock<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> modules embedded in the Schrodinger software package. In the covalent model, the binding of <b>9</b> with cruzain was highly conserved when compared to that of <b>K11777</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Pyrimidine N1 of <b>9</b> was within hydrogen bonding distance of Gln<sub>19</sub> and Trp<sub>184</sub>, allowing the stabilization of the vinyl heterocycle in a nearly analogous fashion to the sulfone moiety in <b>K11777</b>. In addition, the α-carbon of the inhibitor is positioned within 2.4 Å of His<sub>162</sub>, an interatomic distance that would easily allow facile proton transfer between this carbon and the imidazole nitrogen, supporting our hypothesis that a reversible adduct could be formed with cruzain. The noncovalent model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) shared similar shape complementarity with the covalent binding pose, except that it was slightly shifted away from the binding site as militated by the docking algorithm to avoid clashing with Cys<sub>25</sub>. This suggested that covalent bond formation would only slightly perturb the noncovalent binding conformation. Overall, these data suggested that the binding of our newly designed compounds containing a vinyl heterocyclic warhead have the ability to interact with cruzain in a very similar fashion to the characterized, irreversible inactivators of the enzyme. Similarly, we carried out docking for five other PVH compounds (<b>7</b>, <b>11</b>, <b>12</b>, <b>13</b>, and <b>15</b> in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Figure S1</a>), and their covalent-docking affinity values (Cdock affinity) are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Table S1</a>. The corresponding inhibition constants (predicted <i>K</i><sub>i</sub>) converted from these affinity values ranged from 0.79 to 6.1 μM, with the exception of compound <b>7</b>, were similar with the experimental values found in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. In agreement with our dipeptide substrate kinetic data, we observed an increased Cdock affinity for <b>13</b> and <b>15</b> for which each contained an hPhe in the P<sub>1</sub> position instead of Phe. In addition, the substitution of a pyridine ring at the P<sub>1</sub>′ positions of <b>11</b>, <b>12</b>, <b>13</b>, and <b>15</b> may subtly improve the binding compared to the pyrimidine substituent of <b>7</b>. Further, the N-methylation of pyridine resulted in a fairly large shift in Cdock affinity, possibly resulting from an additional ion–ion/dipole interaction. On the basis of these docking analyses, our inhibitor design focused on using a dipeptidic scaffold containing Phe in the P<sub>2</sub> position and either Phe or hPhe in the P<sub>1</sub> position. We varied the identity of the heterocycle to modify the electrophilicity of the olefin bond but generally maintained functional groups that possibly could afford hydrogen bonding with Gln<sub>19</sub> to stabilize the binding of the compounds near Cys<sub>25</sub> of cruzain.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular models of compound <b>9</b> bound to cruzain. (A) <b>K11777</b> (gray) is superimposed with a binding pose (green) in which a covalent bond is formed between the β-carbon of the vinyl group of <b>9</b>. (B) Binding pose (cyan) of <b>9</b> in which no covalent bond is formed with Cys<sub>25</sub>. Yellow and white dashed lines represent hydrogen bonds with surrounding residues for <b>9</b> and <b>K11777</b>, respectively. Red dashed lines are measurements between the catalytic dyad and the vinyl moiety of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinetic Data of Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0003.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">cruzain inhibition or inactivation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>* (μM)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub><i>/K</i><sub>inact</sub> (M<sup>–1</sup> s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>K11777</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-VSPh</td><td class="colsep0 rowsep0" align="left">NMePip</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>I</b></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.002<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">234,000<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-VSPh</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>I</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.0036 ± 0.0001</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>II</b></td><td class="colsep0 rowsep0" align="left">37 ± 2</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">21.7 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>II</b></td><td class="colsep0 rowsep0" align="left">3 ± 1</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">1700 ± 500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-vinyl-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NMePip</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>II</b></td><td class="colsep0 rowsep0" align="left">3.4 ± 0.4</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">1900 ± 200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-Ph</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>III</b></td><td class="colsep0 rowsep0" align="left">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.05</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-(4-NO<sub>2</sub>)Ph</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>III</b>, R<sub>4</sub> = NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.02</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Pyrmd</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>IV</b></td><td class="colsep0 rowsep0" align="left">28 ± 1</td><td class="colsep0 rowsep0" align="left">0.364 ± 0.004</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2Pyrmd</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>IV</b></td><td class="colsep0 rowsep0" align="left">>35</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-vinyl-2Pyrmd</td><td class="colsep0 rowsep0" align="left">NMePip</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>IV</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Ala-vinyl-2Pyrmd</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><b>IV</b></td><td class="colsep0 rowsep0" align="left">58 ± 6</td><td class="colsep0 rowsep0" align="left">25 ± 1</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">5.5 ± 0.4</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.01</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2PyrNMe</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b>, R<sub>4</sub> = Me</td><td class="colsep0 rowsep0" align="left">3.8 ± 0.4</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.08</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">1.06 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.171 ± 0.004</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">NMePip</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">3.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2PyrNMe</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b>, R<sub>4</sub> = Me</td><td class="colsep0 rowsep0" align="left">0.76 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.126 ± 0.004</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2-(4-OMe)-Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b>, R<sub>5</sub> = OMe</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2-(4-CF<sub>3</sub>)-Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b>, R<sub>5</sub> = CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.05</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Cbz-Leu-hPhe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Bn</td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">7.8 ± 0.6</td><td class="colsep0 rowsep0" align="left">1.42 ± 0.09</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Ala-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Lys-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"><b>V</b></td><td class="colsep0 rowsep0" align="left">17.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.02</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-4Pyr</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>VI</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">5.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-4PyrNMe</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>VI</b>, R<sub>4</sub> = Me</td><td class="colsep0 rowsep0" align="left">92 ± 5</td><td class="colsep0 rowsep0" align="left">4.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-4Pyrmd</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>VII</b></td><td class="colsep0 rowsep0" align="left">10.8 ± 1.4</td><td class="colsep0 rowsep0" align="left">1.14 ± 0.07</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Oxz</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>VIII</b></td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.01</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Thz</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>IX</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">1.71 ± 0.09</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2ThzNMe</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>IX</b>, R<sub>4</sub> = Me</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.06</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data obtained at 25°C, pH 7.5; NA, not applicable; ND, not determined; apparent <i>K</i><sub>i</sub> and <i>K</i><sub>i</sub>* are respectively the apparent initial and tight-binding inhibition constants.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Reported as apparent IC50 in ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Reported as 32,500 M<sup>–1</sup> s<sup>–1</sup> (pH 8.0) in ref <a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a>.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of PVHIs</h3><div class="NLM_p">The general synthetic routes employing either Wittig<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> or Horner–Wadsworth–Emmons<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> reactions shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> were used to synthesize peptidomimetic vinyl heterocyclic compounds from aldehydes and halomethyl heterocycles.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route to PVHIs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Conditions and reagents (General Procedures are detailed in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>): GP1, <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride, T3P, DIPEA, DCM, and 0 °C; GP2, LAH, THF, and −10 °C; GP3, (1) NaBH<sub>4</sub>, EtOH, and 0 °C and (2) SOCl<sub>2</sub> and DCM; GP4, PPh<sub>3</sub>, benzene, and reflux; GP5, P(OEt)<sub>3</sub> and 150 °C; GP6, LHMDS, THF, −70 to 0 °C; GP7, LHMDS, THF, −70 to 0 °C; GP8, (1) TFA, DCM, and 0 °C and (2) R<sub>1</sub>-Xaa-OH, T3P, DIPEA, DCM, and 0 °C; GP9, MeI, MeCN, and reflux; GP10, (1) LiOH and H<sub>2</sub>O and (2)ClCOOEt and NH<sub>4</sub>Cl.</p></p></figure><div class="NLM_p">Commercially available Boc-protected <span class="smallcaps smallerCapital">l</span>-amino acids phenylalanine, homophenylalanine, and alanine (<b>a</b>) were converted to Weinreb amides<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> by T3P-catalyzed coupling to <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride to afford <b>b</b> (GP1, General Procedure 1 in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Reduction of the Weinreb amide using LAH at −10 °C in anhydrous THF provided the Boc-amino acid aldehyde (<b>c</b>, GP2), generally in overall yields of ∼80% (<b>a</b>–<b>c</b>).</div><div class="NLM_p">Phosphonium salts of methyl heterocycles were, in general, prepared by derivatization of either the 2-methylcarboxy or 2-hydroxymethyl heterocycle (<b>d</b>–<b>f</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Methyl 2-carboxy-pyrimidine (or pyridine, oxazole, and thiazole) was reduced using sodium borohydride to the primary alcohol, followed by conversion of the alcohol to the 2-chloromethyl-pyrimidine (<b>e</b>) using SOCl<sub>2</sub> or POCl<sub>3</sub> in DCM or CHCl<sub>3</sub> (GP3). The reaction of <b>e</b> with triphenylphosphine provided the Wittig reagent phosphonium salt (<b>f</b>) at overall yields of 28–80% (GP4). Wittig coupling of <b>f</b> with a peptide aldehyde (<b>c</b>) using LHMDS in anhydrous THF or sodium methoxide in benzene as the base provided the peptide vinyl heterocyclic product <b>h</b> (GP6), with general overall yields of 13–54%. Typically, the ratio of <i>E</i>/<i>Z</i> was 4:1, and the separation of these regioisomers was readily achieved using silica gel column chromatography.</div><div class="NLM_p">Alternatively, the 2-chloromethyl-heterocyclic group <b>e</b> was converted to its phosphonate <b>g</b> by use of the Arbuzov reaction with triethylphosphite (∼80% yields, GP5). The resulting phosphonate was deprotonated with LHDMS in THF and then coupled with aldehyde <b>c</b> to provide the peptide vinyl heterocycle <b>h</b> at 20–80% yield (GP7). The Boc group was removed quantitatively by treatment with TFA in DCM, and then the free amine was coupled with the P<sub>3</sub>–P<sub>2</sub> fragment (R<sub>1</sub>-Xaa-OH) using T3P to give the inhibitor <b>i</b> (GP8).</div><div class="NLM_p last">In addition, some of the PVHIs underwent N-methylation of the heterocycle (<b>j</b>, GP9). Further, we also prepared several acrylamides (<b>k</b>) through hydrolysis of the corresponding acrylate ester and subsequent treatment with ethyl chloroformate and NH<sub>4</sub>Cl (GP10). Final products were confirmed structurally by NMR and LCMS, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Supporting Information</a>. It is important to note that proton NMR analysis of the products (<b>i</b>– <b>k</b>) indicated negligible epimerization at the α-carbon in these products, as evidenced by the absence of diastereomers.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Electrophilicity of Vinyl Heterocycles</h3><div class="NLM_p">To evaluate the chemical reactivity of the vinyl group in our PVHIs and <b>K11777</b>, we treated selected compounds with glutathione (GSH) at pH 8.0 to determine their reactivity in the thia-Michael addition of the sulfhydryl group of GSH with the vinyl group of the inhibitors. Normally, the addition of glutathione to an enzyme inhibitor is to be avoided, but, here, this serves as a means to evaluate the electrophilicity of these inhibitors. <b>K11777</b> and compounds <b>7</b>, <b>11</b>, <b>12</b>, <b>15</b>, <b>17</b>, <b>25</b>, and <b>26</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), which respectively contain vinyl sulfone (R<sub>3</sub> = <b>I</b>), vinyl-2-pyrimidine (R<sub>3</sub> = <b>IV</b>), vinyl-2-pyridine (R<sub>3</sub> = <b>V</b>), vinyl-2-<i>N</i>-methylpyridine (R<sub>3</sub> = <b>V</b>; R<sub>4</sub> = Me), vinyl-2-(4-trifluoromethyl)-pyridine (R<sub>3</sub> = <b>V</b>, R<sub>5</sub> = CF<sub>3</sub>), vinyl-2-thiazole (R<sub>3</sub> = <b>IX</b>), and vinyl-2-<i>N</i>-methylthiazole (R<sub>3</sub> = <b>IX</b>; R<sub>4</sub> = Me). As previously reported,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> the formation of a glutathione adduct with <b>K11777</b> was very slow (<i>k</i> = 0.00028 s<sup>–1</sup>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Table S2</a>; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), and we were unable to ascertain an equilibrium constant for the <b>K11777</b>-GSH adduct. For the PVHIs, the reaction between GSH and vinyl-2-pyrimidine (<b>7</b>), vinyl-pyridine (<b>11</b>), vinyl-2-(4-trifluoromethyl)-pyridine (<b>17</b>), and vinyl-thiazole (<b>25</b>) was negligible as no adduct was observed after 90 min of incubation with either a 2:1 or 10:1 molar ratio of GSH/inhibitor. The electron-withdrawing 4-trifluoromethyl group on the pyridine of <b>17</b> had no effect on the electrophilicity of <b>11</b>. In contrast, the addition of GSH to the vinyl group of vinyl-2-<i>N</i>-methylpyridine (<b>12</b> and <b>15</b>) and vinyl-2-<i>N</i>-methylthiazole (<b>26</b>) in a 2:1 molar ratio resulted in the rapid formation of GSH adducts at respective rates of 0.037, 0.054, and 0.015 mM<sup>–1</sup> s<sup>–1</sup>, and apparent equilibrium was achieved for these compounds in 90 min (<i>K</i><sub>eq</sub> = 7400, 2400, and 930 M<sup>–1</sup>, respectively). This demonstrated that the N-methylation of the PVHs afforded a significant increase in the electrophilicity of the vinylic position, enabling rapid addition to thiols, owing to the strong electron-withdrawing effect of the methylpyridinium moiety. For example, compounds <b>11</b> and <b>12</b> are identical except for the N-methylpyridine group of compound <b>12</b>; compound <b>12</b> readily forms an adduct with GSH (97% conversion of <b>12</b> to its GSH adduct in 20 min at a 10:1 molar ratio of GSH to compound), whereas compound <b>11</b> is unreactive toward GSH. Interestingly, the rate of thiolation of compound <b>12</b> is 50% that of <b>15</b>, while the values of <i>K</i><sub>eq</sub> indicated that the <b>12</b>-GSH adduct is three times more abundant than that of <b>15</b>-GSH. This suggested that the phenylalanyl side chain of <b>12</b> may retard the addition of GSH to its vinyl group and also slowed the presumed base-catalyzed elimination of GSH from its adduct with <b>12</b>. Overall, these results demonstrated that the reactivity of vinyl heterocycles with GSH and presumably Cys<sub>25</sub> vary with the nature of the heterocycles. Hence, it is possible to tune the electronic properties of the vinyl bond in the PVHIs, thereby allowing for development of modifiable electrophilic inhibitors of other enzymes that have an active site cysteine or other nucleophile.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time courses of depletion of 0.5 mM <b>K11777</b> (red circles), compound <b>12</b> (blue circles), and compound <b>15</b> (black circles) upon formation of adducts (red, blue, and black squares, respectively) with 1 mM glutathione. Lines drawn through the curves for substrate depletion and adduct formation were respectively [substrate] = (0.5 mM – A)(1 – exp(−<i>k</i> ×<i>t</i>)) + <i>C</i> and [adduct] = A × (1 – exp(−<i>k</i> × <i>t</i>)) + <i>C</i>, with resulting kinetic parameters found in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Table S2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Kinetic Analysis of Cruzain Inhibitors and Inactivators</h3><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> is a kinetic depiction of inhibition and inactivation of cruzain and the relevant kinetic parameters.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The initial, and usually rapid, formation of EI is characterized by the inhibition constant <i>K</i><sub>i</sub>. For time-dependent inhibitors, EI progresses to a second, tighter complex EI*, generally over the course of minutes, characterized by <i>K</i><sub>i</sub>*, for which <i>K</i><sub>i</sub>* < <i>K</i><sub>i</sub> when <i>k</i><sub>4</sub> < <i>k</i><sub>3</sub>. For irreversible covalent inactivators, <i>k</i><sub>4</sub> and <i>K</i><sub>i</sub>* ≈ 0, and the kinetic parameter <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> is generally reported. For reversible time-dependent inhibitors, initiation of the reaction by adding enzyme to the substrate and inhibitor leads to concave-downward, curvilinear time courses of product formation in which reaction rates demonstrably decrease as the EI* complex forms. Typical data, as exemplified for compound <b>15</b>, are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A. Alternatively, extended preincubation of the enzyme and inhibitor, followed by dilution of the inhibitor and initiation of the reaction with high concentrations of the substrate, leads to concave-upward curvilinear plots of product formation as E reforms from EI* (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Results of this analysis for cruzain inhibitors and inactivators are collected in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent inhibition of cruzain by <b>15</b>. (A) Reaction initiated by addition of cruzain (100 pM) with Cbz-Phe-Arg-AMC (10 μM) and 0–20 μM <b>15</b> (pH 7.5). Lines drawn through the experimental data points were from fitting of each inhibitor concentration to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, from which the replot of <i>k</i><sub>obs</sub> vs [<b>15</b>] is shown in the inset (fitting to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>: <i>K</i><sub>i</sub> = 2.00 ± 0.9 μM, <i>k</i><sub>3</sub> = 0.004 ± 0.001 s<sup>–1</sup>, and <i>k</i><sub>4</sub> ≈ 0). (B) Following 1 h of preincubation of cruzain (100 pM) with 0–6 μM <b>15</b>, the reaction was initiated by addition of Cbz-Phe-Arg-AMC (10 μM). (C) Fitting of cruzain inhibition by compound <b>15</b> for <i>v</i><sub>i</sub>/<i>v</i><sub>0</sub> (black) and <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> (red) using <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a> with results of this found in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Kinetic Depiction of Inhibition and Inactivation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>K11777</b> comprises a useful benchmark compound despite the fact that it is an irreversible inactivator of cruzain (reported kinetic data: apparent IC<sub>50</sub> of 2 nM, <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> = 234,000 M<sup>–1</sup> s<sup>–1</sup>).<a onclick="showRef(event, 'ref32 ref53'); return false;" href="javascript:void(0);" class="ref ref32 ref53">(32,53)</a> We replaced the P<sub>1</sub> hPhe group of <b>K11777</b> with a Phe side chain to provide vinyl sulfone <b>1</b>, which had apparently equivalent potency (<i>K</i><sub>i</sub>* = 3.6 nM) to that of <b>K11777</b>, but which, interestingly, exhibited kinetically reversible inhibition of cruzain. However, a crystal structure we obtained for <b>1</b> bound to cruzain indicated the formation of a C–S bound between Cys<sub>25</sub> and <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Figure S4</a>). This may indicate that a phenylalanyl group at the P<sub>1</sub> position partly impedes the ability of an adjacent vinyl electrophile to access Cys<sub>25</sub>, as was observed with the solution phase GSH addition studies to our PVH compounds.</div><div class="NLM_p">We next evaluated three C-terminal acrylamides (R<sub>3</sub> = <b>II</b>) within the Cbz-Phe-Phe, Cbz-Phe-hPhe, and NMePip-Phe-hPhe scaffolds (<b>2</b>–<b>4</b>). The acrylamides within the Cbz-Phe-hPhe and NMePip-Phe-hPhe scaffolds afforded apparently irreversible covalent inactivation (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> = 1700–1900 M<sup>–1</sup> s<sup>–1</sup>), while Cbz-Phe-Phe-acrylamide (<b>2</b>) was less effective (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> = 22 M<sup>–1</sup> s<sup>–1</sup>). Comparing the values of <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> for <b>K11777</b> and <b>4</b> indicated that the vinyl sulfone is overwhelmingly more effective as a covalent inactivator than its acrylamide counterpart, possibly owing to hydrogen bond contacts of the sulfone oxygen with Gln<sub>19</sub>, which position the vinyl group proximal to Cys<sub>25</sub> of cruzain. As with <b>1</b>, a Phe rather than an hPhe group at the P<sub>1</sub> position may retard covalent formation over the time course of kinetic analysis when one compares the rates of apparent inactivation of <b>2</b> versus <b>3</b> and <b>4</b>, as was also seen with peptide substrates.</div><div class="NLM_p">We therefore sought to explore the effects of replacement of both the vinyl-phenylsulfone and acrylamide groups with phenyl and heterocyclic groups conjugated to the vinyl group. The Cbz-Phe-Phe-vinyl-benzene compound <b>5</b> is a time-dependent inhibitor of cruzain (<i>K</i><sub>i</sub>* = 0.87 μM), but substitution of the <i>para</i> position of the phenyl ring with an electron-withdrawing nitro group (compound <b>6</b>) led to a nearly 3-fold improvement in potency (<i>K</i><sub>i</sub>* = 0.34 μM), suggesting that the vinyl group of <b>6</b> is more capable of thiolation by the cruzain. As seen with <b>1</b>, these compounds also demonstrated reversible inhibition of cruzain, possibly due to the P<sub>1</sub> phenylalanine. Due to poor aqueous solubility (solubility of <b>5</b> and <b>6</b>, ≤2 μM in 10% DMSO), the inhibitors containing vinyl-benzene were not explored further.</div><div class="NLM_p">Subsequently, six heterocyclic groups (R<sub>3</sub> = <b>IV</b>–<b>IX</b>) conjugated to the presumed electrophilic vinyl group were evaluated within several dipeptide scaffolds. The vinyl-2-pyrimidine (R<sub>3</sub> = <b>IV</b>), vinyl-2-pyridine (R<sub>3</sub> = <b>V</b>), vinyl-2-oxazole (R<sub>3</sub> = <b>VIII</b>), and vinyl-2-thiazole (R<sub>3</sub> = <b>IX</b>) groups, unlike the vinyl-4-pyridine (R<sub>3</sub> = <b>VI</b>) and vinyl-4-pyrimidine (R<sub>3</sub> = <b>VII</b>), maintain bioisosteric similarity to the reactive acrylamides and vinyl sulfones, which is reflected in their more potent inhibition of cruzain as detailed below. Most of these compounds induced time-dependent inhibition on cruzain and were found to be kinetically reversible with residence times (τ) of 6–20 min.</div><div class="NLM_p">The vinyl-2-pyrimidine moiety (R<sub>3</sub> = <b>IV</b>) in the Cbz-Phe-Phe scaffold afforded compound <b>7</b>, which exerted time-dependent inhibition of cruzain with an initial value of <i>K</i><sub>i</sub> = 5 μM and subsequent tight-binding inhibition of <i>K</i><sub>i</sub>* = 0.38 μM. Substitution of the phenyl group of <b>5</b> by a pyrimidine group greatly improved the solubility of <b>7</b> (≥100 μM in 10% DMSO). Extended preincubation with <b>7</b>, followed by dilution, and addition of an excess of substrate, resulted in slow recovery of cruzain activity, indicating that any covalent reaction between cruzain and <b>7</b> was kinetically reversible (<i>k</i><sub>4</sub> = 0.0018 ± 0.0003 s<sup>–1</sup>; τ = 9 min). Interestingly, when the 2-pyrimidinyl moiety is appended to Cbz-Phe-hPhe (<b>8</b>), the resulting compound is a poor inhibitor of cruzain (<i>K</i><sub>i</sub> > 35 μM); however, when the 2-pyrimidinyl group is attached to afford the same scaffold as <b>K11777</b>, we obtained an inhibitor of low micromolar potency (<b>9</b>, <i>K</i><sub>i</sub>* = 2.2 μM). Substitution of the P<sub>1</sub> Phe with Ala (<b>10</b>, <i>K</i><sub>i</sub> = 25 μM) produced a poor inhibitor of cruzain, indicating the essentiality of a larger side chain in the P<sub>1</sub> position, as was observed with dipeptide substrates. To probe the importance of the vinyl group for the inhibition of cruzain, we prepared an analogue in which the vinyl group of <b>7</b> was reduced (compound <b>27</b>). This inhibitor lacked time-dependent behavior (<i>K</i><sub>i</sub> = 22 μM) and was 100-fold less potent than its vinyl analogue <b>7</b>, which demonstrated the importance of the vinyl group for the inhibition of cruzain. We prepared inhibitor <b>23</b>, which contains a vinyl-4-pyrimidinyl (R<sub>3</sub> = <b>VII</b>) group that does not maintain bioisosteric similarity to the acrylamides. <b>23</b> exhibited 3-fold less potency than the bioisosteric vinyl-2-pyrimidine (<b>7</b>). Similarly, inhibitors containing the vinyl-4-pyridyl (R<sub>3</sub> = <b>VI)</b> (<b>21</b> and <b>22</b>) lack bioisosteric equivalence to the acrylamides and were found to be only modest inhibitors of cruzain.</div><div class="NLM_p">Inhibitors containing a vinyl-2-pyridinyl group (R<sub>3</sub> = <b>V</b>) were explored more widely. Cbz-Phe-Phe-vinyl-2-pyridine <b>11</b> exhibited time-dependent inhibition of cruzain with an initial value of <i>K</i><sub>i</sub> = 5.5 μM and subsequent tight-binding inhibition of <i>K</i><sub>i</sub>* = 0.31 μM (<i>k</i><sub>4</sub> = 0.0012 ± 0.0002 s<sup>–1</sup>; τ = 13 min), and solubility of <b>11</b> was ≤30 μM in 10% DMSO. Unlike the vinyl-pyrimidinyl group of <b>7</b>, placement of the vinyl-2-pyridinyl group in the Cbz-Phe-hPhe scaffold improved inhibition by 3-fold (<b>13</b>, <i>K</i><sub>i</sub>* = 0.17 μM), while the vinyl-2-pyridinyl group was much less effective in the NMePip-Phe-Phe scaffold (<b>14</b>, <i>K</i><sub>i</sub>* = 3.4 μM). Substitution of an electron-donating methoxy group on the pyridine ring (<b>16</b>) of the Cbz-Phe-hPhe scaffold diminished the inhibitory activity of the vinyl-2-pyridinyl heterocycle compared to its unsubstituted counterpart <b>13</b> by >50-fold, suggesting that the methoxy group is large enough to create a steric barrier to inhibitor binding. In contrast, the substitution at C-4 of the pyridine with the electron-withdrawing trifluoromethyl group resulted in better inhibition (<b>17</b>, <i>K</i><sub>i</sub>* = 0.57 μM), but nonetheless was less potent than the unsubstituted pyridine <b>13</b>. Apparently, this result arises from steric crowding as OMe > CF<sub>3</sub> > H, implicating that substitution at the C-4 position of the pyridine heterocycles are not well tolerated.</div><div class="NLM_p">We next investigated how the P<sub>1</sub> and P<sub>2</sub> side chains of these vinyl-2-pyridinyl inhibitors affect inhibition. The replacement of the P<sub>2</sub> Phe with Leu resulted in diminished potency (<b>18</b>, <i>K</i><sub>i</sub>* = 1.42 μM) compared to the Cbz-Phe-Phe and Cbz-Phe-hPhe scaffolds, overall demonstrating that inhibitors with bulky hydrophobic substituents in P<sub>1</sub> and P<sub>2</sub> enhanced binding to cruzain. To analyze how short alkyl and charged groups effected inhibition, we prepared Cbz-Phe-Ala-vinyl-2-pyridine (<b>19</b>) and Cbz-Phe-Lys-vinyl-2-pyridine (<b>20</b>). We found that the Cbz-Phe-Lys scaffold, which mimics our most optimal substrate, Cbz-Phe-Arg-AMC, exhibited good inhibition (<i>K</i><sub>i</sub>* = 0.87 μM), whereas <b>19</b> was a poor inhibitor (<i>K</i><sub>i</sub>* = 4.8 μM), in concert with the poor substrate activity of Cbz-Phe-Ala-AMC.</div><div class="NLM_p">Seeking to improve the electrophilicity of the vinyl-2-pyridinyl group, we prepared N-methylated analogues <b>12</b> and <b>15</b>. This modification resulted in improved aqueous solubility (≥ 50 μM in 10% DMSO) and provided potent time-dependent inhibition of cruzain (<b>12</b>, <i>K</i><sub>i</sub>* = 0.28 μM; <b>15</b>, <i>K</i><sub>i</sub>* = 0.126 μM) comparable to, or exceeding, the inhibition exerted by their unmethylated counterparts (<b>11</b> and <b>13</b>).</div><div class="NLM_p">Inhibition data for compound <b>15</b> were fitted by all methods outlined in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. We fitted each curve in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, and the resulting values of <i>k</i><sub>obs</sub> were replotted versus [<b>15</b>] (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, inset), which demonstrated a hyperbolic dependence of the inhibitor (fitting to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>: <i>K</i><sub>i</sub> = 2.0 ± 0.9 μM, <i>k</i><sub>3</sub> = 0.004 ± 0.001 s<sup>–1</sup>, and <i>k</i><sub>4</sub> ≈ 0). Alternatively, global fitting of these curves to <a class="ref internalNav" href="#eq6" aria-label="eq 6">eq 6</a> provided values of <i>K</i><sub>i</sub> = 4.3 ± 0.1 μM, <i>k</i><sub>3</sub> = 0.0012 ± 0.0004 s<sup>–1</sup>, and <i>k</i><sub>4</sub> = 0.00019 ± 0.00005 s<sup>–1</sup>, from which was calculated a value of <i>K</i><sub>i</sub>* = 0.6 ± 0.2 μM. Fitting of the data globally for <b>15</b> and other potent PVHIs using KinTek Explorer is found in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Supporting Information</a>. Preincubation of cruzain and variable concentrations of <b>15</b>, followed by initiation of the reaction by the addition of substrate, produced time courses like that shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B. These data demonstrated a significant lag phase for recovery of cruzain activity, indicative of the slow desorption of the inhibitor, with or without the formation of a covalent bond with Cys<sub>25</sub>. Finally, analysis of inhibition of cruzain by <b>15</b> at early and late phases of the time courses in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A by fitting to <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a> provided values of <i>K</i><sub>i</sub> = 0.76 ± 0.04 μM and <i>K</i><sub>i</sub>* = 0.126 ± 0.004 μM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Of note, in preincubation studies, all PVHIs, which contain the vinyl-pyridinyl substituent, displayed kinetic reversibility.</div><div class="NLM_p">We investigated five-membered ring heterocycles that are bioisosteric with acrylamide inactivators. The syntheses of vinyl-2-oxazole (<b>24</b>), vinyl-2-thiazole (<b>25</b>), and its N-methylated counterpart (<b>26</b>) into the Cbz-Phe-Phe scaffold proved facile and provided useful inhibitors. Vinyl-2-oxazole <b>24</b> was a submicromolar inhibitor of cruzain (<i>K</i><sub>i</sub>* = 0.71 μM). Vinyl-2-thiazole inhibitors <b>25</b> and <b>26</b> were inhibitors of similar potency (<i>K</i><sub>i</sub>* = 1.71 and 0.94 μM, respectively), for which N-methylation of the thiazole improved potency by nearly 2-fold.</div><div class="NLM_p last">Cruzain inhibitors <b>5</b>–<b>26</b> allowed the evaluation of six heterocyclic groups (R<sub>3</sub> = <b>IV</b>–<b>IX</b>) appended to the presumed electrophilic vinyl group within several dipeptide scaffolds. The vinyl-2-pyrimidine, vinyl-2-pyridine, vinyl-2-<i>N</i>-methylpyridinium, vinyl-2-oxazole, and vinyl-2-thiazole substituents, unlike the vinyl-4-pyrimidine and vinyl-4-pyridine heterocycles, maintained bioisosteric similarity to the reactive acrylamides and provided potent, time-dependent inhibitors in accord with our hypothesis. Of these PVHIs, 2-pyridine, charged 2-<i>N</i>-methylpyridine, and vinyl-2-pyrimidine presented the most interesting heterocycles for further exploration. The inhibition of cruzain displayed by these PVHIs may be due to the reversible formation of an adduct with active site Cys<sub>25</sub>, as is supported by the loss of time-dependent inhibition when the vinyl group is saturated. Importantly, we have no evidence that such a reversible covalent bond is formed, and ongoing studies are underway to address this point.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Selectivity of PVHIs for Cruzain over Homologous Human Cathepsins</h3><div class="NLM_p">Cruzain has 25, 15, and 23% amino acid identity with human cathepsins L, B, and S respectively.<a onclick="showRef(event, 'ref31 ref55'); return false;" href="javascript:void(0);" class="ref ref31 ref55">(31,55)</a> It is preferable to proceed with cruzain inhibitors that do not readily inhibit these human lysosomal cathepsins, which might engender cellular toxicity. We evaluated selected cruzain inhibitors versus the human cysteine proteases cathepsins L, B, and S (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). For this selectivity comparison, all inhibition data were obtained at pH 5.5 for which <i>K</i><sub>i</sub>* values were invariant for all inhibitors except compound <b>15</b> (<i>K</i><sub>i</sub>* = 88 nM). The cruzain inhibitors demonstrated moderate selectivity versus cathepsins L and S (generally, 3-fold or greater), while all of these inhibitors displayed 40-fold or higher selectivity versus cathepsin B. The vinyl-2-pyridine inhibitors <b>13</b> and <b>15</b> are particularly selective as their <i>K</i><sub>i</sub> values are over 10-fold lower than the corresponding values with the three human cathepsins. In contrast, <b>K11777</b> showed potent inactivation at nanomolar concentrations for all three human cathepsins; this apparent lack of selectivity possibly arising from its irreversible mode of inactivation. These results suggest that suitable selectivity for reversible cruzain inhibitors may be more easily attained than for irreversible ones.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzymatic Selectivity of Cruzain Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub>* (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center">cruzain</th><th class="colsep0 rowsep0" align="center">human cathepsin L</th><th class="colsep0 rowsep0" align="center">human cathepsin B</th><th class="colsep0 rowsep0" align="center">human cathepsin S</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>K11777</b></td><td class="colsep0 rowsep0" align="left">NMePip-Phe-hPhe-VSPh</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 0.2 nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 0.2 nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 5.7 nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 0.6 nM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Pyrmd</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">32 ± 3</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.02</td><td class="colsep0 rowsep0" align="left">4.3 ± 0.5</td><td class="colsep0 rowsep0" align="left">28 ± 4</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-Phe-vinyl-2PyrNMe</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.70 ± 0.04</td><td class="colsep0 rowsep0" align="left">19 ± 4</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2Pyr</td><td class="colsep0 rowsep0" align="left">0.123 ± 0.004</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">6.5 ± 0.9</td><td class="colsep0 rowsep0" align="left">1.41 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Cbz-Phe-hPhe-vinyl-2PyrNMe</td><td class="colsep0 rowsep0" align="left">0.088 ± 0.002</td><td class="colsep0 rowsep0" align="left">0.88 ± 0.06</td><td class="colsep0 rowsep0" align="left">37 ± 6</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Inhibition data obtained at pH 5.5 and 25 °C in 10% DMSO (v/v).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Reported as apparent IC<sub>50</sub> in ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effects of PVHIs in Axenic Cultures of <i>T. cruzi</i> and in a Cell Model of <i>T. cruzi</i> Infection</h3><div class="NLM_p">Initially, we tested selected compounds against epimastigotes of <i>T. cruzi</i> (strain Y, ATCC 50832GFP) in axenic cultures. As is observed here (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) and has been shown previously, <b>K11777</b> weakly inhibited the growth of <i>T. cruzi</i> epimastigotes (EC<sub>50</sub> ≈ 60 μM).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> PVHIs <b>7</b>, <b>12</b>, and <b>15</b> inhibited the growth of epimastigotes of <i>T. cruzi</i> (EC<sub>50</sub> = 2–20 μM), while <b>11</b>, <b>13</b>, and <b>24</b> were poorly effective. Compounds <b>12</b> and <b>15</b> were comparably potent against cultures of <i>T. cruzi</i> (EC<sub>50</sub> = 8.6 and 2.1 μM, respectively), and were, at a minimum, 10-fold more active than <b>K11777</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects of Cruzain Inhibitors on Trypanosome and Human Cell Growth<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">cruzain <i>K</i>i* (μM)</th><th class="colsep0 rowsep0" align="center"><i>T. cruzi</i> axenic culture EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>T. cruzi</i>-infected cardiomyoblasts (C2C12) EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>T. brucei brucei</i> PCFs EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>T. brucei brucei</i> BSFs EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">human cell cytotoxicity CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">C2C12 Cytotoxicity CC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">selectivity index CC<sub>50</sub>/EC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>K11777</b></td><td class="colsep0 rowsep0" align="left">IC50 = 2 nM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.06</td><td class="colsep0 rowsep0" align="left">60–100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.364 ± 0.004</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">9.0 ± 0.5</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.9</td><td class="colsep0 rowsep0" align="left">10.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">15 ± 2</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.31 ± 0.01</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">5 ± 1</td><td class="colsep0 rowsep0" align="left">5 ± 4</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.28 ± 0.08</td><td class="colsep0 rowsep0" align="left">8.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">9.9 ± 0.5</td><td class="colsep0 rowsep0" align="left">13 ± 3</td><td class="colsep0 rowsep0" align="left">6.6 ± 0.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.171 ± 0.004</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4 ± 2</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.126 ± 0.004</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">5.4 ± 0.9</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.71 ± 0.01</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">27 ± 5</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Effects of inhibitors were evaluated as EC<sub>50</sub> for axenic <i>T. cruzi</i>, PCFs/BSFs of <i>T. b. brucei</i> and <i>T. cruzi</i>-infected murine cardiomyoblasts. The selectivity index is the ratio of inhibitor cytotoxicity in human dermal fibroblasts (CC<sub>50</sub>)/trypanocidal activity (EC<sub>50</sub>) in infected cardiomyoblasts. ND, not determined.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>.</p></div></div></div><div class="NLM_p">Selected cruzain inhibitors were further evaluated in a more relevant cellular model of Chagas disease: <i>T. cruzi</i>-infected murine cardiomyoblasts (C2C12 cells) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Inhibitors <b>7</b>, <b>11</b>, <b>12</b>, <b>13</b>, and <b>15</b> exhibited antiparasitic efficacy at values of EC<sub>50</sub> = 5–10 μM while displaying no cytotoxicity against the host cardiomyoblasts (CC<sub>50</sub> > 10 μM). These EC<sub>50</sub> values demonstrated that the antitrypanosomal activities of the reversible PVHIs are within an order of magnitude of potency of the irreversible inactivator, <b>K11777</b> (EC<sub>50</sub> = 0.7 μM), despite the large difference in activity versus cruzain. Accordingly, the PVHIs, while reversible in action and with no apparent mammalian or human cytotoxicity, are nearly as effective as the potent, irreversible inactivator <b>K11777</b>. Further, the best of the PVHIs is less than 3-fold less potent than the currently used antichagasic drug benznidazole (LD<sub>50</sub> = 1.5 μM),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> suggesting that a second generation of PVHIs may provide clinical candidates.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A–F) Effects of cruzain inhibitors on growth of <i>T. cruzi</i>-infected murine cardiomyoblasts in which growth of inhibition of <i>T. cruzi</i> (red) is superimposed with the viability of the cardiomyoblasts (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Effects of PVHIs in Axenic Cultures of <i>T. b. brucei</i></h3><div class="NLM_p">We additionally tested our cruzain inhibitors in axenic cultures of the related protozoan <i>T. b. brucei</i> owing to the high structural similarity and reported essentiality of the cysteine protease brucipain (TbCatL) in <i>T. b. brucei</i>.<a onclick="showRef(event, 'ref24 ref34 ref57'); return false;" href="javascript:void(0);" class="ref ref24 ref34 ref57">(24,34,57)</a> It has been demonstrated that the cruzain inhibitor <b>K11777</b> is active in cellular cultures of both <i>T. b. brucei</i> and <i>T. cruzi</i>, supporting the notion that our PVHIs could be effective in growth inhibition of both species of parasite. For insect procyclic forms (PCFs) of <i>T. b. brucei</i> (ATCC PRA-381), compounds <b>7</b>, <b>9</b>, <b>11</b>, <b>12</b>, and <b>15</b> demonstrated growth inhibition at EC<sub>50</sub> values of 5–15 μM (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). When compared to <b>K11777</b> (EC<sub>50</sub> = 1.7 μM), these PVHIs exhibited potent cell growth inhibition. For example, compound <b>15</b> (EC<sub>50</sub> = 5.9 μM) was only 3-fold less potent versus <i>T. b. brucei</i> than <b>K11777</b>. Values of EC<sub>50</sub> for these PVHIs roughly correlated with their values of <i>K</i><sub>i</sub>*, with the exception of compound <b>13</b>.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell growth inhibition of <i>T. b. brucei</i>. (A) Inhibition of bloodstream forms by <b>15</b>. (B) Inhibition of bloodstream forms by <b>7</b>. (C) Inhibition of procyclic forms by <b>15</b>. (D) Correlation plot of values of EC<sub>50</sub> for trypanocidal activity versus <i>T. b. brucei</i> BSFs (closed circles, <i>r</i><sup>2</sup> = 0.979, slope = 0.80) and <i>T. cruzi</i> in murine cardiomyoblasts (open circles).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next evaluated these inhibitors in axenic cultures of human bloodstream forms (BSFs) of <i>T. b. brucei</i> (ATCC PRA-383). All PVHIs that were active versus procyclic forms of <i>T. b. brucei</i> were also trypanocidal versus the bloodstream forms but with equal or lower EC<sub>50</sub> values compared to the procyclic forms (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compared to PVHIs that had similar potencies in both PCFs and BSFs, <b>K11777</b> was nearly 20-fold more potent in <i>T. b. brucei</i> BSFs than in PCFs. These results suggested that a cathepsin L-like cysteine protease in <i>T. b. brucei</i><i>,</i> such as brucipain (or TbCatL),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> is essential for growth of procyclic and bloodstream <i>T. b. brucei</i>, but perhaps an additional cysteine protease, such as TbCatB, is also essential in BSFs of <i>T. b. brucei</i> as this enzyme is sensitive to <b>K11777</b> but not to the PVHIs. This is similar to the findings of Yang et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> who showed using an activity-based protein probe of <b>K11777</b> that TbCatB and brucipain (TbCatL) are both labeled in BSFs of <i>T. b. brucei</i> while only brucipain is labeled in PCFs. This could explain the exceptional trypanocidal activity of <b>K11777</b> in BSFs. This will be the focus of our future studies. Nonetheless, the activity of the PVHIs versus <i>T. b. brucei</i> BSFs may hold promise for progression to their evaluation in models of African trypanosomiasis.</div><div class="NLM_p last">Interestingly, the values of EC<sub>50</sub> obtained for PCFs of <i>T. b. brucei</i> and amastigotes of <i>T. cruzi</i> were nearly identical for most PVHIs despite their more modest inhibition of cruzain. Shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D is a correlation plot of log EC<sub>50</sub> for antitrypanosomal activity for bloodstream forms of <i>T. b. brucei</i> and the amastigote forms of <i>T. cruzi</i> from the murine cardiomyoblast infection model. For the former, the correlation is excellent (<i>r</i><sup>2</sup> = 0.979, slope = 0.80), and the activity against parasites is nearly a 1:1 correlation with log <i>K</i><sub>i</sub> with these inhibitors. This result provided support that our PVHIs are targeting a cruzain-like protease in <i>T. b. brucei</i><i>.</i> For <i>T. cruzi</i>, this correlation is not as strong, in part, due to the absence of a sufficient range of data. We have also compared the cytotoxicity of selected inhibitors in human dermal fibroblasts versus <i>T. cruzi</i>-infected cardiomyoblasts (selectivity index in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), which demonstrates that the PVHIs are more than 10-fold selective for trypanosomes versus human cells.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have developed a novel class of reversible inhibitors for the essential cysteine protease of <i>T. cruzi</i>, cruzain. These compounds, peptidomimetic vinyl heterocycles, contain bioisosteric replacements for the acrylamide and vinyl sulfone warheads present in irreversible, covalent inactivators such as <b>K11777</b>. We also demonstrated that PVHIs containing vinyl-2-<i>N</i>-methylpyridine or vinyl-2-<i>N</i>-methylthiazole groups, unlike other inhibitors, readily form Michael adducts with glutathione. Our survey demonstrated that the most optimal cruzain inhibitors contained vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-<i>N</i>-methylpyridinium groups. These PVHIs proved to be potent, time-dependent inhibitors of cruzain, albeit fully reversible in terms of the mode of action. These PVHIs are significantly active in both axenic cultures of <i>T. b. brucei</i> and in a cell infection model of <i>T. cruzi</i>, and further optimization may produce more potent antitrypanosomal agents. Importantly, the concept of reversible covalent inactivation by vinyl heterocycles is potentially expandable to other enzymes, which contain active site cysteines, such as EGFR, G12C K-Ras, and other protein kinases for which irreversible acrylamide inactivators comprise effective drugs.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Synthetic Chemistry Methods and Compound Characterization</h3><div class="NLM_p">All reagents and starting materials were obtained from commercial suppliers and used without further purification unless otherwise stated. Reactions were run under an atmosphere of nitrogen or argon and at ambient temperature unless otherwise noted. Reaction progress was monitored using thin-layer chromatography and by analysis employing an HPLC–MS (UltiMate 3000 equipped with a diode array coupled to an MSQ Plus single quadrupole mass spectrometer, Thermo Fisher Scientific) using electrospray positive and negative ionization detectors. Reported liquid chromatography retention times (<i>t</i><sub>R</sub>) were established using the following conditions: column: Phenomenex Luna 5 μm C18(2) 100 Å, 4.6 mm, 50 mm; mobile phase A: water with 0.1% formic acid (v/v); mobile phase B: MeCN with 0.1% formic acid (v/v); temperature: 25 °C; gradient: 0–100% B over 6 min, then a 2 min hold at 100% B; flow: 1 mL min<sup>–1</sup>; and detection: MS and UV at 254, 280, 214, and 350 nm.</div><div class="NLM_p">Semi-preparative HPLC purification of compounds was performed on a Thermo Fisher Scientific UltiMate 3000 with a single wavelength detector coupled to a fraction collector. Purifications were conducted using the following conditions: column: Phenomenex Luna 5 μm C18(2) 100 Å, 21.2 mm, 250 mm; mobile phase A: water with 0.1% formic acid (v/v); mobile phase B: MeCN with 0.1% formic acid (v/v); temperature: room temperature; gradient: 0–100% B over 30 min, then a 5 min hold at 100% B; flow: 20 mL min<sup>–1</sup>; and detection: UV (254 nm).</div><div class="NLM_p"><sup>1</sup>H/<sup>13</sup>C NMR magnetic resonance spectra were obtained in CDCl<sub>3</sub>, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> at 400 MHz/100 MHz at 298 K on a Bruker AVANCE III Nanobay console with an Ascend magnet unless otherwise noted. The following abbreviations were utilized to describe peak patterns when appropriate: br = broad, s = singlet, d = doublet, q = quartet, t = triplet, and m = multiplet. All final compounds used for testing in assays and biological studies had purities that were determined to be >95% as evaluated by their proton NMR spectra and their HPLC/MS based on ultraviolet detection at 254 nm (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Supporting Information</a>). Similar RP-HPLC conditions were used for the experiments of GSH addition to vinyl heterocycles. Masses detected were in the range of 100–1000 Da and were detected in the positive or negative mode, depending on the ionization of the molecule.</div><div class="NLM_p">General procedures (GP1–GP10 in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) of synthesizing PVHIs are detailed below. Each GP described the synthesis of one representative compound. In addition, substrate synthesis and characterization are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> GP1: Synthesis of Weinreb Amides (<b>a</b> to <b>b</b>)</h4><div class="NLM_p last">A solution of Boc-<span class="smallcaps smallerCapital">l</span>-homophenylalanine (12.02 g, 43.03 mmol) in anhydrous DCM (200 mL) was cooled to 0 °C under a N<sub>2</sub> atmosphere. Et<sub>3</sub>N (18.1 mL, 129.09 mmol, 3 equiv) was added slowly, followed by the addition of <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride (6.3 g, 64.5 mmol, 1.5 equiv) and dropwise addition of T3P (50% (w/v) in MeCN, 41.1 mL, 64.55 mmol, 1.5 equiv). The resulting mixture was stirred at 0 °C for 30 min to 1 h until TLC analysis (EtOAc/hexane = 1:1, v/v) showed the disappearance of the starting material. The reaction mixture was diluted with DCM and washed with H<sub>2</sub>O. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude product. Purification of the crude product by silica gel column chromatography using a gradient of 5–50% of EtOAc in hexane as the eluent yielded the pure Weinreb amide <i>tert</i>-butyl (<i>S</i>)-(1-(methoxy(methyl)amino)-1-oxo-4-phenylbutan-2-yl)carbamate (<b>b</b>, 13.3 g, 41.31 mmol, 96% yield) as a colorless gum.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> GP2: LAH Reduction of Weinreb Amides (<b>b</b> to <b>c</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>S</i>)-(1-(methoxy(methyl)amino)-1-oxo-4-phenylbutan-2-yl)carbamate (<b>b</b>, 6.7 g, 20.78 mmol) in anhydrous THF (120 mL) at −10 °C under a N<sub>2</sub> atmosphere was added dropwise LAH (2.0 M in THF, 12.5 mL, 24.93 mmol, 1.2 equiv). The resulting mixture was stirred at −10 °C for 30 min. Upon completion of the reaction as shown by TLC analysis (EtOAc/hexane = 1:1, v/v), the reaction was quenched at the same temperature by adding dropwise 1 N HCl, followed by removal of THF by rotary evaporation. Diethyl ether (500 mL) was added to the solid residue, and the solution was washed with aqueous NaHCO<sub>3</sub> (1 × 50 mL) and brine (1 × 50 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude product. Purification of the crude material by silica gel column chromatography using a gradient of 10–60% of EtOAc in hexane as the eluent yielded the pure aldehyde <i>tert</i>-butyl (<i>S</i>)-(1-oxo-4-phenylbutan-2-yl)carbamate (<b>c</b>, 4.89 g, 18.57 mmol, 89% yield) as a white solid.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> GP3: Preparation of Chloromethyl Heterocycles (<b>d</b> to <b>e</b>)</h4><div class="NLM_p last">To a suspension of methyl pyrimidine-2-carboxylate (<b>d</b>, 1.156 g, 8.37 mmol) in anhydrous EtOH (20 mL) at 0 °C under a N<sub>2</sub> atmosphere was added portionwise NaBH<sub>4</sub> (0.443 g, 11.72 mmol, 5 equiv). The reaction mixture was stirred at 25 °C for 2 h. Upon completion of the reaction as shown by TLC analysis (EtOAc/hexane = 1:1, v/v), the reaction solvents were removed by rotary evaporation. To the resultant colorless gummy residue was added ice cold H<sub>2</sub>O (20 mL) followed by extraction with DCM (5 × 50 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude product pyrimidin-2-yl-methanol (0.900 g, 8.17 mmol). To this pyrimidin-2-yl-methanol in CHCl<sub>3</sub> (20 mL) at 0 °C under a N<sub>2</sub> atmosphere was added dropwise POCl<sub>3</sub> (1.95 mL, 3.21 g, 2.5 equiv). The reaction mixture was stirred at 25 °C for 1 h, followed by refluxing for an additional 3 h under gentle heating until TLC analysis (EtOAc/hexane = 3:1, v/v) showed the completion of the reaction. The reaction was quenched by a careful addition of aqueous NaHCO<sub>3</sub> and further addition of solid NaHCO<sub>3</sub> to afford a basic pH. The aqueous layer was extracted with CHCl<sub>3</sub> (3 × 50 mL), and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the pure product 2-(chloromethyl)pyrimidine (<b>e</b>, 0.948 g, 7.43 mmol, 63% yield) as a light yellow semi-solid, which was used further without any purification.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> GP4: Preparation of Heterocyclic Phosphonium Ylides (<b>e</b> to <b>f</b>, Wittig Reagents)</h4><div class="NLM_p last">A mixture of 2-(chloromethyl)pyrimidine (<b>e</b>, 0.92 g, 7.22 mmol) and triphenylphosphine (2.1 g, 7.94 mmol, 1.1 equiv) in anhydrous benzene (25 mL) was refluxed under a N<sub>2</sub> atmosphere for 24 h until TLC analysis (MeOH/DCM = 1:19, v/v) showed the completion of the reaction. The reaction mixture was concentrated via rotary evaporation, and the gummy residue was triturated with diethyl ether (3 × 10 mL). The solid obtained was purified by silica gel column chromatography using a gradient of 1–10% of MeOH in DCM as the eluent to afford the pure product triphenyl(pyrimidin-2-ylmethyl)phosphonium chloride (<b>g</b>, 0.797 g, 2.039 mmol, 28% yield).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> GP5: Preparation of Heterocyclic Phosphonates (<b>e</b> to <b>g</b>, HWE Reagents)</h4><div class="NLM_p last">2-(Chloromethyl)pyridine hydrochloride (<b>e</b>, 16.5 g, 100.6 mmol) in DCM (100 mL) was treated with aqueous NaHCO<sub>3</sub> (20 mL), and the DCM layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The filtrate was concentrated by rotary evaporation. The alkyl halide thus obtained along with triethyl phosphite (35 mL, 201.2 mmol, 2.0 equiv) was heated at 150 °C under a N<sub>2</sub> atmosphere for 5 h until TLC analysis (MeOH/DCM = 1:19, v/v) showed the completion of the reaction. The reaction mixture was purified by silica gel column chromatography using a gradient of 10–100% of EtOAc in hexane and later 1–10% of MeOH in DCM as the eluent to yield the pure product 2-pyridyl methyl phosphonate (<b>g</b>, 18.26 g, 79.66 mmol, 79% yield).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> GP6: Wittig Reaction (<b>c</b> + <b>f</b> to <b>h</b>)</h4><div class="NLM_p last">To a suspension of the Wittig reagent triphenyl(pyrimidin-2-ylmethyl)phosphonium chloride (<b>f</b>, 0.719 g, 1.839 mmol) in anhydrous THF (40 mL) at −70 °C under a N<sub>2</sub> atmosphere was added dropwise LHMDS (1.0 M in THF, 2.03 mL, 2.024 mmol, 1.1 equiv), which was stirred at the same temperature for 15 min. To this mixture a solution of Boc-Phe-H (<b>c</b>, 0.321 g, 1.287 mmol, 0.7 equiv) in THF (10 mL) was added and stirred over 2 h until the temperature reached −40 °C. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), the reaction was quenched by the addition of 0.1 mL of glacial acetic acid, followed by aqueous NaHCO<sub>3</sub>. Most of the THF was removed carefully using a rotary evaporator, and the residue was extracted with EtOAc (2×). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude material, which was purified by silica gel column chromatography using a gradient of 5–30% of EtOAc in hexane as the eluent, yielding the pure olefin <i>tert</i>-butyl (<i>S</i>,<i>E</i>)-(1-phenyl-4-(pyrimidin-2-yl)but-3-en-2-yl)carbamate (<i>h</i>, <i>E</i> isomer, 0.060 g, 14% yield). The other <i>Z</i> isomer (0.014 g) was isolated as a side product, and the ratio of <i>E</i> to <i>Z</i> isomers was typically 4:1.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> GP7: Horner–Wadsworth–Emmons Reaction (<b>c</b> + <b>g</b> to <b>h</b>)</h4><div class="NLM_p last">To a solution of the 2-pyridyl methyl phosphonate ester (<b>g</b>, 1.30 g, 5.65 mmol) in anhydrous THF (25 mL) at −70 °C under a N<sub>2</sub> atmosphere was added dropwise LHMDS (1.0 M in THF, 6.22 mL, 6.22 mmol, 1.1 equiv). The reaction was stirred at the same temperature for 15 min, followed by the dropwise addition of a solution of Boc-hPhe-H (<b>c</b>, 1.34 g in 10 mL THF, 5.09 mmol, 0.9 equiv). The reaction was stirred until it reached a temperature of −20 °C over 2 h. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), to the reaction mixture at 0 °C was added glacial acetic acid (0.5 mL), followed by the addition of 20 mL of saturated NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc (3 ×100 mL). Extracts were washed with brine (1 × 50 mL), and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude product, which was purified by silica gel column chromatography using a gradient of 10–50% of EtOAc in hexane as the eluent to yield the pure product <i>tert</i>-butyl (<i>S</i>,<i>E</i>)-(5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)carbamate (<b>h</b>, 0.344 g, 1.016 mmol, 20% yield).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> GP8: Amide Coupling with P<sub>3</sub>–P<sub>2</sub> Fragment (<b>h</b> to <b>j</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>S</i>,<i>E</i>)-(5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)carbamate (<b>h</b>, 0.143 g, 0.423 mmol) in anhydrous DCM (5 mL) at 0 °C was added dropwise TFA (1.5 mL in 1 mL DCM) with stirring at the same temperature for 1 h. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), the reaction solvent was removed by a rotary evaporator. The resulting oil was coevaporated on a rotary evaporator with CHCl<sub>3</sub> (3×) and ether (3×). The solid product was dried on high vacuum to yield the TFA salt (<i>S</i>,<i>E</i>)-5-phenyl-1-(pyridin-2-yl)pent-1-en-3-aminium trifluoroacetate (0.149 g, 0.423 mmol), which was used in subsequent synthetic steps without further purification. To a solution of the above TFA salt in anhydrous DCM (5 mL) at −10 °C under a N<sub>2</sub> atmosphere was added dropwise DIPEA (0.6 mL, 0.3.44 mmol, 8 equiv), followed by the addition of Cbz-Phe-OH (0.13 g, 0.43 mmol, 1 equiv) and T3P (50% in EtOAc, 0.41 mL, 1.5 equiv). The reaction was stirred at 0 °C for an additional 1 h. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), the reaction mixture was diluted with DCM (50 mL) and then washed with H<sub>2</sub>O (3×) and brine (3×). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo to afford the crude product, which was purified by silica gel column chromatography using a gradient of 10–50% of EtOAc in hexane as the eluent to yield the pure product benzyl ((<i>S</i>)-1-oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)carbamate (<b>i</b>, 0.113 g, 0.217 mmol, 51% yield).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> GP9: N-Methylation Using Methyl Iodide (<b>i</b> to <b>j</b>)</h4><div class="NLM_p last">To a suspension of benzyl ((<i>S</i>)-1-oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(pyridin-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>i</b>, 0.049 g, 0.098 mmol) in anhydrous MeCN (5 mL) under a N<sub>2</sub> atmosphere was added MeI (0.03 mL, 0.490 mmol, 5 equiv), and the reaction mixture was heated under reflux for 9 h. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), the solvents were removed by rotary evaporation. The resulting gummy residue was dissolved in CHCl<sub>3</sub> (1 mL) and precipitated with ether (5 mL). The solvents were decanted, and this procedure was repeated twice. The solid obtained was dried under high vacuum to give pure product 2-((<i>S</i>,<i>E</i>)-3-((<i>S</i>)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-4-phenylbut-1-en-1-yl)-1-methylpyridin-1-ium iodide as a yellow solid (<b>j</b>, 0.039 g, 61% yield).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> GP10: Preparation of Peptide Acrylamide (<b>i</b> to <b>k</b>)</h4><div class="NLM_p last">A solution of ethyl (<i>S,E</i>)-4-((<i>S</i>)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-5-phenylpent-2-enoate (<b>i</b>, 0.346 g, 0.69 mmol) in THF (6 mL) at 0 °C was treated with LiOH (1 N in H<sub>2</sub>O, 0.83 mL, 0.83 mmol, 1.2 equiv) and stirred overnight. The reaction was concentrated by rotary evaporation, and the aqueous layer was added to water, acidified to pH 1–2, and extracted with EtOAc (3×). The combined organic layers were dried and concentrated to yield the crude acrylic acid. To a solution of this acrylic acid (0.124 g, 0.262 mmol) in THF (6 mL) at −15 °C were added Et<sub>3</sub>N (0.11 mL, 0.787 mmol, 3 equiv) and the dropwise addition of ClCO<sub>2</sub>Et (0.035 mL, 0.367 mmol), which resulted in a white precipitate. The reaction mixture was stirred at the same temperature for an additional 30 min, and then aqueous 1 M NH<sub>4</sub>Cl (0.4 mL) was added dropwise with continuous stirring over 3 h until a temperature of 25 °C was attained. Upon completion of the reaction as revealed by TLC analysis (EtOAc/hexane = 1:1, v/v), most of the reaction solvent was removed using a rotary evaporator, and the solid residue was extracted with EtOAc. The organic layer was washed with aqueous NaHCO<sub>3</sub> (2×), H<sub>2</sub>O (1×), and brine (1×), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo to afford the crude product. Purification of the crude product by silica gel chromatography using a gradient of 20–100% of EtOAc in hexane as the eluent yielded the pure product benzyl ((<i>S</i>)-1-(((<i>S,E</i>)-5-amino-5-oxo-1-phenylpent-3-en-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (0.027 g, 0.057 mmol, 22% yield).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-Methyl-<i>N</i>-((<i>S</i>)-1-oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(phenylsulfonyl)but-3-en-2-yl)amino)propan-2-yl)piperazine-1-carboxamide (<b>1</b>, Cbz-Phe-Phe-VSPh)</h4><div class="NLM_p last">White solid, 0.115 g, 0.202 mmol, 56% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.79 (d, <i>J</i> = 6.8 Hz, 2H), 2.85–3.12 (m, 2H), 4.26 (q, <i>J</i> = 7.3 Hz, 1H), 4.79–4.95 (m, 1H), 5.04 (s, 2H), 5.13 (s, 1H), 5.75 (s, 1H), 5.96 (dd, <i>J</i><sub>1</sub> = 1.8 Hz, <i>J</i><sub>2</sub> = 15.1 Hz, 1H), 6.78 (dd, <i>J</i><sub>1</sub> = 4.8 Hz, <i>J</i><sub>2</sub> = 15.1 Hz, 1H), 6.95–7.03 (m, 2H), 7.05–7.11 (m, 2H), 7.12–7.23 (m, 6H), 7.27–7.39 (m, 5H), 7.47–7.56 (m, 2H), 7.57–7.67 (m, 1H), 7.72–7.84 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.4, 40.3, 50.4, 56.7, 67.4, 127.3, 127.4, 127.8, 128.2, 128.5, 128.7 (2C), 128.8, 129.0, 129.3, 129.4, 131.1, 133.6, 135.5, 136.1, 136.2, 140.2, 144.6, 156.0, 170.5. LC–MS <i>m/z</i>: 569.31 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>32</sub>N<sub>2</sub>O<sub>5</sub>S<sup>+</sup>, 569.21); <i>t</i><sub>R</sub> = 7.27 min.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-5-Amino-5-oxo-1-phenylpent-3-en-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>2</b>, Cbz-Phe-Phe-vinyl-CONH<sub>2</sub>)</h4><div class="NLM_p last">White solid, 0.027 g, 0.057 mmol, 22% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.64–2.77 (m, 1H), 2.84 (d, <i>J</i> = 7.2 Hz, 2H), 2.96 (dd, <i>J</i><sub>1</sub> = 3.9 Hz, <i>J</i><sub>2</sub> = 13.7 Hz, 1H), 4.19–4.31 (m, 1H), 4.62 (pentet, <i>J</i> = 6.8 Hz, 1H), 4.95 (s, 1H), 5.85 (d, <i>J</i> = 15.5 Hz, 1H), 6.56 (dd, <i>J</i><sub>1</sub> = 5.9 Hz, <i>J</i><sub>2</sub> = 15.5 Hz, 1H), 6.93 (s, 1H), 7.12–7.46 (m, 17H), 8.25 (d, <i>J</i> = 8.2 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 28.7, 37.6, 50.9, 56.07, 65.1, 124.1, 126.2, 126.4, 127.4, 127.6, 127.9, 128.1, 128.2, 129.2, 129.5, 137.0, 137.8, 138.0, 142.0, 155.6, 166.2, 170.7. LC–MS <i>m/z</i>: 472.46 [M + H]<sup>+</sup> (calcd for C<sub>28</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup>, 472.22); <i>t</i><sub>R</sub> = 4.71 min.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-6-Amino-6-oxo-1-phenylhex-4-en-3-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>3</b>, Cbz-Phe-hPhe-vinyl-CONH<sub>2</sub>)</h4><div class="NLM_p last">White solid, 0.013 g, 0.027 mmol, 15% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.64–1.92 (m, 2H), 2.54–2.72 (m, 2H), 2.81 (dd, <i>J</i><sub>1</sub> = 10.6 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 3.03 (dd, <i>J</i><sub>1</sub> = 4.0 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 4.25–4.33 (m, 1H), 4.35–4.43 (m, 1H), 4.85–5.04 (m, 2H), 5.90 (d, <i>J</i> = 15.5 Hz, 1H), 6.54 (dd, <i>J</i><sub>1</sub> = 5.7 Hz, <i>J</i><sub>2</sub> = 15.5 Hz, 1H), 6.94 (s, 1H), 7.15–7.35 (m, 15H), 7.41 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 8.22 (d, <i>J</i> = 8.2 Hz, 1H). LC–MS <i>m/z</i>: 486.24 [M + H]<sup>+</sup> (calcd for C<sub>29</sub>H<sub>31</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup>, 486.24); <i>t</i><sub>R</sub> = 4.89 min.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-6-Amino-6-oxo-1-phenylhex-4-en-3-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methylpiperazine-1-carboxamide (<b>4</b>, NMePip-Phe-hPhe-vinyl-CONH<sub>2</sub>)</h4><div class="NLM_p last">White solid, 0.022 g, 0.048 mmol, 18% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.66–1.91 (m, 2H), 2.23 (s, 3H), 2.25–2.34 (m, 4H), 2.50–2.64 (m, 2H), 2.99–3.15 (m, 2H), 3.25–3.41 (m, 4H), 4.44–4.57 (m, 1H), 4.62 (q, <i>J</i> = 7.4 Hz, 1H), 5.37 (d, <i>J</i> = 7.6 Hz, 1H), 5.60 (dd, <i>J</i><sub>1</sub> = 1.3 Hz, <i>J</i><sub>2</sub> = 15.3 Hz, 1H), 5.75 (s, 1H), 6.01 (s, 1H), 6.62 (dd, <i>J</i><sub>1</sub> = 5.5 Hz, <i>J</i><sub>2</sub> = 15.3 Hz, 1H), 6.93 (d, <i>J</i> = 8.2 Hz, 1H), 7.04–7.31 (m, 11H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 32.0, 36.1, 38.5, 43.9, 46.1, 49.9, 54.6, 56.2, 122.9, 126.2, 126.9, 128.5, 128.6, 128.8, 129.7, 137.3, 141.1, 144.4, 157.3, 167.5, 172.0. LC–MS <i>m/z</i>: 478.36 [M + H]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub><sup>+</sup>, 478.28); <i>t</i><sub>R</sub> = 2.54 min.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-1,4-Diphenylbut-3-en-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>5</b>, Cbz-Phe-Phe-vinyl-Ph)</h4><div class="NLM_p last">Off-white solid, 0.054 g, 0.107 mmol, 35% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.87 (dt, <i>J</i> = 2.8, 6.3 Hz, 2H), 2.96–3.16 (m, 2H), 4.35 (q, <i>J</i> = 7.6 Hz, 1H), 4.80–4.96 (m, 1H), 5.29 (d, <i>J</i> = 9.6 Hz, 1H), 5.69 (d, <i>J</i> = 9.9 Hz, 1H), 5.94 (ddt, <i>J</i> = 3.0, 6.3, 15.9 Hz, 1H), 6.27 (d, <i>J</i> = 15.9 Hz, 1H), 7.03–7.14 (m, 2H), 7.14–7.28 (m, 10H), 7.28–7.40 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 29.7, 38.6, 41.3, 51.8, 67.1, 126.4, 126.6, 127.1, 127.6, 128.0, 128.2, 128.3, 128.4, 128.5, 128.7, 129.3, 129.4, 130.9, 136.5, 136.8, 169.8. LC–MS <i>m/z</i>: 505.31 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>, 505.25); <i>t</i><sub>R</sub> = 6.20 min.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-4-(4-Nitrophenyl)-1-phenylbut-3-en-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>6</b>, Cbz-Phe-Phe-vinyl-(4-NO<sub>2</sub>)Ph)</h4><div class="NLM_p last">White fluffy solid, 0.530 g, 0.964 mmol, 55% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.76 (dd, <i>J</i><sub>1</sub> = 9.7 Hz, <i>J</i><sub>2</sub> = 13.4 Hz, 1H), 2.85–2.97 (m, 3H), 4.18–4.35 (m, 1H), 4.68 (pentet, <i>J</i> = 6.7 Hz, 1H), 4.99 (s, 2H), 6.41 (d, <i>J</i> = 16.1 Hz, 1H), 6.50 (dd, <i>J</i><sub>1</sub> = 5.4 Hz, <i>J</i><sub>2</sub> = 16.1 Hz, 1H), 7.13–7.37 (m, 15H), 7.42 (d, <i>J</i> = 8.5 Hz, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 8.14–8.25 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 37.7, 39.0, 51.9, 56.2, 65.2, 123.9, 126.1, 126.2, 127.0, 127.4, 127.6, 127.9, 128.0, 128.1, 128.2, 129.2, 129.3, 135.6, 137.0, 137.8, 138.0, 143.3, 146.2, 155.6, 170.6. LC–MS <i>m/z</i>: 550.28 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup>, 550.23); <i>t</i><sub>R</sub> = 6.12 min.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(pyrimidin-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>7</b>, Cbz-Phe-Phe-vinyl-2Pyrmd)</h4><div class="NLM_p last">White solid, 0.026 g, 0.0513 mmol, 33% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.73–2.96 (m, 2H), 3.01 (d, <i>J</i> = 4.8 Hz, 2H), 4.23–4.50 (m, 1H), 4.91–5.02 (m, 1H), 5.05 (s, 2H), 5.30 (s, 1H), 6.05 (s, 1H), 6.48 (d, <i>J</i> = 15.7 Hz, 1H), 7.00 (dd, <i>J</i><sub>1</sub> = 5.6 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.05–7.37 (m, 16H), 8.63 (d, <i>J</i> = 4.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.6, 41.0, 51.6, 56.5, 67.3, 119.0, 126.9, 127.2, 128.2, 128.3, 128.6, 128.7, 128.9, 129.4, 129.5, 130.3, 136.3. 136.5, 136.7, 139.2, 156.1, 157.1, 164.2, 170.3. LC–MS <i>m/z</i>: 507.26 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 507.24); <i>t</i><sub>R</sub> = 5.14 min.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyrimidin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)carbamate (<b>8</b>, Cbz-Phe-hPhe-vinyl-2Pyrmd)</h4><div class="NLM_p last">Off-white solid, 0.280 g, 0.538 mmol, 29% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.76–2.03 (m, 2H), 2.63 (t, <i>J</i> = 7.9 Hz, 2H), 3.10 (t, <i>J</i> = 8.4 Hz, 2H), 4.47 (s, 1H), 4.74 (h, <i>J</i> = 7.3 Hz, 1H), 5.10 (d, <i>J</i> = 7.9 Hz, 2H), 5.53 (s, 1H), 6.27 (s, 1H), 6.56–6.72 (m, 1H), 6.96–7.05 (m, 1H), 7.06–7.14 (m, 3H), 7.19 (d, <i>J</i> = 7.3 Hz, 3H), 7.21–7.34 (m, 10H), 8.66 (dd, <i>J</i> = 4.9, 15.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.0, 36.2, 38.6, 50.5, 56.6, 67.1, 118.9, 126.0, 127.0, 128.0, 128.1, 128.3, 128.4, 128.5, 128.7, 128.8, 129.3, 129.4, 130.1, 136.4, 139.6, 141.2, 156.9, 164.1, 170.3. LC–MS <i>m/z</i>: 521.24 [M + H]<sup>+</sup> (calcd for C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 521.26); <i>t</i><sub>R</sub> = 5.56 min.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-Methyl-<i>N</i>-((<i>S</i>)-1-oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyrimidin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)piperazine-1-carboxamide (<b>9</b>, NMePip-Phe-hPhe-vinyl-2Pyrmd)</h4><div class="NLM_p last">Off-white gum, 0.054 g, 0.105 mmol, 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.82–1.99 (m, 2H), 2.29 (s, 3H), 2.34–2.46 (m, 4H), 2.61 (t, <i>J</i> = 7.5 Hz, 1H), 3.09 (d, <i>J</i> = 7.5 Hz, 2H), 3.39 (s, 4H), 4.58–4.74 (m, 2H), 5.47 (d, <i>J</i> = 6.3 Hz, 1H), 6.61 (d, <i>J</i> = 15.7 Hz, 1H), 6.87 (d, <i>J</i> = 8.2 Hz, 1H), 6.98 (dd, <i>J</i><sub>1</sub> = 6.3 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.06–7.31 (m, 11H), 8.66 (d, <i>J</i> = 4.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.1, 36.5, 38.8, 43.5, 45.6, 50.6, 54.3, 56.1, 118.9, 126.0, 126.9, 128.4, 128.5 (2C), 128.6, 129.6, 130.1, 137.2, 140.1, 141.3, 157.0, 164.3, 171.8. LC–MS <i>m/z</i>: 513.17 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>36</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup>, 513.30); <i>t</i><sub>R</sub> = 2.96 min.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-4-(pyrimidin-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>10</b>, Cbz-Phe-Ala-vinyl-2Pyrmd)</h4><div class="NLM_p last">White fluffy solid, 0.017 g, 0.039 mmol, 14% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + MeOD): δ 1.32 (d, <i>J</i> = 6.6 Hz, 3H), 2.96 (dd, <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 3.10 (dd, <i>J</i><sub>1</sub> = 6.4 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 4.36–4.44 (m, 4H), 4.71 (pentet, <i>J</i> = 6.4 Hz, 1H), 4.97–5.12 (m, 2H), 6.52 (d, <i>J</i> = 15.7 Hz, 1H), 6.98 (dd, <i>J</i><sub>1</sub> = 5.8 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.13–7.36 (m, 11H), 8.70 (d, <i>J</i> = 4.9 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> + MeOD): δ 19.6, 38.7, 46.1, 56.1, 66.7, 119.0, 126.7, 127.6, 127.9, 128.1, 128.3 (2C), 129.2, 136.3, 141.6, 156.9 (2C), 157.0, 163.9, 171.0. LC–MS <i>m/z</i>: 430.91 [M + H]<sup>+</sup> (calcd for C<sub>25</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 431.21); <i>t</i><sub>R</sub> = 4.68 min.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(pyridin-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>11</b>, Cbz-Phe-Phe-vinyl-2Pyr)</h4><div class="NLM_p last">White solid, 0.554 g, 1.096 mmol, 81% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.87 (dq, <i>J</i><sub>1</sub> = 6.8 Hz, <i>J</i><sub>2</sub> = 13.7 Hz, 1H), 3.01 (d, <i>J</i> = 7.1 Hz, 2H), 4.35 (q, <i>J</i> = 7.0 Hz, 1H), 4.91 (pentet, <i>J</i> = 6.8 Hz, 1H), 5.06 (s, 2H), 5.24 (s, 1H), 5.88 (d, <i>J</i> = 8.4 Hz, 1H), 6.32 (d, <i>J</i> = 15.7 Hz, 1H), 6.58 (dd, <i>J</i><sub>1</sub> = 6.1 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.08–7.36 (m, 17H), 7.59 (dt, <i>J</i><sub>1</sub> = 1.6 Hz, <i>J</i><sub>2</sub> = 7.7 Hz, 1H), 8.53 (d, <i>J</i> = 4.3 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.4, 41.1, 51.7, 56.4, 67.1, 122.1, 122.2, 126.7, 127.0, 128.0, 128.2, 128.4, 128.5 (2C), 128.8, 129.4 (2C), 130.5, 133.0, 136.1, 136.4, 136.8, 149.5, 154.8, 155.9, 170.0. LC–MS <i>m/z</i>: 506.24 [M + H]<sup>+</sup> (calcd for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 506.24); <i>t</i><sub>R</sub> = 4.39 min.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-((<i>S</i>,<i>E</i>)-3-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)-4-phenylbut-1-en-1-yl)-1-methylpyridin-1-ium Iodide (<b>12</b>, Cbz-Phe-Phe-Vinyl-2PyrNMe)</h4><div class="NLM_p last">Yellow solid, 0.039 g, 0.060 mmol, 61% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.01–3.15 (m, 3H), 3.19 (dd, <i>J</i><sub>1</sub> = 7.7 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 4.19 (s, 3H), 4.51 (q, <i>J</i> = 7.0 Hz, 1H), 4.90–5.02 (m, 2H), 5.06 (s, 1H), 5.81 (s, 1H), 6.69 (d, <i>J</i> = 15.7 Hz, 1H), 6.86 (dd, <i>J</i><sub>1</sub> = 4.6 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.08–7.28 (m, 14H), 7.65–7.79 (m, 2H), 7.89–8.01 (m, 1H), 8.21–8.31 (m, 1H), 8.97–9.09 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.1, 39.8, 47.5, 52.6, 57.1, 66.8, 119.9, 126.1, 126.3, 126.9, 127.1, 127.5, 127.6, 127.9, 128.5, 128.6, 128.8, 129.6, 129.7, 136.7, 136.9, 144.9, 146.0, 147.6, 152.8, 156.2, 171.5. LC–MS <i>m/z</i>: 520.32 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 520.26); <i>t</i><sub>R</sub> = 3.25 min.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)carbamate (<b>13</b>, Cbz-Phe-hPhe-vinyl-2Pyr)</h4><div class="NLM_p last">White solid, 0.113 g, 0.217 mmol, 51% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.73–1.95 (m, 2H), 2.59 (t, <i>J</i> = 7.9 Hz, 2H), 3.04 (d, <i>J</i> = 7.0 Hz, 2H), 4.38–4.52 (m, 1H), 4.65 (pentet, <i>J</i> = 7.1 Hz, 1H), 5.03 (s, 2H), 5.59 (d, <i>J</i> = 6.4 Hz, 1H), 6.34 (d, <i>J</i> = 5.1 Hz, 1H), 6.43 (d, <i>J</i> = 15.7 Hz, 1H), 6.53 (dd, <i>J</i><sub>1</sub> = 6.2 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.02–7.32 (m, 17H), 7.57 (dt, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 7.7 Hz, 1H), 8.51 (d, <i>J</i> = 4.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.1, 36.4, 38.7, 50.8, 56.6, 67.1, 122.1, 122.3, 126.0, 127.0, 128.0, 128.2, 128.4, 128.5 (2C), 128.7, 129.5, 130.5, 133.8, 136.2, 136.5 (2C), 141.4, 149.5, 155.0, 156.1, 170.4. LC–MS <i>m/z</i>: 518.74, 520.41 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 520.26); <i>t</i><sub>R</sub> = 4.68 min.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-Methyl-<i>N</i>-((<i>S</i>)-1-oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)piperazine-1-carboxamide (<b>14</b>, NMePip-Phe-hPhe-vinyl-2Pyr)</h4><div class="NLM_p last">Off-white solid, 0.090 g, 0.176 mmol, 44% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.77–1.94 (m, 2H), 2.21 (s, 3H), 2.22–2.27 (m, 4H), 2.59 (t, <i>J</i> = 8.0 Hz, 2H), 3.08 (d, <i>J</i> = 7.0 Hz, 2H), 3.28 (m, 4H), 4.61 (pentet, <i>J</i> = 7.3 Hz, 1H), 4.7 (q, <i>J</i> = 7.3 Hz, 1H), 5.39 (d, <i>J</i> = 7.7 Hz, 1H), 6.46 (d, <i>J</i> = 15.8 Hz, 1H), 6.56 (dd, <i>J</i><sub>1</sub> = 6.2 Hz, <i>J</i><sub>2</sub> = 15.8 Hz, 1H), 6.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.06–7.24 (m, 12H), 7.59 (dt, <i>J</i><sub>1</sub> = 1.8 Hz, <i>J</i><sub>2</sub> = 7.7 Hz, 1H), 8.53 (d, <i>J</i> = 4.3 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.1, 36.6, 39.0, 43.8, 46.1, 50.7, 54.6, 55.9, 122.0, 122.2, 125.9, 126.8, 128.4 (2C), 128.5, 129.6, 130.3, 134.2, 136.4, 137.2, 141.4, 149.5, 155.1, 157.0, 171.6. LC–MS <i>m/z</i>: 512.28 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub><sup>+</sup>, 512.30); <i>t</i><sub>R</sub> = 2.60 min.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-((<i>S</i>,<i>E</i>)-3-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)-5-phenylpent-1-en-1-yl)-1-methylpyridin-1-ium (<b>15</b>, Cbz-Phe-hPhe-vinyl-2PyrNMe)</h4><div class="NLM_p last">Yellow solid, 0.029 g, 0.044 mmol, 89% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.98–2.10 (m, 1H), 2.11–2.25 (m, 1H), 2.56–2.85 (m, 2H), 3.04–3.35(m, 2H), 4.22 (s, 3H), 4.62 (d, <i>J</i> = 5.5 Hz, 1H), 4.79 (s, 1H), 4.92–5.09 (m, 2H), 5.88 (s, 1H), 6.70 (d, <i>J</i> = 15.8 Hz, 1H), 6.77 (dd, <i>J</i><sub>1</sub> = 3.6 Hz, <i>J</i><sub>2</sub> = 15.8 Hz, 1H), 7.09–7.34 (m, 14H), 7.66–7.79 (m, 2H), 7.90 (d, <i>J</i> = 6.0 Hz, 1H), 8.17–8.30 (m, 1H), 8.98 (d, <i>J</i> = 4.5 Hz, 1H). LC–MS <i>m/z</i>: 534.25 [M + H]<sup>+</sup> (calcd for C<sub>34</sub>H<sub>36</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 534.28); <i>t</i><sub>R</sub> = 3.48 min.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-1-(4-Methoxypyridin-2-yl)-5-phenylpent-1-en-3-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>16</b>, Cbz-Phe-hPhe-vinyl-2-(4-OMe)-Pyr)</h4><div class="NLM_p last">Pale yellow solid, 0.072 g, 0.131 mmol, 33% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.73–2.01 (m, 2H), 2.59 (dt, <i>J</i> = 7.9, 37.9 Hz, 2H), 3.11 (dd, <i>J</i> = 7.0, 11.7 Hz, 2H), 3.87 (d, <i>J</i> = 9.2 Hz, 3H), 4.50 (dd, <i>J</i> = 7.6, 23.1 Hz, 1H), 4.68 (t, <i>J</i> = 7.1 Hz, 1H), 5.08 (d, <i>J</i> = 4.6 Hz, 2H), 5.74 (dd, <i>J</i> = 8.1, 65.8 Hz, 1H), 6.39–6.58 (m, 1H), 6.67–6.81 (m, 2H), 7.11–7.15 (m, 2H), 7.16–7.26 (m, 8H), 7.27–7.34 (m, 7H), 8.37 (dd, <i>J</i> = 5.8, 23.3 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.0, 36.3, 38.7, 50.6, 55.2, 56.5, 67.1, 108.3, 108.5, 126.0, 126.6, 127.0, 127.9, 128.0, 128.1, 128.1, 128.3, 128.4, 128.4, 128.4, 128.5, 128.5, 128.7, 129.4, 129.4, 134.7, 135.1, 136.5, 141.3, 150.0, 156.1, 166.6, 170.3. LC–MS <i>m/z</i>: 550.16 [M + H]<sup>+</sup> (calcd for C<sub>34</sub>H<sub>35</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup>, 549.26); <i>t</i><sub>R</sub> = 3.57 min.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(4-(trifluoromethyl)pyridin-2-yl)pent-1-en-3-yl)amino)propan-2-yl)carbamate (<b>17</b>, Cbz-Phe-hPhe-vinyl-2-(4-CF<sub>3</sub>)-Pyr)</h4><div class="NLM_p last">White solid, 0.260 g, 0.442 mmol, 79% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.76–1.95 (m, 2H), 2.59 (t, <i>J</i> = 7.8 Hz, 2H), 3.06 (d, <i>J</i> = 7.1 Hz, 2H), 4.36–4.51 (m, 1H), 4.65 (pentet, <i>J</i> = 7.1 Hz, 1H), 5.05 (s, 2H), 5.49 (s, 1H), 6.13 (s, 1H), 6.35 (d, <i>J</i> = 15.7 Hz, 1H), 6.59 (dd, <i>J</i><sub>1</sub> = 6.0 Hz, <i>J</i><sub>2</sub> = 15.7 Hz, 1H), 7.06–7.11 (m, 2H), 7.14–7.33 (m, 15H), 8.67 (d, <i>J</i> = 4.9 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 32.1, 36.4, 38.7, 50.7, 56.8, 67.3, 117.5, 121.6, 124.3, 126.2, 127.0 (C–F), 127.2, 128.1, 128.3, 128.5, 128.6 (3C), 128.8, 129.2, 129.5, 136.2, 136.6, 138.7, 139.1, 141.2, 150.5, 156.2 (C–F), 156.4, 170.4. LC–MS <i>m/z</i>: 587.95 [M + H]<sup>+</sup> (calcd for C<sub>34</sub>H<sub>32</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 588.25); <i>t</i><sub>R</sub> = 5.16 min.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Benzyl ((<i>S</i>)-4-Methyl-1-oxo-1-(((<i>S</i>,<i>E</i>)-5-phenyl-1-(pyridin-2-yl)pent-1-en-3-yl)amino)pentan-2-yl)carbamate (<b>18</b>, Cbz-Leu-hPhe-vinyl-2Pyr)</h4><div class="NLM_p last">White solid, 0.038 g, 0.078 mmol, 26% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.92 (t, <i>J</i> = 6.4 Hz, 6H), 1.45–1.57 (m, 1H), 1.59–1.73 (m, 2H), 1.79 (s, 1H), 1.86–2.05 (m, 2H), 2.68 (t, <i>J</i> = 7.9 Hz, 2H), 4.03–4.27 (m, 1H), 4.71 (pentet, <i>J</i> = 6.9 Hz, 1H), 5.10 (s, 2H), 5.14 (s, 1H), 6.26 (d, <i>J</i> = 6.2 Hz, 1H), 6.58 (d, <i>J</i> = 15.8 Hz, 1H), 6.69 (dd, <i>J</i><sub>1</sub> = 6.0 Hz, <i>J</i><sub>2</sub> = 15.8 Hz, 1H), 7.10–7.34 (m, 12H), 7.60 (dt, <i>J</i><sub>1</sub> = 1.7 Hz, <i>J</i><sub>2</sub> = 7.7 Hz, 1H), 8.54 (d, <i>J</i> = 4.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 23.1, 24.9, 32.3, 36.7, 41.2, 50.9, 54.0, 67.3, 122.3, 122.4, 126.1, 128.2, 128.4, 128.6 (2C), 128.7, 130.6, 134.0, 136.3, 136.7, 141.6, 149.7, 155.1, 156.5, 171.6. LC–MS <i>m/z</i>: 484.46, 485.49, 486.38 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 486.28); <i>t</i><sub>R</sub> = 4.58 min.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-4-(pyridin-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>19</b>, Cbz-Phe-Ala-vinyl-2Pyr)</h4><div class="NLM_p last">White solid, 0.590 g, 1.374 mmol, 75% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.58 (s, 3H), 2.96–3.23 (m, 2H), 4.36 (q, <i>J</i> = 7.4 Hz, 1H), 4.63–4.80 (m, 1H), 5.10 (d, <i>J</i> = 1.4 Hz, 2H), 5.33 (s, 1H), 5.67 (d, <i>J</i> = 8.3 Hz, 1H), 6.40 (dd, <i>J</i> = 1.3, 15.8 Hz, 1H), 6.51 (dd, <i>J</i> = 5.5, 15.8 Hz, 1H), 7.13 (ddd, <i>J</i> = 1.1, 4.8, 7.4 Hz, 1H), 7.16–7.21 (m, 3H), 7.21–7.37 (m, 8H), 7.62 (td, <i>J</i> = 1.8, 7.7 Hz, 1H), 8.45–8.61 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 20.0, 38.8, 46.4, 56.2, 66.8, 121.8, 122.3, 126.7, 127.7, 128.0, 128.3, 128.7, 129.3, 135.6, 136.4, 137.0, 148.8, 155.0, 170.8. LC–MS <i>m/z</i>: 430.35 [M + H]<sup>+</sup> (calcd for C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 430.21); <i>t</i><sub>R</sub> = 3.49 min.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>,<i>E</i>)-5-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)-7-(pyridin-2-yl)hept-6-en-1-aminium Chloride (<b>20</b>, Cbz-Phe-Lys-vinyl-2Pyr)</h4><div class="NLM_p last">White solid, 0.027 g, 0.048 mmol, 51% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.44–1.59 (m, 2H), 1.65–1.84 (m, 4H), 2.89–3.02 (m, 3H), 3.09–3.19 (m, 1H), 4.43 (t, <i>J</i> = 7.5 Hz, 1H), 4.64–4.70 (m, 1H), 5.01–5.11 (m, 2H), 6.54 (d, <i>J</i> = 16.1 Hz, 1H), 6.92 (dd, <i>J</i><sub>1</sub> = 5.7 Hz, <i>J</i><sub>2</sub> = 16.1 Hz, 1H), 7.11 (t, <i>J</i> = 7.5 Hz, 1H), 7.21 (t, <i>J</i> = 7.5 Hz, 2H), 7.25–7.40 (m, 7H), 7.91 (t, <i>J</i> = 6.8 Hz, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 8.54 (t, <i>J</i> = 8.0 Hz, 1H), 8.69 (d, <i>J</i> = 5.2 Hz, 1H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 23.8, 27.9, 34.0, 39.1, 40.6, 51.9, 58.2, 67.6, 121.6, 125.9, 126.5, 127.7, 128.5, 128.9, 129.5, 129.7, 130.5, 138.1, 138.4, 142.0, 146.3, 147.8, 151.2, 158.3, 174.1. LC–MS <i>m/z</i>: 486.98 [M + H]<sup>+</sup>, 508.94 [M + Na] <sup>+</sup> (calcd for C<sub>29</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 487.27 and calcd for C<sub>29</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub>Na<sup>+</sup>, 509.25, respectively); <i>t</i><sub>R</sub> = 3.16 min.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(pyridin-4-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>21</b>, Cbz-Phe-Phe-vinyl-4Pyr)</h4><div class="NLM_p last">Off-white solid, 0.051 g, 0.109 mmol, 50% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.83 (d, <i>J</i> = 6.8 Hz, 2H), 3.02 (d, <i>J</i> = 7.8 Hz, 2H), 4.36 (s, 1H), 4.86 (s, 1H), 5.08 (s, 2H), 5.90 (s, 1H), 6.13 (s, 1H), 7.10 (dd, <i>J</i> = 6.5, 31.0 Hz, 6H), 7.18–7.27 (m, 6H), 7.31 (dd, <i>J</i> = 3.6, 6.4 Hz, 5H), 8.50 (d, <i>J</i> = 6.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.4, 41.0, 51.5, 52.1, 67.1, 105.0, 120.9, 126.9, 127.1, 127.9, 128.3, 128.4, 128.5, 128.6, 128.8, 129.3, 129.4, 133.4, 136.4, 150.0, 170.1. LC–MS <i>m/z</i>: 506.29 [M + H]<sup>+</sup> (calcd for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 506.24); <i>t</i><sub>R</sub> = 3.49 min.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-((<i>S</i>,<i>E</i>)-3-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)-4-phenylbut-1-en-1-yl)-1-methylpyridin-1-ium Iodide (<b>22</b>, Cbz-Phe-Phe-vinyl-4PyrNMe)</h4><div class="NLM_p last">Yellow solid, 0.020 g, 0.030 mmol, 87% yield. <sup>1</sup>H NMR (400 MHz, MeOD + CDCl<sub>3</sub>): δ 2.75–3.09 (m, 4H), 4.28–4.43 (m,5H), 4.87 (q, <i>J</i> = 6.3 Hz, 1H), 5.08 (s, 2H), 6.28 (d, <i>J</i> = 15.9 Hz, 1H), 6.83 (dd, <i>J</i><sub>1</sub> = 5.0 Hz, <i>J</i><sub>2</sub> = 15.9 Hz, 1H), 7.16–7.35 (m, 15H), 7.82 (d, <i>J</i> = 6.5 Hz, 2H), 8.71 (d, <i>J</i> = 6.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> + MeOD): δ 38.2, 40.1, 47.8, 52.2, 56.3, 66.8, 124.5, 126.8 (2C), 127.6, 128.0, 128.3, 128.4 (3C), 128.5, 129.1, 129.2, 136.1, 136.4, 143.9, 144.7, 153.1, 156.2, 171.3. LC–MS <i>m/z</i>: 521.33 [M + H]<sup>+</sup> (calcd for C<sub>33</sub>H<sub>34</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 521.27); <i>t</i><sub>R</sub> = 3.36 min.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(pyrimidin-4-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>23</b>, Cbz-Phe-Phe-vinyl-4Pyrmd)</h4><div class="NLM_p last">Off-white solid, 0.800 g, 1.579 mmol, 64% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.79–2.93 (m, 2H), 3.01 (d, <i>J</i> = 6.9 Hz, 2H), 4.35–4.48 (m, 1H), 4.93 (pentet, <i>J</i> = 6.7 Hz, 1H), 5.04 (s, 2H), 5.49 (s, 1H), 6.16 (d, <i>J</i> = 15.6 Hz, 1H), 6.29 (s, 1H), 6.88 (dd, <i>J</i><sub>1</sub> = 5.8 Hz, <i>J</i><sub>2</sub> = 15.6 Hz, 1H), 6.97 (d, <i>J</i> = 4.6 Hz, 1H), 7.05–7.33 (m, 15H), 8.56 (d, <i>J</i> = 5.2 Hz, 1H), 9.06 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.5, 40.9, 51.6, 56.6, 67.2, 118.8, 126.9, 127.1, 128.0, 128.2, 128.3, 128.6 (3C), 128.8, 129.4 (2C), 136.2, 136.5, 138.6, 156.1, 157.4, 158.8, 161.5, 170.4. LC–MS <i>m/z</i>: 507.35 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 507.24); <i>t</i><sub>R</sub> = 5.27 min.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Benzyl ((<i>S</i>)-1-(((<i>S</i>,<i>E</i>)-4-(Oxazol-2-yl)-1-phenylbut-3-en-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate (<b>24</b>, Cbz-Phe-Phe-vinyl-2Oxz)</h4><div class="NLM_p last">White solid, 0.020 g, 0.040 mmol, 29% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.72–2.88 (m, 2H), 2.93–3.11 (m, 2H), 4.35 (q, <i>J</i> = 7.0 Hz, 1H), 4.88 (pentet, <i>J</i> = 6.7 Hz, 1H), 5.05 (s, 2H), 5.30 (s, 1H), 5.99 (d, <i>J</i> = 5.8 Hz, 1H), 6.14 (d, <i>J</i> = 16.1 Hz, 1H), 6.48 (dd, <i>J</i><sub>1</sub> = 5.9 Hz, <i>J</i><sub>2</sub> = 16.1 Hz, 1H), 7.04–7.35 (m, 16H), 7.54 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.6, 40.9, 51.5, 56.7, 67.3, 117.3, 127.1, 127.4, 128.2, 128.4, 128.7 (3C), 129.0, 129.4 (2C), 136.2, 136.4 (2C), 137.1, 138.3, 156.1, 160.8, 170.3. LC–MS <i>m/z</i>: 496.25 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub><sup>+</sup>, 496.22); <i>t</i><sub>R</sub> = 5.41 min.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>,<i>E</i>)-1-phenyl-4-(thiazol-2-yl)but-3-en-2-yl)amino)propan-2-yl)carbamate (<b>25</b>, Cbz-Phe-Phe-vinyl-2Thz)</h4><div class="NLM_p last">Light yellow solid, 0.206 g, 0.403 mmol, 54% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.75–2.89 (m, 2H), 2.99 (d, <i>J</i> = 7.1 Hz, 2H), 4.28–4.46 (m, 1H), 4.87 (d, <i>J</i> = 6.4 Hz, 1H), 4.96–5.11 (m, 2H), 5.44 (s, 1H), 6.19 (s, 1H), 6.39 (dd, <i>J</i><sub>1</sub> = 5.1 Hz, <i>J</i><sub>2</sub> = 16.0 Hz, 1H), 6.45 (d, <i>J</i> = 16.0 Hz, 1H), 7.01–7.39 (m, 16H), 7.71 (d, <i>J</i> = 3.2 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.7, 41.0, 51.5, 56.6, 67.2, 118.5, 123.9, 126.9, 127.2, 128.1, 128.3, 128.6 (2C), 128.8, 129.4 (2C), 135.0, 136.2, 136.5 (2C), 143.4, 156.0, 166.0, 170.4. LC–MS <i>m/z</i>: 512.18 [M + H]<sup>+</sup> (calcd for C<sub>30</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, 512.20); <i>t</i><sub>R</sub> = 5.64 min.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-((<i>S</i>,<i>E</i>)-3-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-3-phenylpropanamido)-4-phenylbut-1-en-1-yl)-3-methylthiazol-3-ium Iodide (<b>26</b>, Cbz-Phe-Phe-vinyl-2ThzNMe)</h4><div class="NLM_p last">Yellow solid, 0.003 g, 0.005 mmol, 15% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.51 (s, 1H), 2.81–3.96 (m, 1H), 2.98–3.18 (m, 3H), 3.71 (s, 3H), 3.93 (s, 2H), 4.36–4.49 (m, 1H), 4.99 (s, 2H), 5.85–6.11 (m, 1H), 6.81 (d, <i>J</i> = 15.6 Hz, 1H), 6.91 (dd, <i>J</i><sub>1</sub> = 3.4 Hz, <i>J</i><sub>2</sub> = 15.6 Hz, 1H), 7.06–7.33 (m, 15H), 7.76 (s, 1H), 7.96 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 38.1, 39.8, 52.5, 54.7, 57.3, 66.7, 115.1, 121.6, 126.9, 127.1, 127.6, 128.0 (2C), 128.5, 128.7, 128.8, 129.5 (2C), 136.9, 137.0, 138.8, 150.6, 156.4, 168.7, 171.9. LC–MS <i>m/z</i>: 526.18 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub>S<sup>+</sup>, 526.22); <i>t</i><sub>R</sub> = 3.31 min.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Benzyl ((<i>S</i>)-1-Oxo-3-phenyl-1-(((<i>S</i>)-1-phenyl-4-(pyrimidin-2-yl)butan-2-yl)amino)propan-2-yl)carbamate (<b>27</b>, Cbz-Phe-Phe-(CH<sub>2</sub>)<sub>2</sub>-2Pyrmd)</h4><div class="NLM_p last">To a solution of Boc-Phe-vinyl-2Pyrmd (<b>h</b>, prepared following GP1–GP7, 0.05 g, 0.15 mmol) in anhydrous EtOAc (8 mL) was added Pd/C (10%wt, 0.016 mg) under a H<sub>2</sub> atmosphere and stirred overnight. The reaction was filtered, and the filtrate was concentrated. The product was coupled with the P<sub>3</sub>–P<sub>2</sub> fragment following GP8 to give compound <b>27</b>. White solid, 0.031 g, 0.060 mmol, 48% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.63–1.82 (m, 1H), 1.85–2.01 (m, 1H), 2.63–2.77 (m, 2H), 2.78–2.94 (m, 2H), 2.99 (d, <i>J</i> = 6.8 Hz, 2H), 4.05–4.23 (m, 1H), 4.31 (pentet, <i>J</i> = 7.1 Hz, 1H), 5.07 (s, 2H), 5.34 (s, 1H), 6.43 (d, <i>J</i> = 6.4 Hz, 1H), 7.04–7.38 (m, 16H), 8.59 (d, <i>J</i> = 4.9 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 31.5, 35.8, 38.8, 41.1, 51.1, 56.8, 67.2, 118.6, 126.6, 127.0, 128.2, 128.3, 128.5, 128.7, 128.8, 129.4, 129.6, 136.4, 136.7, 137.9, 155.9, 157.0, 170.5, 170.9. LC–MS <i>m/z</i>: 509.15, 509.28 [M + H]<sup>+</sup> (calcd for C<sub>31</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub><sup>+</sup>, 509.26); <i>t</i><sub>R</sub> = 5.10 min.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Solubility of Cruzain Inhibitors</h3><div class="NLM_p last">Synthetic PVHIs such as <b>5</b>–<b>16</b> and <b>22</b>–<b>24</b> at final concentrations of 1–200 μM were added to 0.25 mL solutions of 10% DMSO (v/v) in clear 96-well Greiner plates, and absorbance at 620 nm was measured using a BioTek M2 Synergy plate reader at <i>t</i> = 0 and 120 min to evaluate increased light scattering and precipitated inhibitor.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Evaluation of Covalent Adducts of Glutathione and Cruzain Inhibitors</h3><div class="NLM_p last">The compounds <b>7</b>, <b>11</b>, <b>12</b>, <b>15</b>, <b>25</b>, <b>26</b>, and <b>K1777</b> (0.5 mM) were added to 100 mM Tris (pH 8.0), 10% (v/v) DMSO, and 1 mM or 5 mM reduced glutathione to a final volume of 0.2 mL at room temperature. Samples were analyzed by HPLC–MS (as described above) by injecting 0.01 mL aliquots onto a Luna 5 mm C18(2) 100 Å, 4.6 mm, 50 mm column (Phenomenex) using the HPLC method described in the chemistry section at 0–6 h time points. The chromatographic peaks for each cruzain inhibitor and its covalent adduct with glutathione were characterized by their values of <i>m/z</i> using electrospray positive ionization detection and UV absorbance at 254 nm: <b>K11777</b>, retention time: 4.75 min, <i>m/z</i>: 575.05; <b>K11777</b>-GSH, retention time: 4.64 min, <i>m/z</i>: 882.30; <b>7</b>, retention time: 6.71 min, <i>m/z</i>: 507.11; <b>11</b>, retention time: 5.48 min, <i>m/z</i>: 506.06; <b>12</b>, retention time: 4.77 min, <i>m/z</i>: 520.10; <b>15</b>, retention time: 4.81 min, <i>m/z</i>: 535.23; <b>15</b>-GSH, retention time: 4.72 min, <i>m/z</i>: 842.42; <b>17</b>, retention time: 5.03 min, <i>m/z</i>: 587.95; <b>25</b>, retention time: 4.43 min, <i>m/z</i>: 511.87; <b>26</b>, retention time: 4.42 min, <i>m/z</i>: 525.90; <b>26</b>-GSH, retention time: 3.61 min, <i>m/z</i>: 833.97. Integration of the chromatographic peaks of the inhibitors and their GSH adducts at each time point was used to determine the rate of GSH adduct formation.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Enzyme Expression and Purification</h3><div class="NLM_p last">Recombinant human cathepsins B, L, and S were purchased from Millipore Sigma and used without further treatment. General procedures for cruzain expression, purification, and activation were performed according to published protocols<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> with modifications as described.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Activated cruzain at >95% purity was stored either as MMTS-conjugated samples, as described, at −80 °C in a buffer containing 50 mM Tris (pH 8.0) and 20% glycerol, at protein concentrations of 5 mg mL<sup>–1</sup>. Prior to use, MMTS was removed by successive dialysis in the presence of 5 mM DTT. Activated samples of cruzain were used immediately or stored after use at 4 °C for a period of 1–2 months.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Enzyme Assays and Evaluation of Inhibitors</h3><div class="NLM_p">All enzyme assays were performed at 25 °C. Initial rates of the peptidolytic reaction catalyzed by cruzain were measured by monitoring the fluorescence generated by cleavage of the dipeptide–AMC bond. Assays were conducted in 96-well plates (Greiner; flat-bottom, clear black plates) in a total volume of 250 μL, containing either 50 mM MES (pH 7.5), 50 mM TAPSO, 100 mM DEA, 1 mM CHAPS, 1 mM Na<sub>2</sub>EDTA, 5 mM DTT, and 10% DMSO (v/v) or 50 mM sodium acetate (pH 5.5), 50 mM MES, 100 mM TEA, 1 mM CHAPS, 1 mM Na<sub>2</sub>EDTA, 5 mM DTT, and 10% DMSO (v/v). Substrates were dissolved in 100% DMSO and were then diluted 10-fold such that when added to reaction mixtures, final DMSO concentration was 10% (v/v). Reactions were initiated with the addition of 1–10 μL of cruzain (final concentrations: 0.1–3.0 nM (preincubation studies)). Fluorescence was measured on either a SpectraMax M5 (Molecular Devices) or a Synergy HTX (BioTek, Winooski, VT) microplate reader (λ<sub>ex</sub> = 360 nm, λ<sub>em</sub> = 460 nm). Initial rates were determined from continuous kinetic time courses and calculated from the earliest time points, typically at less than 10 min.</div><div class="NLM_p">Compounds were evaluated as inhibitors or inactivators of cruzain in two ways: (1) enzyme was added to reaction mixtures containing the substrate (typically, 10 μM Cbz-Phe-Arg-AMC) and inhibitor, and reaction time courses were measured for 0–40 min. In addition to other methods, the effects of all inhibitors on reaction rates were determined at <i>t</i> = 0–200 s (<i>v</i><sub>i</sub>) and at longer incubation times (<i>t</i> > 1000 s; <i>v</i><sub>s</sub>), to ascertain the respective inhibition constants <i>K</i><sub>i</sub> and <i>K</i><sub>i</sub>*. (2) Enzyme and compound were preincubated over extended periods of time, and then aliquots were removed and diluted 50-fold to 100-fold into reaction mixtures containing 10 μM Cbz-Phe-Arg-AMC, followed by the assessment of the resulting time courses.</div><div class="NLM_p last">For assays of cathepsin B, L, and S, cruzain inhibitors were evaluated in reaction mixtures containing a buffer of sodium acetate (pH 5.5), 1 mM CHAPS, 1 mM Na<sub>2</sub>EDTA, and 5 mM DTT at 25 °C. The substrate Cbz-Phe-Arg-AMC was dissolved in 100% DMSO, as were all inhibitors, and aliquots of both substrates and inhibitors were added to 0.25 mL reaction mixtures to final concentrations of 10% DMSO (v/v). Michaelis constants for Cbz-Phe-Arg-AMC were determined for all three human cathepsins as cathepsin L (2.9 μM), cathepsin S (60 μM), and cathepsin B (150 μM), and fixed concentrations of Cbz-Phe-Arg-AMC of 1 or 2 <i>K</i><sub>m</sub> were used to evaluate inhibitors. Cruzain inhibitors were added at seven concentrations and one fixed concentration of Cbz-Phe-Arg-AMC, and time courses of AMC formation were analyzed as with cruzain.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Evaluation of Cruzain Inhibitors in Axenic Cell Cultures of <i>T. b. brucei</i> and <i>T. cruzi</i></h3><div class="NLM_p last">Selected cruzain inhibitors were evaluated in axenic cell cultures of <i>T. b. brucei</i> and <i>T. cruzi</i><i>.</i> Procyclic trypomastigotes of <i>T. b. brucei</i> (ATCC PRA-381) were grown in the SDM-79 medium at 26 °C, and bloodstream forms (ATCC PRA-383) were grown at 37 °C in the HMI-9 medium at 5% CO<sub>2</sub>. <i>T. cruzi</i> (epimastigote forms, strain Y, ATCC 50832GFP) was grown in the ATCC medium (1029 LIT medium). Both forms of <i>T. b. brucei</i> and <i>T. cruzi</i> were grown in media containing 10% fetal bovine serum (FBS) and penicillin/streptomycin (50 U mL<sup>–1</sup>). Test compounds, including <b>K11777</b>, were dissolved in 100% DMSO and added to cell cultures at final concentrations of 0.5–20 μM (maximum DMSO = 1% (v/v)). Control samples contained equal amounts of DMSO. <i>T. b. brucei</i> and <i>T. cruzi</i> (5 mL in flask cultures) were seeded at ∼3 × 10<sup>6</sup> cells and diluted daily, maintaining a mid-log growth phase for up to 120 h. Treated cells were typically grown for 4 days (<i>T. b. brucei</i>) or 5 days (<i>T. cruzi</i>). After each cell dilution, fresh compound or an equal volume of DMSO (control samples) was supplemented into the cultures, while maintaining a constant concentration of each inhibitor. Cell counts were scored using a Z2 Coulter Counter.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Evaluation of Cruzain Inhibitors in <i>T. cruzi</i>-Infected Murine Cardiomyoblasts</h3><div class="NLM_p last">For the evaluation of the antitrypanocidal activity of cruzain inhibitors, we infected a C2C12 mouse cardiomyoblast cell line (ATCC CRL-1772) with <i>T. cruzi</i> strain Ca-I/72 (a gift from James Dvorak, National Institutes of Health) in 1536-microwell plates. In each well were added 10<sup>3</sup> cells and 10<sup>4</sup> parasites in a total volume of 10 μL including the test compounds in 10-point dose–response dilutions starting at 10 μM (3-fold dilutions). The plates were incubated at 37 °C for 48 h, and the wells were fixed with 2% paraformaldehyde in PBS and stained with 5 μg mL<sup>–1</sup> 4′,6-diamidino-2-phenylindole. After at least 30 min of incubation at room temperature in the dark, the plates were read in an automated microscope, ImageXpress Micro XL (Molecular Devices), and the images were analyzed by custom-built software to quantify and assess viability of the parasites, as well as the host cells independently. The compilation of data was used to calculate the antiparasitic activity (EC<sub>50</sub>) and host cytotoxicity (CC<sub>50</sub>).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Evaluation of Human Cell Toxicity</h3><div class="NLM_p last">Primary human dermal fibroblast (HDF) cells were used to evaluate human cell toxicity of cruzain inhibitors. HDF cells were plated in a 384-well plate at 2400 cells per well (62,000 cells mL<sup>–1</sup>). Inhibitors in 100% DMSO were added in duplicate to final concentrations of 0.001–0.1 mM and 1% DMSO (v/v) with 1% DMSO as a control sample, and cells were cultured at 37 °C for 48 h, followed by the addition of resazurin. Cell viability was then assessed by reading of fluorescence (excitation/emission: 544 nm/590 nm) after an additional 24 h of incubation.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Kinetic Data Analysis</h3><div class="NLM_p">Initial velocity data for cruzain-catalyzed reactions of fluorogenic peptide substrates were determined by fitting to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> using GraphPad Prism 6.0 or SigmaPlot 12.0. For <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, <i>k</i><sub>cat</sub> is the turnover number, [E]<i><sub>t</sub></i> is the concentration of active sites of cruzain, and <i>K</i><sub>a</sub> is the Michaelis constant for the substrate A. Cruzain concentrations were determined by spectrophotometric analysis of purified sample solutions as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m001.gif" alt="" id="_i66" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">Competitive inhibition was fitted to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>, in which A and I are concentrations of substrate and inhibitor, respectively, <i>V</i><sub>max</sub> is the maximal velocity, and <i>K</i><sub>is</sub> is the slope inhibition constant.<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m002.gif" alt="" id="_i67" /></img><span class="labelSpan">(2)</span></span></div><div class="NLM_p">Data for time-dependent inhibition were fitted by several methods. All time-course data were fitted to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> for studies in which the reaction was initiated by the addition of enzyme, wherein <i>P</i> is the fluorescence generated by AMC formation, <i>C</i> is a nonzero constant, <i>v</i><sub>s</sub> and <i>v</i><sub>i</sub> are respectively the steady-state and initial enzymatic rates, <i>t</i> is time, and <i>k</i><sub>obs</sub> is the observed rate of conversion of the initial inhibited rate to the final inhibited rate.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In cases for which the reaction was initiated with an excess of substrate, following preincubation of enzyme and inhibitor, for <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, <i>v</i><sub>i</sub> = 0.<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m003.gif" alt="" id="_i68" /></img><span class="labelSpan">(3)</span></span></div><div class="NLM_p">Values of <i>k</i><sub>obs</sub> versus [inhibitor] were then replotted and fitted to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a> for which <i>k</i><sub>3</sub> and <i>k</i><sub>4</sub> represent the respective rates of formation and dissolution of the EI* complex as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m004.gif" alt="" id="_i69" /></img><span class="labelSpan">(4)</span></span></div><div class="NLM_p">Inhibition constants were also obtained by fitting <i>v</i><sub>i</sub> and <i>v</i><sub>s</sub> data to <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a>, in which <i>v</i><sub>x</sub> is the rate in the presence of inhibitor I for either early (<i>v</i><sub>i</sub>) or late (<i>v</i><sub>s</sub>) phases of each time course, <i>v</i><sub>0</sub> is the rate in the absence of inhibitor, <i>K</i><sub>a</sub> is the Michaelis constant of the substrate A, and <i>K</i><sub>ix</sub> is the apparent inhibition constant, <i>K</i><sub>i</sub> or <i>K</i><sub>i</sub>*, obtained from fitting of <i>v</i><sub>i</sub> or <i>v</i><sub>s</sub>, respectively.<span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m005.gif" alt="" id="_i70" /></img><span class="labelSpan">(5)</span></span><span class="NLM_disp-formula" id="eq6"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_m006.gif" alt="" id="_i71" /></img><span class="labelSpan">(6)</span></span></div><div class="NLM_p last">In addition, time-course data were fitted globally by two methods. First, expressions for <i>v</i><sub>s</sub>, <i>v</i><sub>i</sub>, and <i>k</i><sub>obs</sub> were substituted into <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> to generate <a class="ref internalNav" href="#eq6" aria-label="eq 6">eq 6</a>, which was used to fit time-course data at all concentrations of inhibitors simultaneously. Second, time-course data were fitted using KinTek Explorer as either a single-binding step model with the two kinetic parameters <i>k</i><sub>3</sub>/<i>K</i><sub>i</sub> and <i>k</i><sub>4</sub> or a two-step binding mechanism as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> from which rate constants <i>k</i><sub>1</sub>–<i>k</i><sub>4</sub> are determined (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02078" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02078?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02078</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular modeling information, fitting of time-course inhibition data using KinTek Explorer, thiolation of cruzain inhibitors by glutathione, synthesis and characterization of AMC-peptide substrates, structures of PVHIs, HPLC traces and NMR spectra of synthesized substrates and inhibitors, and unpublished crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of S2–S5 and S7–S11 and compounds <b>1</b>−<b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Model coordinates for cruzain bound to 7, 9, 11–13, and 15 using CovDock module(<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Model coordinates for cruzain bound to 7, 9, 11–13, and 15 using Glide module (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf">jm9b02078_si_001.pdf (6.32 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_002.csv">jm9b02078_si_002.csv (4.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_003.pdb">jm9b02078_si_003.pdb (289.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_004.pdb">jm9b02078_si_004.pdb (287.76 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02078" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas D. Meek</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1931-8073" title="Orcid link">http://orcid.org/0000-0002-1931-8073</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4b3f2f262e2e200b3f2a263e652e2f3e"><span class="__cf_email__" data-cfemail="0773636a62626c4773666a7229626372">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bala C. Chenna</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2660-5302" title="Orcid link">http://orcid.org/0000-0002-2660-5302</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linfeng Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6185-4999" title="Orcid link">http://orcid.org/0000-0001-6185-4999</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Drake M. Mellott</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Zhai</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span>; 
    <span>Present Address:
                        X.Z.: AstraZeneca Pharmaceuticals, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jair L. Siqueira-Neto</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Calvet Alvarez</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean A. Bernatchez</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8309-1627" title="Orcid link">http://orcid.org/0000-0002-8309-1627</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Desormeaux</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span>; 
    <span>Present Address:
                        E.D.: Department of Chemistry, University of Illinois, 161 RAL, 600 South Matthews Avenue, Urbana, Illinois 61801, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Alvarez Hernandez</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Gomez</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James H. McKerrow</span> - <span class="hlFld-Affiliation affiliation">Skaggs
School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Cruz-Reyes</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry & Biophysics, Texas
A&M University, 301 Old Main Drive, College Station, Texas 77843, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>B.C.C. and L.L. contributed equally to this work. The manuscript was written by T.D.M., L.L., D.M.M., and B.C.C. with contributions from X.Z., J.C.-R., and J.L.S.-N. Synthetic chemistry was performed by B.C.C., L.L., and D.M.M., and enzymatic studies were conducted by L.L., X.Z., D.M.M., and T.M.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We wish to thank Jasmin Ackermann and Ivani Pauli for assisting with testing of cruzain inhibitors in <i>T. cruzi</i><i>-</i>infected cardiomyoblasts; Thomas Snavely, Dr. Deeann Wallis, and Kim Loesch in the laboratory of Prof. James C. Sacchettini for testing cruzain inhibitors for human cell toxicity; Prof. James Sacchettini and Dr. Su Tang for crystallography analysis; Jiyun Zhu, Charis Fernandez, and Nora McGuffey for assistance with analysis of inhibitors versus cruzain and human cathepsins; and Mireya Luna for support with synthetic chemistry. The authors thank Professor Charles S. Craik for providing a construct for the expression of cruzain and Dr. Larry Dangott for providing protein sequencing. The authors also thank Professor Ken Johnson for assistance with the use of KinTek Explorer. Financial support for the research was provided by NIH grant R21AI127634 and Texas A&M AgriLife Research.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">BSF</td><td class="NLM_def"><p class="first last">bloodstream form</p></td></tr><tr><td class="NLM_term">CHAPS</td><td class="NLM_def"><p class="first last">3-[3-(cholamidopropyl)dimethylammonio]-1-propanesulfonate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">hPhe</td><td class="NLM_def"><p class="first last">homophenylalanine</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-(<i>N</i>-morpholino)ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">MMTS</td><td class="NLM_def"><p class="first last">S-methyl methanethiosulfonate</p></td></tr><tr><td class="NLM_term">Oxz</td><td class="NLM_def"><p class="first last">oxazolyl</p></td></tr><tr><td class="NLM_term">NMePip</td><td class="NLM_def"><p class="first last"><i>N</i>-methylpiperazinyl</p></td></tr><tr><td class="NLM_term">PCF</td><td class="NLM_def"><p class="first last">procyclic form</p></td></tr><tr><td class="NLM_term">PVHI</td><td class="NLM_def"><p class="first last">peptidomimetic vinylheterocyclic inhibitor</p></td></tr><tr><td class="NLM_term">Pyr</td><td class="NLM_def"><p class="first last">pyridinyl</p></td></tr><tr><td class="NLM_term">Pyrmd</td><td class="NLM_def"><p class="first last">pyrimidinyl</p></td></tr><tr><td class="NLM_term">Thz</td><td class="NLM_def"><p class="first last">thiazolyl</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">VS</td><td class="NLM_def"><p class="first last">vinyl sulfone</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Saravia, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimke, I.</span></span> <span> </span><span class="NLM_article-title">Chronic Chagas’ Heart Disease: a Disease on its Way to Becoming a Worldwide Health Problem: Epidemiology, Etiopathology, Treatment, Pathogenesis and Laboratory Medicine</span>. <i>Heart Fail. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1007/s10741-010-9211-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2Fs10741-010-9211-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=21165698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fps1yquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=45-64&author=S.+G.+Mu%C3%B1oz-Saraviaauthor=A.+Haberlandauthor=G.+Wallukatauthor=I.+Schimke&title=Chronic+Chagas%E2%80%99+Heart+Disease%3A+a+Disease+on+its+Way+to+Becoming+a+Worldwide+Health+Problem%3A+Epidemiology%2C+Etiopathology%2C+Treatment%2C+Pathogenesis+and+Laboratory+Medicine&doi=10.1007%2Fs10741-010-9211-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine</span></div><div class="casAuthors">Munoz-Saravia Silvia Gilka; Haberland Annekathrin; Wallukat Gerd; Schimke Ingolf</div><div class="citationInfo"><span class="NLM_cas:title">Heart failure reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas' disease, caused by Trypanosoma cruzi infection, is ranked as the most serious parasitic disease in Latin America.  Nearly 30% of infected patients develop life-threatening complications, and with a latency of 10-30 years, mostly Chagas' heart disease which is currently the major cause of morbidity and mortality in Latin America, enormously burdening economic resources and dramatically affecting patients' social and labor situations.  Because of increasing migration, international tourism and parasite transfer by blood contact, intrauterine transfer and organ transplantation, Chagas' heart disease could potentially become a worldwide problem.  To raise awareness of this problem, we reflect on the epidemiology and etiopathology of Chagas' disease, particularly Chagas' heart disease.  To counteract Chagas' heart disease, in addition to the general interruption of the infection cycle and chemotherapeutic elimination of the infection agent, early and effective causal or symptomatic therapies would be indispensable.  Prerequisites for this are improved knowledge of the pathogenesis and optimized patient management.  From economic and logistics viewpoints, this last prerequisite should be performed using laboratory medicine tools.  Consequently, we first summarize the mechanisms that have been suggested as driving Chagas' heart disease, mainly those associated with the presence of autoantibodies against G-protein-coupled receptors; secondly, we indicate new treatment strategies involving autoantibody apheresis and in vivo autoantibody neutralization; thirdly, we present laboratory medicine tools such as autoantibody estimation and heart marker measurement, proposed for diagnosis, risk assessment and patient guidance and lastly, we critically reflect upon the increase in inflammation and oxidative stress markers in Chagas' heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4A6JSV6MuoE2yPDyEFiigfW6udTcc2eZQBw1sJiKazLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fps1yquw%253D%253D&md5=2b9715cca8da00f753fac995ae459777</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs10741-010-9211-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10741-010-9211-5%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Saravia%26aufirst%3DS.%2BG.%26aulast%3DHaberland%26aufirst%3DA.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DSchimke%26aufirst%3DI.%26atitle%3DChronic%2520Chagas%25E2%2580%2599%2520Heart%2520Disease%253A%2520a%2520Disease%2520on%2520its%2520Way%2520to%2520Becoming%2520a%2520Worldwide%2520Health%2520Problem%253A%2520Epidemiology%252C%2520Etiopathology%252C%2520Treatment%252C%2520Pathogenesis%2520and%2520Laboratory%2520Medicine%26jtitle%3DHeart%2520Fail.%2520Rev.%26date%3D2012%26volume%3D17%26spage%3D45%26epage%3D64%26doi%3D10.1007%2Fs10741-010-9211-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <i>Centers for Disease Control and Prevention</i>.  (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Centers+for+Disease+Control+and+Prevention.+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coura, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viñas, P. A.</span></span> <span> </span><span class="NLM_article-title">Chagas Disease: a New Worldwide Challenge</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">S6</span>– <span class="NLM_lpage">S7</span>, <span class="refDoi"> DOI: 10.1038/nature09221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnature09221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=20571554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotleiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=S6-S7&author=J.+R.+Couraauthor=P.+A.+Vi%C3%B1as&title=Chagas+Disease%3A+a+New+Worldwide+Challenge&doi=10.1038%2Fnature09221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas disease: a new worldwide challenge</span></div><div class="casAuthors">Coura, Jose Rodrigues; Vinas, Pedro Albajar</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7301</span>),
    <span class="NLM_cas:pages">S6-S7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1sTY-jAEB7Vg90H21EOLACvtfcHk0lhEXs0WzjQ57Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotleiu7o%253D&md5=c4fe0c1df4366c775bbd40af6cdca437</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09221%26sid%3Dliteratum%253Aachs%26aulast%3DCoura%26aufirst%3DJ.%2BR.%26aulast%3DVi%25C3%25B1as%26aufirst%3DP.%2BA.%26atitle%3DChagas%2520Disease%253A%2520a%2520New%2520Worldwide%2520Challenge%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3DS6%26epage%3DS7%26doi%3D10.1038%2Fnature09221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, R.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of Chagas Disease in the USA: High-Risk Patient Populations for Screening</span>. <i>Curr. Trop. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/s40475-019-0169-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2Fs40475-019-0169-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=8-12&author=Y.+Castroauthor=R.+Marcus&title=Epidemiology+of+Chagas+Disease+in+the+USA%3A+High-Risk+Patient+Populations+for+Screening&doi=10.1007%2Fs40475-019-0169-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40475-019-0169-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40475-019-0169-7%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DY.%26aulast%3DMarcus%26aufirst%3DR.%26atitle%3DEpidemiology%2520of%2520Chagas%2520Disease%2520in%2520the%2520USA%253A%2520High-Risk%2520Patient%2520Populations%2520for%2520Screening%26jtitle%3DCurr.%2520Trop.%2520Med.%2520Rep.%26date%3D2019%26volume%3D6%26spage%3D8%26epage%3D12%26doi%3D10.1007%2Fs40475-019-0169-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialek, S. R.</span></span> <span> </span><span class="NLM_article-title">What Do We Know About Chagas Disease in the United States?</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.16-0213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.4269%2Fajtmh.16-0213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=27402515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ptFGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=1225-1227&author=S.+P.+Montgomeryauthor=M.+E.+Pariseauthor=E.+M.+Dotsonauthor=S.+R.+Bialek&title=What+Do+We+Know+About+Chagas+Disease+in+the+United+States%3F&doi=10.4269%2Fajtmh.16-0213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">What Do We Know About Chagas Disease in the United States?</span></div><div class="casAuthors">Montgomery Susan P; Parise Monica E; Dotson Ellen M; Bialek Stephanie R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of tropical medicine and hygiene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1225-1227</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, caused by the parasite Trypanosoma cruzi, affects more than 5 million people worldwide leading to serious heart and gastrointestinal disease in a proportion of chronically infected patients.  Important modes of transmission include vector-borne, congenital, and via blood transfusion or organ transplant from an infected donor.  Vector-borne transmission of Chagas disease occurs in the Americas, including the southern half of North America, where the specific vector insects (triatomines), T. cruzi, and infected reservoir mammalian hosts are found.  In the United States, there are estimated to be at least 300,000 cases of chronic Chagas disease among people originally from countries of Latin America where Chagas disease is endemic.  Fewer than 30 cases of locally acquired infection have been documented in the United States, although a sylvatic transmission cycle has been known to exist in this country for at least a century.  Studies defining risks for locally acquired infection and effective prevention strategies are needed to help prevent domestic transmission of T. cruzi To help address Chagas disease in the United States, improved health-care provider awareness and knowledge, better tools for screening and diagnosing patients, and wider availability of treatment drugs are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdnJB8GcYb4L9KldV63DuefW6udTcc2ebyH58Fz3fMKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ptFGhtA%253D%253D&md5=e1a514f5cf7872365b0715403e5e0ed0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.16-0213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.16-0213%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DS.%2BP.%26aulast%3DParise%26aufirst%3DM.%2BE.%26aulast%3DDotson%26aufirst%3DE.%2BM.%26aulast%3DBialek%26aufirst%3DS.%2BR.%26atitle%3DWhat%2520Do%2520We%2520Know%2520About%2520Chagas%2520Disease%2520in%2520the%2520United%2520States%253F%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2016%26volume%3D95%26spage%3D1225%26epage%3D1227%26doi%3D10.4269%2Fajtmh.16-0213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes de Rezende, J.</span></span> <span> </span><span class="NLM_article-title">American Trypanosomiasis (Chagas Disease)</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.idc.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22632639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=275-291&author=A.+Rassiauthor=A.+Rassiauthor=J.+Marcondes+de+Rezende&title=American+Trypanosomiasis+%28Chagas+Disease%29&doi=10.1016%2Fj.idc.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">American trypanosomiasis (Chagas disease)</span></div><div class="casAuthors">Rassi Anis Jr; Rassi Anis; Marcondes de Rezende Joffre</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by Trypanosoma cruzi, a protozoan parasite.  It is transmitted to human beings mainly through the feces of infected triatomine bugs.  The disease affects an estimated 8 to 10 million people in the Americas, putting them at risk of developing life-threatening cardiac and gastrointestinal complications.  This article provides a brief update on the epidemiology, clinical manifestations, diagnosis, and treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJzahk2B7NOeRS7coPn-RtfW6udTcc2ebyH58Fz3fMKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D&md5=ef2274a813974a0cf8a7995a06ef1b71</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DMarcondes%2Bde%2BRezende%26aufirst%3DJ.%26atitle%3DAmerican%2520Trypanosomiasis%2520%2528Chagas%2520Disease%2529%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D275%26epage%3D291%26doi%3D10.1016%2Fj.idc.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lejon, V.</span>; <span class="NLM_string-name">Bentivoglio, M.</span>; <span class="NLM_string-name">Franco, J. R.</span></span> <span> </span><span class="NLM_article-title">Human African Trypanosomiasis</span>. In  <i>Handbook of Clinical Neurology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, H. H.</span>; <span class="NLM_string-name">Tanowitz, H. B.</span>; <span class="NLM_string-name">Del Brutto, O. H.</span></span>, Eds; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">181</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=169-181&author=V.+Lejon&author=M.+Bentivoglio&author=J.+R.+Francoauthor=H.+H.+Garcia&author=H.+B.+Tanowitz&author=O.+H.+Del+Brutto&title=Handbook+of+Clinical+Neurology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLejon%26aufirst%3DV.%26atitle%3DHuman%2520African%2520Trypanosomiasis%26btitle%3DHandbook%2520of%2520Clinical%2520Neurology%26aulast%3DGarcia%26aufirst%3DH.%2BH.%26pub%3DElsevier%26date%3D2013%26spage%3D169%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">World
Health Organization</span>.  <i>Trypanosomiasis,
human African (sleeping
sickness)</i><a href="https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness" class="extLink">https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness</a>) (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World%0AHealth+Organization.+Trypanosomiasis%2C%0Ahuman+African+%28sleeping%0Asickness%29https%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Ftrypanosomiasis-human-african-%28sleeping-sickness%29+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DTrypanosomiasis%252C%250Ahuman%2520African%2520%2528sleeping%250Asickness%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span> <i>Drugs for Neglected Diseases
initiative</i>. <a href="https://www.dndi.org/wp-content/uploads/2019/09/Factsheet2019_SleepingSickness.pdf" class="extLink">https://www.dndi.org/wp-content/uploads/2019/09/Factsheet2019_SleepingSickness.pdf</a> (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Drugs+for+Neglected+Diseases%0Ainitiative.+https%3A%2F%2Fwww.dndi.org%2Fwp-content%2Fuploads%2F2019%2F09%2FFactsheet2019_SleepingSickness.pdf+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520for%2520Neglected%2520Diseases%250Ainitiative" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simarro, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jannin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattand, P.</span></span> <span> </span><span class="NLM_article-title">Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?</span>. <i>PLOS Medicine</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e55</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0050055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pmed.0050055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=18303943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ksFGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&author=P.+P.+Simarroauthor=J.+Janninauthor=P.+Cattand&title=Eliminating+Human+African+Trypanosomiasis%3A+Where+Do+We+Stand+and+What+Comes+Next%3F&doi=10.1371%2Fjournal.pmed.0050055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating human African trypanosomiasis: where do we stand and what comes next?</span></div><div class="casAuthors">Simarro Pere P; Jannin Jean; Cattand Pierre</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnJHeJ_kKhEUkUaC_kzhvyfW6udTcc2ebyH58Fz3fMKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ksFGjsA%253D%253D&md5=540cbe2cec177b8d6b0d629f33187d59</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0050055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0050055%26sid%3Dliteratum%253Aachs%26aulast%3DSimarro%26aufirst%3DP.%2BP.%26aulast%3DJannin%26aufirst%3DJ.%26aulast%3DCattand%26aufirst%3DP.%26atitle%3DEliminating%2520Human%2520African%2520Trypanosomiasis%253A%2520Where%2520Do%2520We%2520Stand%2520and%2520What%2520Comes%2520Next%253F%26jtitle%3DPLOS%2520Medicine%26date%3D2008%26volume%3D5%26doi%3D10.1371%2Fjournal.pmed.0050055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, P. G. E.</span></span> <span> </span><span class="NLM_article-title">Clinical Features, Diagnosis, and Treatment of Human African Trypanosomiasis (Sleeping Sickness)</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(12)70296-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS1474-4422%2812%2970296-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=23260189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=186-194&author=P.+G.+E.+Kennedy&title=Clinical+Features%2C+Diagnosis%2C+and+Treatment+of+Human+African+Trypanosomiasis+%28Sleeping+Sickness%29&doi=10.1016%2FS1474-4422%2812%2970296-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span></div><div class="casAuthors">Kennedy Peter Ge</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis, or sleeping sickness, is caused by infection with parasites of the genus Trypanosoma, transmitted by the tsetse fly.  The disease has two forms, Trypanosoma brucei (T b) rhodesiense and T b gambiense; and is almost always fatal if untreated.  Despite a recent reduction in the number of reported cases, patients with African trypanosomiasis continue to present major challenges to clinicians.  Because treatment for CNS-stage disease can be very toxic, diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic.  Melarsoprol is the only available treatment for late-stage T b rhodesiense infection, but can be lethal to 5% of patients owing to post-treatment reactive encephalopathy.  Eflornithine combined with nifurtimox is the first-line treatment for late-stage T b gambiense.  New drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDi0PRo3CXkCEJCPKhJPuqfW6udTcc2eaF-Ajmi0nfZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D&md5=c9ac342f345240d413300c17cd1ae80f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970296-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970296-X%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DP.%2BG.%2BE.%26atitle%3DClinical%2520Features%252C%2520Diagnosis%252C%2520and%2520Treatment%2520of%2520Human%2520African%2520Trypanosomiasis%2520%2528Sleeping%2520Sickness%2529%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D186%26epage%3D194%26doi%3D10.1016%2FS1474-4422%2812%2970296-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, C. J.</span></span> <span> </span><span class="NLM_article-title">First Century of Chagas’ Disease: An Overview on Novel Approaches to Nifurtimox and Benznidazole Delivery Systems</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1002/jps.23010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2Fjps.23010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22161779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Snsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=888-894&author=C.+J.+Salomon&title=First+Century+of+Chagas%E2%80%99+Disease%3A+An+Overview+on+Novel+Approaches+to+Nifurtimox+and+Benznidazole+Delivery+Systems&doi=10.1002%2Fjps.23010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">First century of Chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems</span></div><div class="casAuthors">Salomon, Claudio J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">888-894</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Hundred years after the discovery of Chagas' disease, there is a lack of effective treatment to control this neglected disease caused by the parasite Trypanosoma cruzi.  The transmission is primarily through vector-borne blood transfusion or during pregnancy, producing high mortality and morbidity among poor people in many countries of Latin America.  In the last decades, the efforts have been focused mainly on the elimination of vectors.  At the same time, screening of blood donors in order to avoid transfusional transmission has been improved all over the world.  However, Chagas' disease is still a major public health problem, with ests. of nearly 90 million people at risk of infection and more than eight million infected in 18 endemic countries.  Despite the high incidence in endemic regions and the dissemination of neglected diseases in North America and Europe, to date, there are only two drugs developed and prescribed for the treatment of Chagas' disease, nifurtimox (tablets of 120 mg) and benznidazole (tablets of 100 mg).  In this review, different approaches carried out in the last decades for developing novel pharmaceutical formulations for the delivery of nifurtimox and benznidazole are discussed. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdTQqKE_luKLVg90H21EOLACvtfcHk0liSqwbdnQIuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Snsr%252FO&md5=98f783103b6d7e247d85784bee746eb6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fjps.23010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23010%26sid%3Dliteratum%253Aachs%26aulast%3DSalomon%26aufirst%3DC.%2BJ.%26atitle%3DFirst%2520Century%2520of%2520Chagas%25E2%2580%2599%2520Disease%253A%2520An%2520Overview%2520on%2520Novel%2520Approaches%2520to%2520Nifurtimox%2520and%2520Benznidazole%2520Delivery%2520Systems%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D888%26epage%3D894%26doi%3D10.1002%2Fjps.23010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10497</span>– <span class="NLM_lpage">10525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00683</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00683" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGkur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10497-10525&author=L.+Cianniauthor=C.+W.+Feldmannauthor=E.+Gilbergauthor=M.+G%C3%BCtschowauthor=L.+Julianoauthor=A.+Leit%C3%A3oauthor=J.+Bajorathauthor=C.+A.+Montanari&title=Can+Cysteine+Protease+Cross-Class+Inhibitors+Achieve+Selectivity%3F&doi=10.1021%2Facs.jmedchem.9b00683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?</span></div><div class="casAuthors">Cianni, Lorenzo; Feldmann, Christian Wolfgang; Gilberg, Erik; Gutschow, Michael; Juliano, Luiz; Leitao, Andrei; Bajorath, Jurgen; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10497-10525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cysteine proteases are important targets for the discovery of novel therapeutics for many human diseases.  From parasitic diseases to cancer, cysteine proteases follow a common mechanism, the formation of an encounter complex with subsequent nucleophilic reactivity of the catalytic cysteine thiol group toward the carbonyl carbon of a peptide bond or an electrophilic group of an inhibitor.  Modulation of target enzymes occurs preferably by covalent modification, which imposes challenges in balancing cross-reactivity and selectivity.  Given the resurgence of irreversible covalent inhibitors, can they impair off-target effects or are reversible covalent inhibitors a better route to selectivity.  This Perspective addresses how small mol. inhibitors may achieve selectivity for different cathepsins, cruzain, rhodesain, and falcipain-2.  We discuss target- and ligand-based designs emphasizing repurposing inhibitors from one cysteine protease to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr75s_t-OU9gbVg90H21EOLACvtfcHk0liSqwbdnQIuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGkur7I&md5=49fc0900174dfad403d33e906498ae28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00683%26sid%3Dliteratum%253Aachs%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DFeldmann%26aufirst%3DC.%2BW.%26aulast%3DGilberg%26aufirst%3DE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DCan%2520Cysteine%2520Protease%2520Cross-Class%2520Inhibitors%2520Achieve%2520Selectivity%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10497%26epage%3D10525%26doi%3D10.1021%2Facs.jmedchem.9b00683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brömme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span>. <i>J Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">12824</span>– <span class="NLM_lpage">12832</span>, <span class="refDoi"> DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+Profiling+of+Cysteine+Proteases+Using+a+Combinatorial+Peptide+Library+Identifies+Functionally+Unique+Specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0liES-k0wWVwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520Profiling%2520of%2520Cysteine%2520Proteases%2520Using%2520a%2520Combinatorial%2520Peptide%2520Library%2520Identifies%2520Functionally%2520Unique%2520Specificities%26jtitle%3DJ%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Authié, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serveau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span> <span> </span><span class="NLM_article-title">Subsite Specificity of Trypanosomal Cathepsin L-Like Cysteine Proteases</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">2733</span>– <span class="NLM_lpage">2741</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.02172.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1046%2Fj.1432-1327.2001.02172.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=11322895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVyht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2733-2741&author=F.+Lecailleauthor=E.+Authi%C3%A9author=T.+Moreauauthor=C.+Serveauauthor=F.+Gauthierauthor=G.+Lalmanach&title=Subsite+Specificity+of+Trypanosomal+Cathepsin+L-Like+Cysteine+Proteases&doi=10.1046%2Fj.1432-1327.2001.02172.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids</span></div><div class="casAuthors">Lecaille, Fabien; Authie, Edith; Moreau, Thierry; Serveau, Carole; Gauthier, Francis; Lalmanach, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2733-2741</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The S2 subsite of mammalian cysteine proteinases of the papain family is essential for specificity.  Among natural amino acids, all these enzymes prefer bulky hydrophobic residues such as phenylalanine at P2.  This holds true for their trypanosomal counterparts: cruzain from Trypanosoma cruzi and congopain from T. congolense.  A detailed anal. of the S2 specificity of parasitic proteases was performed to gain information that might be of interest for the design of more selective pseudopeptidyl inhibitors.  Nonproteogenic phenylalanyl analogs (Xaa) have been introduced into position P2 of fluorogenic substrates dansyl-Xaa-Arg-Ala-Pro-Trp, and their kinetic consts. (Km, kcat/Km) have been detd. with congopain and cruzain, and related host cathepsins B and L.  Trypanosomal cysteine proteases are poorly stereoselective towards D/L-Phe, the inversion of chirality modifying the efficiency of the reaction but not the Km.  Congopain binds cyclohexylalanine better than arom. Phe derivs.  Another characteristic feature of congopain compared to cruzain and cathepsins B and L was that it could accommodate a phenylglycyl residue (kcat/Km = 1300 mM-1·s-1), while lengthening of the side chain by a methylene group only slightly impaired the specificity const. towards trypanosomal cysteine proteases.  Mono- and di-halogenation or nitration of Phe did not affect Km for cathepsin L-like enzymes, but the presence of constrained Phe derivs. prevented a correct fitting into the S2 subsite.  A model of congopain has been built to study the fit of Phe analogs within the S2 pocket.  Phe analogs adopted a positioning within the S2 pocket similar to that of the Tyr of the cruzain/Z-Tyr-Ala-fluoromethylketone complex.  However, cyclohexylalanine has an energetically favorable chair-like conformation and can penetrate deeper into the subsite.  Fitting of modeled Phe analogs were in good agreement with kinetic parameters.  Furthermore, a linear relationship could be established with logP, supporting the suggestion that fitting into the S2 pocket of trypanosomal cysteine proteases depends on the hydrophobicity of Phe analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZKMvltPtELVg90H21EOLACvtfcHk0liES-k0wWVwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVyht7Y%253D&md5=5c1e95dfd70e2a77634bc76795076e70</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02172.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02172.x%26sid%3Dliteratum%253Aachs%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DAuthi%25C3%25A9%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DT.%26aulast%3DServeau%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DLalmanach%26aufirst%3DG.%26atitle%3DSubsite%2520Specificity%2520of%2520Trypanosomal%2520Cathepsin%2520L-Like%2520Cysteine%2520Proteases%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2733%26epage%3D2741%26doi%3D10.1046%2Fj.1432-1327.2001.02172.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sudhan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L Targeting in Cancer Treatment</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.pharmthera.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=26299995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2015&pages=105-116&author=D.+R.+Sudhanauthor=D.+W.+Siemann&title=Cathepsin+L+Targeting+in+Cancer+Treatment&doi=10.1016%2Fj.pharmthera.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L targeting in cancer treatment</span></div><div class="casAuthors">Sudhan, Dhivya R.; Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-116</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Proteolytic enzymes may serve as promising targets for novel therapeutic treatment strategies seeking to impede cancer progression and metastasis.  One such enzyme is cathepsin L (CTSL), a lysosomal cysteine protease.  CTSL upregulation, a common occurrence in a variety of human cancers, has been widely correlated with metastatic aggressiveness and poor patient prognosis.  In addn., CTSL has been implicated to contribute to cancer-assocd. osteolysis, a debilitating morbidity affecting both life expectancy and the quality of life.  In this review, we highlight the mechanisms by which CTSL contributes to tumor progression and dissemination and discuss the therapeutic utility of CTSL intervention strategies aimed at impeding metastatic progression and bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrea3FRSr1_j7Vg90H21EOLACvtfcHk0liES-k0wWVwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jL&md5=84201f3d9494d7a1ef52a0610e1d038d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSudhan%26aufirst%3DD.%2BR.%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DCathepsin%2520L%2520Targeting%2520in%2520Cancer%2520Treatment%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D155%26spage%3D105%26epage%3D116%26doi%3D10.1016%2Fj.pharmthera.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span> <span> </span><span class="NLM_article-title">Epithelial Desquamation Observed in a Phase I Study of an Oral Cathepsin C Inhibitor (GSK2793660)</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1111/bcp.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1111%2Fbcp.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=28800383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=2813-2820&author=B.+E.+Millerauthor=R.+J.+Mayerauthor=N.+Goyalauthor=J.+Balauthor=N.+Dallowauthor=M.+Boyceauthor=D.+Carpenterauthor=A.+Churchillauthor=T.+Heslopauthor=A.+L.+Lazaar&title=Epithelial+Desquamation+Observed+in+a+Phase+I+Study+of+an+Oral+Cathepsin+C+Inhibitor+%28GSK2793660%29&doi=10.1111%2Fbcp.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span></div><div class="casAuthors">Miller, Bruce E.; Mayer, Ruth J.; Goyal, Navin; Bal, Joanne; Dallow, Nigel; Boyce, Malcolm; Carpenter, Donald; Churchill, Alison; Heslop, Teresa; Lazaar, Aili L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2813-2820</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Cathepsin C (CTSC) is necessary for the activation of several serine proteases including neutrophil elastase (NE), cathepsin G and proteinase 3.  GSK2793660 is an oral, irreversible inhibitor of CTSC that is hypothesized to provide an alternative route to achieve NE inhibition and was tested in a Phase I study.  Methods : Single escalating oral doses of GSK2793660 from 0.5 to 20 mg or placebo were administered in a randomized crossover design to healthy male subjects; a sep. cohort received once daily doses of 12 mg or placebo for 21 days.  Data were collected on safety, pharmacokinetics, CTSC enzyme inhibition and blood biomarkers.  Results : Single, oral doses of GSK2793660 were able to dose-dependently inhibit whole blood CTSC activity.  Once daily dosing of 12 mg GSK2793660 for 21 days achieved ≥90% inhibition (95% CI: 56, 130) of CTSC within 3 h on day 1.  Only modest redns. of whole blood enzyme activity of approx. 20% were obsd. for NE, cathepsin G and proteinase 3.  Seven of 10 subjects receiving repeat doses of GSK2793660 manifested epidermal desquamation on palmar and plantar surfaces beginning 7-10 days after dosing commencement.  There were no other clin. important safety findings.  Conclusions : GSK2793660 inhibited CTSC activity but not the activity of downstream neutrophil serine proteases.  The palmar-plantar epidermal desquamation suggests a previously unidentified role for CTSC or one of its target proteins in the maintenance and integrity of the epidermis at these sites, with some similarities to the phenotype of CTSC-deficient humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzbhfHPivxrVg90H21EOLACvtfcHk0lgOQvl-ocS6ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM&md5=7adcac6bc9dc5a24bffda1afd89e1f88</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13398%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BE.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DGoyal%26aufirst%3DN.%26aulast%3DBal%26aufirst%3DJ.%26aulast%3DDallow%26aufirst%3DN.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DChurchill%26aufirst%3DA.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26atitle%3DEpithelial%2520Desquamation%2520Observed%2520in%2520a%2520Phase%2520I%2520Study%2520of%2520an%2520Oral%2520Cathepsin%2520C%2520Inhibitor%2520%2528GSK2793660%2529%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D83%26spage%3D2813%26epage%3D2820%26doi%3D10.1111%2Fbcp.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burden, R. E.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S: Therapeutic, Diagnostic, and Prognostic Potential</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1515%2Fhsz-2015-0114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=25872877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSrtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2015&pages=867-882&author=R.+D.+A.+Wilkinsonauthor=R.+Williamsauthor=C.+J.+Scottauthor=R.+E.+Burden&title=Cathepsin+S%3A+Therapeutic%2C+Diagnostic%2C+and+Prognostic+Potential&doi=10.1515%2Fhsz-2015-0114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S: therapeutic, diagnostic, and prognostic potential</span></div><div class="casAuthors">Wilkinson, Richard D. A.; Williams, Rich; Scott, Christopher J.; Burden, Roberta E.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-882</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Cathepsin S is a member of the cysteine cathepsin protease family.  It is a lysosomal protease which can promote degrdn. of damaged or unwanted proteins in the endo-lysosomal pathway.  Addnl., it has more specific roles such as MHC class II antigen presentation, where it is important in the degrdn. of the invariant chain.  Unsurprisingly, mis-regulation has implicated cathepsin S in a variety of pathol. processes including arthritis, cancer, and cardiovascular disease, where it becomes secreted and can act on extracellular substrates.  In comparison to many other cysteine cathepsin family members, cathepsin S has uniquely restricted tissue expression and is more stable at a neutral pH, which supports its involvement and importance in localised disease microenvironments.  In this review, we examine the known involvement of cathepsin S in disease, particularly with respect to recent work indicating its role in mediating pain, diabetes, and cystic fibrosis.  We provide an overview of current literature with regards cathepsin S as a therapeutic target, as well as its role and potential as a predictive diagnostic and/or prognostic marker in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ9-OsCJWtTLVg90H21EOLACvtfcHk0lgOQvl-ocS6ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSrtLbK&md5=1e8637a0213779c1c5105756c0c978d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0114%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DR.%2BD.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DBurden%26aufirst%3DR.%2BE.%26atitle%3DCathepsin%2520S%253A%2520Therapeutic%252C%2520Diagnostic%252C%2520and%2520Prognostic%2520Potential%26jtitle%3DBiol.%2520Chem.%26date%3D2015%26volume%3D396%26spage%3D867%26epage%3D882%26doi%3D10.1515%2Fhsz-2015-0114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drake, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oursler, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khosla, S.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1210/er.2015-1114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1210%2Fer.2015-1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=28651365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC1cjhvFCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=325-350&author=M.+T.+Drakeauthor=B.+L.+Clarkeauthor=M.+J.+Ourslerauthor=S.+Khosla&title=Cathepsin+K+Inhibitors+for+Osteoporosis%3A+Biology%2C+Potential+Clinical+Utility%2C+and+Lessons+Learned&doi=10.1210%2Fer.2015-1114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned</span></div><div class="casAuthors">Drake Matthew T; Clarke Bart L; Oursler Merry Jo; Khosla Sundeep</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-350</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cathepsin K is a cysteine protease member of the cathepsin lysosomal protease family.  Although cathepsin K is highly expressed in osteoclasts, lower levels of cathepsin K are also found in a variety of other tissues.  Secretion of cathepsin K from the osteoclast into the sealed osteoclast-bone cell interface results in efficient degradation of type I collagen.  The absence of cathepsin K activity in humans results in pycnodysostosis, characterized by increased bone mineral density and fractures.  Pharmacologic cathepsin K inhibition leads to continuous increases in bone mineral density for ≤5 years of treatment and improves bone strength at the spine and hip.  Compared with other antiresorptive agents, cathepsin K inhibition is nearly equally efficacious for reducing biochemical markers of bone resorption but comparatively less active for reducing bone formation markers.  Despite multiple efforts to develop cathepsin K inhibitors, potential concerns related to off-target effects of the inhibitors against other cathepsins and cathepsin K inhibition at nonbone sites, including skin and perhaps cardiovascular and cerebrovascular sites, prolonged the regulatory approval process.  A large multinational randomized, double-blind phase III study of odanacatib in postmenopausal women with osteoporosis was recently completed.  Although that study demonstrated clinically relevant reductions in fractures at multiple sites, odanacatib was ultimately withdrawn from the regulatory approval process after it was found to be associated with an increased risk of cerebrovascular accidents.  Nonetheless, the underlying biology and clinical effects of cathepsin K inhibition remain of considerable interest and could guide future therapeutic approaches for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYsuGMEuOzAyXXDYhVZBdlfW6udTcc2ebvLyzkvEXu3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjhvFCrsw%253D%253D&md5=e57986276b10974f6636e86351903c10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1210%2Fer.2015-1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2015-1114%26sid%3Dliteratum%253Aachs%26aulast%3DDrake%26aufirst%3DM.%2BT.%26aulast%3DClarke%26aufirst%3DB.%2BL.%26aulast%3DOursler%26aufirst%3DM.%2BJ.%26aulast%3DKhosla%26aufirst%3DS.%26atitle%3DCathepsin%2520K%2520Inhibitors%2520for%2520Osteoporosis%253A%2520Biology%252C%2520Potential%2520Clinical%2520Utility%252C%2520and%2520Lessons%2520Learned%26jtitle%3DEndocr.%2520Rev.%26date%3D2017%26volume%3D38%26spage%3D325%26epage%3D350%26doi%3D10.1210%2Fer.2015-1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span>; <span class="NLM_string-name">Robertson, S. A.</span>; <span class="NLM_string-name">Brinen, L. S.</span>; <span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cruzain</span>. In  <i>Cysteine Proteases of Pathogenic Organisms</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. W.</span>; <span class="NLM_string-name">Dalton, J. P.</span></span>, Eds; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">115</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2F978-1-4419-8414-2_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=100-115&author=M.+Sajid&author=S.+A.+Robertson&author=L.+S.+Brinen&author=J.+H.+McKerrowauthor=M.+W.+Robinson&author=J.+P.+Dalton&title=Cysteine+Proteases+of+Pathogenic+Organisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-8414-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-8414-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DSajid%26aufirst%3DM.%26atitle%3DCruzain%26btitle%3DCysteine%2520Proteases%2520of%2520Pathogenic%2520Organisms%26aulast%3DRobinson%26aufirst%3DM.%2BW.%26pub%3DSpringer%26date%3D2011%26spage%3D100%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eakin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">The Sequence, Organization, and Expression of the Major Cysteine Protease (Cruzain) from <i>Trypanosoma cruzi</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">7411</span>– <span class="NLM_lpage">7420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1559982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3sXitVygtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=7411-7420&author=A.+E.+Eakinauthor=A.+A.+Millsauthor=G.+Harthauthor=J.+H.+McKerrowauthor=C.+S.+Craik&title=The+Sequence%2C+Organization%2C+and+Expression+of+the+Major+Cysteine+Protease+%28Cruzain%29+from+Trypanosoma+cruzi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi</span></div><div class="casAuthors">Eakin, Ann E.; Mills, Alea A.; Harth, Guenter; McKerrow, James H.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7411-20</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The complete sequence of the gene encoding the major cysteine protease from T. cruzi is reported.  The amino acid sequence predicted from the gene sequence aligns well with members of the papain family of cysteine proteases, suggesting the name cruzain.  The sequence is most closely related to the cysteine protease of Trypanosoma brucei (59.3%) and the murine cathepsin L (42.2%).  At least six copies of the gene are present in the genome and are organized in a tandem array of copies which are identical in all restriction endonucleases sites tested.  The gene appears to be expressed in all developmental stages of T. cruzi with mRNA levels approx. 2-fold higher in the intracellular amastigote form.  The T. cruzi gene was expressed in bacteria as an inactive, insol. fusion polypeptide to approx. 5% of the total cell protein.  The fusion protein was readily purified, solubilized in urea, and successfully refolded to produce a polyprotein which processed autocatalytically to yield active protease.  The processed form of the recombinant protease has an N-terminal sequence identical to that of the mature form of the protease purified from T. cruzi (Murta, A. C. M., et al., 1990; Cazzulo, J. J., et al., 1989).  This suggests that the recombinant protease possesses the requisite specificity and activity to correctly process the proform of the protease in vitro.  Kinetic assays with peptide substrates demonstrate that the substrate specificity and kinetic parameters for the recombinant protease are consistent with those of the endogenous protease.  The proteolytic activity of the recombinant protease is enhanced by dithiothreitol, inhibited by leupeptin, Nα-p-tosyl-L-lysine chloromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) but is unaffected by phenylmethylsulfonyl fluoride, pepstatin, and 1,10-phenanthroline.  More specifically, the recombinant enzyme was inhibited by benzyloxycarbonyl-Phe-Arg-fluoromethyl ketone, which inhibits replication and differentiation of T. cruzi within mammalian cells in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaeq71ROrbVg90H21EOLACvtfcHk0lg_9V54SM-2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVygtr0%253D&md5=7606ae983cdbd4ea0fca4711502d980d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEakin%26aufirst%3DA.%2BE.%26aulast%3DMills%26aufirst%3DA.%2BA.%26aulast%3DHarth%26aufirst%3DG.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DThe%2520Sequence%252C%2520Organization%252C%2520and%2520Expression%2520of%2520the%2520Major%2520Cysteine%2520Protease%2520%2528Cruzain%2529%2520from%2520Trypanosoma%2520cruzi%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D7411%26epage%3D7420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eakin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span> <span> </span><span class="NLM_article-title">The Crystal Structure of Cruzain: A Therapeutic Target for Chagas’ Disease</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1994.0137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1006%2Fjmbi.1994.0137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=7707373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK2MXkvV2ku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1995&pages=251-259&author=M.+E.+McGrathauthor=A.+E.+Eakinauthor=J.+C.+Engelauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=R.+J.+Fletterick&title=The+Crystal+Structure+of+Cruzain%3A+A+Therapeutic+Target+for+Chagas%E2%80%99+Disease&doi=10.1006%2Fjmbi.1994.0137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of cruzain: a therapeutic target for Chagas' disease</span></div><div class="casAuthors">McGrath, Mary E.; Eakin, Ann E.; Engel, Juan C.; McKerrow, James H.; Craik, Charles C.; Fletterick, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-9</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Trypanosoma cruzi, a protozoan parasite, is the etiol. agent of American trypanosomiasis or Chagas' disease.  Chagas disease afflicts >24 million individuals in South and Central America producing a debilitating life-long disease.  It is the leading cause of heart failure in many Latin American countries.  Currently, there is no satisfactory treatment for this parasitic infection.  Cruzain (also known as cruzipain; gp 57/51), the major cysteine protease present in T. cruzi, is crit. for the development and survival of the parasite within the host cells, making this enzyme a target for potential trypanocidal drugs.  Here, the x-ray crystal structure of cruzain complexed with the potent inhibitor, Z-Phe-Ala-fluoromethyl ketone, is reported.  The structure was detd. at 2.35 Å (Rcryst = 0.15) by mol. replacement using a modified papain as the search model.  The refined structure was compared to papain.  Features which distinguish cruzain from papain were discussed since they may aid in the design of specificity inhibitors.  Fluorescence microscopy showed that a biotinylated form of the bound inhibitor did not effectively reach the host protease in their lysosomal compartment, but was selectively taken up by the parasite.  The inhibitor greatly reduced parasitemia in a cell culture system, without adverse effects to mammalian cells.  This biol. selectivity could be exploited, in conjunction with unique active site features revealed by the crystal structure, to develop chemotherapy for Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPcmJ9Y_oG7Vg90H21EOLACvtfcHk0lg_9V54SM-2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvV2ku7c%253D&md5=9107eb6e0a3982fac7bb8bf636b154b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1994.0137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1994.0137%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DEakin%26aufirst%3DA.%2BE.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520Cruzain%253A%2520A%2520Therapeutic%2520Target%2520for%2520Chagas%25E2%2580%2599%2520Disease%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D247%26spage%3D251%26epage%3D259%26doi%3D10.1006%2Fjmbi.1994.0137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stierhof, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Active Site Mapping, Biochemical Properties and Subcellular Localization of Rhodesain, the Major Cysteine Protease of <i>Trypanosoma brucei rhodesiense</i></span>. <i>Mol. Biochem. Parasitol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(01)00368-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0166-6851%2801%2900368-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=11704274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2001&pages=61-73&author=C.+R.+Caffreyauthor=E.+Hansellauthor=K.+D.+Lucasauthor=L.+S.+Brinenauthor=A.+A.+Hernandezauthor=J.+Chengauthor=S.+L.+Gwaltneyauthor=W.+R.+Roushauthor=Y.+D.+Stierhofauthor=M.+Bogyoauthor=D.+Steverdingauthor=J.+H.+McKerrow&title=Active+Site+Mapping%2C+Biochemical+Properties+and+Subcellular+Localization+of+Rhodesain%2C+the+Major+Cysteine+Protease+of+Trypanosoma+brucei+rhodesiense&doi=10.1016%2FS0166-6851%2801%2900368-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Caffrey, Conor R.; Hansell, Elizabeth; Lucas, Kimberley D.; Brinen, Linda S.; Alvarez Hernandez, Alejandro; Cheng, Jiamning; Gwaltney, Stephen L., II; Roush, William R.; Stierhof, York-Dieter; Bogyo, Matthew; Steverding, Dietmar; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-73</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cysteine protease activity of African trypanosome parasites is a target for new chemotherapy using synthetic protease inhibitors.  To support this effort and further characterize the enzyme, we expressed and purified rhodesain, the target protease of Trypanosoma brucei rhodesiense (MVAT4 strain), in reagent quantities from Pichia pastoris.  Rhodesain was secreted as an active, mature protease.  Site-directed mutagenesis of a cryptic glycosylation motif not previously identified allowed prodn. of rhodesain suitable for crystn.  An invariable ER(A/V)FNAA motif in the pro-peptide sequence of rhodesain was identified as being unique to the genus Trypanosoma.  Antibodies to rhodesain localized the protease in the lysosome and identified a 40-kDa protein in long slender forms of T. b. rhodesiense and all life-cycle stages of T. b. brucei.  With the latter parasite, protease expression was five times greater in short stumpy trypanosomes than in the other stages.  Radiolabeled active site-directed inhibitors identified brucipain as the major cysteine protease in T. b. brucei.  Peptidomimetic vinyl sulfone and epoxide inhibitors designed to interact with the S2, S1 and S' subsites of the active site cleft revealed differences between rhodesain and the related trypanosome protease cruzain.  Using fluorogenic dipeptidyl substrates, rhodesain and cruzain had acid pH optima, but unlike some mammalian cathepsins retained significant activity and stability up to pH 8.0, consistent with a possible extracellular function.  S2 subsite mapping of rhodesain and cruzain with fluorogenic peptidyl substrates demonstrates that the presence of alanine rather than glutamate at S2 prevents rhodesain from cleaving substrates in which P2 is arginine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJfvYdkg17bVg90H21EOLACvtfcHk0lg_9V54SM-2gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFSqsrk%253D&md5=756484ab3694e015c7aef9591eb2bb7c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2801%2900368-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252801%252900368-1%26sid%3Dliteratum%253Aachs%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DLucas%26aufirst%3DK.%2BD.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DHernandez%26aufirst%3DA.%2BA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DStierhof%26aufirst%3DY.%2BD.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DActive%2520Site%2520Mapping%252C%2520Biochemical%2520Properties%2520and%2520Subcellular%2520Localization%2520of%2520Rhodesain%252C%2520the%2520Major%2520Cysteine%2520Protease%2520of%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DMol.%2520Biochem.%2520Parasitol%26date%3D2001%26volume%3D118%26spage%3D61%26epage%3D73%26doi%3D10.1016%2FS0166-6851%2801%2900368-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span> <span> </span><span class="NLM_article-title"><i>Trypanosoma brucei:</i> Chemical Evidence that Cathepsin L is Essential for Survival and a Relevant Drug Target</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.ijpara.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.ijpara.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22549023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=481-488&author=D.+Steverdingauthor=D.+W.+Sextonauthor=X.+Wangauthor=S.+S.+Gehrkeauthor=G.+K.+Wagnerauthor=C.+R.+Caffrey&title=Trypanosoma+brucei%3A+Chemical+Evidence+that+Cathepsin+L+is+Essential+for+Survival+and+a+Relevant+Drug+Target&doi=10.1016%2Fj.ijpara.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosoma brucei: Chemical evidence that cathepsin L is essential for survival and a relevant drug target</span></div><div class="casAuthors">Steverding, Dietmar; Sexton, Darren W.; Wang, Xia; Gehrke, Sebastian S.; Wagner, Gerd K.; Caffrey, Conor R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-488</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protozoan parasite causing human African trypanosomiasis, Trypanosoma brucei, displays cysteine peptidase activity, the chem. inhibition of which is lethal to the parasite.  This activity comprises a cathepsin B (TbCATB) and a cathepsin L (TbCATL).  Previous RNA interference (RNAi) data suggest that TbCATB rather than TbCATL is essential to survival even though silencing of the latter was incomplete.  Also, chem. evidence supporting the essentiality of either enzyme which would facilitate a target-based drug development program is lacking.  Using specific peptidyl inhibitors and substrates, we quantified the contributions of TbCATB and TbCATL to the survival of T. brucei.  At 100 μM, the minimal inhibitory concn. that kills all parasites in culture, the non-specific cathepsin inhibitors, benzyloxycarbonyl-phenylalanyl-arginyl-diazomethyl ketone (Z-FA-diazomethyl ketone) and (l-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l-proline Me ester (CA-074Me) inhibited TbCATL and TbCATB by >99%.  The cathepsin L (CATL)-specific inhibitor, ((2S,3S)-oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide}) (CAA0225), killed parasites with >99% inhibition of TbCATL but only 70% inhibition of TbCATB.  Conversely, the cathepsin B (CATB)-specific inhibitor, (l-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l-proline (CA-074), did not affect survival even though TbCATB inhibition at >95% was statistically indistinguishable from the complete inhibition by Z-FA-diazomethyl ketone and CA-074Me.  The obsd. inhibition of TbCATL by CA-074 and CA-074Me was shown to be facilitated by the reducing intracellular environment.  All inhibitors, except the CATB-specific inhibitor, CA-074, blockaded lysosomal hydrolysis prior to death.  The results suggest that TbCATL, rather than TbCATB, is essential to the survival of T. brucei and an appropriate drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr675aPCwLVBbVg90H21EOLACvtfcHk0lh8200xWNU6Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWht7Y%253D&md5=c90f0f98b9727b92406f43d3a6a94bd8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpara.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpara.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGehrke%26aufirst%3DS.%2BS.%26aulast%3DWagner%26aufirst%3DG.%2BK.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26atitle%3DTrypanosoma%2520brucei%253A%2520Chemical%2520Evidence%2520that%2520Cathepsin%2520L%2520is%2520Essential%2520for%2520Survival%2520and%2520a%2520Relevant%2520Drug%2520Target%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2012%26volume%3D42%26spage%3D481%26epage%3D488%26doi%3D10.1016%2Fj.ijpara.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetter, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span> <span> </span><span class="NLM_article-title">A Parasite Cysteine Protease is Key to Host Protein Degradation and Iron Acquisition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">28934</span>– <span class="NLM_lpage">28943</span>, <span class="refDoi"> DOI: 10.1074/jbc.M805824200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M805824200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=18701454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Glsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28934-28943&author=T.+C.+O%E2%80%99Brienauthor=Z.+B.+Mackeyauthor=R.+D.+Fetterauthor=Y.+Choeauthor=A.+J.+O%E2%80%99Donoghueauthor=M.+Zhouauthor=C.+S.+Craikauthor=C.+R.+Caffrey&title=A+Parasite+Cysteine+Protease+is+Key+to+Host+Protein+Degradation+and+Iron+Acquisition&doi=10.1074%2Fjbc.M805824200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Parasite Cysteine Protease Is Key to Host Protein Degradation and Iron Acquisition</span></div><div class="casAuthors">O'Brien, Theresa C.; Mackey, Zachary B.; Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.; Caffrey, Conor R.; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">28934-28943</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the Clan CA (papain) family are the predominant protease group in primitive invertebrates.  Cysteine protease inhibitors arrest infection by the protozoan parasite, Trypanosoma brucei.  RNA interference studies implicated a cathepsin B-like protease, tbcatB, as a key inhibitor target.  Utilizing parasites in which one of the two alleles of tbcatb has been deleted, the key role of this protease in degrdn. of endocytosed host proteins is delineated.  TbcatB deficiency results in a decreased growth rate and dysmorphism of the flagellar pocket and the subjacent endocytic compartment.  Western blot and microscopic anal. indicate that deficiency in tbcatB results in accumulation of both host and parasite proteins, including the lysosomal marker p67.  A crit. function for parasitism is the degrdn. of host transferrin, which is necessary for iron acquisition.  Substrate specificity anal. of recombinant tbcatB revealed the optimal peptide cleavage sequences for the enzyme and these were confirmed exptl. using FRET-based substrates.  Degrdn. of transferrin was validated by SDS-PAGE and the specific cleavage sites identified by N-terminal sequencing.  Because even a modest deficiency in tbcatB is lethal for the parasite, tbcatB is a logical target for the development of new anti-trypanosomal chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0xdbV3G4STbVg90H21EOLACvtfcHk0lh8200xWNU6Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Glsb7I&md5=27c09cee7b81bf5991513010a65ee0ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M805824200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M805824200%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BC.%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DFetter%26aufirst%3DR.%2BD.%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26atitle%3DA%2520Parasite%2520Cysteine%2520Protease%2520is%2520Key%2520to%2520Host%2520Protein%2520Degradation%2520and%2520Iron%2520Acquisition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28934%26epage%3D28943%26doi%3D10.1074%2Fjbc.M805824200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span> <span> </span><span class="NLM_article-title">The <i>Trypanosoma cruzi</i> Protease Cruzain Mediates Immune Evasion</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1002139</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.ppat.1002139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=21909255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1altLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&author=P.+S.+Doyleauthor=Y.+M.+Zhouauthor=I.+Hsiehauthor=D.+C.+Greenbaumauthor=J.+H.+McKerrowauthor=J.+C.+Engel&title=The+Trypanosoma+cruzi+Protease+Cruzain+Mediates+Immune+Evasion&doi=10.1371%2Fjournal.ppat.1002139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Trypanosoma cruzi protease cruzain mediates immune evasion</span></div><div class="casAuthors">Doyle, Patricia S.; Zhou, Yuan M.; Hsieh, Ivy; Greenbaum, Doron C.; McKerrow, James H.; Engel, Juan C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002139</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Trypanosoma cruzi is the causative agent of Chagas' disease.  Novel chemotherapy with the drug K11777 targets the major cysteine protease cruzain and disrupts amastigote intracellular development.  Nevertheless, the biol. role of the protease in infection and pathogenesis remains unclear as cruzain gene knockout failed due to genetic redundancy.  A role for the T. cruzi cysteine protease cruzain in immune evasion was elucidated in a comparative study of parental wild type- and cruzain-deficient parasites.  Wild type T. cruzi did not activate host macrophages during early infection (<60 min) and no increase in ∼P iκB was detected.  The signaling factor NF-κB P65 colocalized with cruzain on the cell surface of intracellular wild type parasites, and was proteolytically cleaved.  No significant IL-12 expression occurred in macrophages infected with wild type T. cruzi and treated with LPS and BFA, confirming impairment of macrophage activation pathways.  In contrast, cruzain-deficient parasites induced macrophage activation, detectable iκB phosphorylation, and nuclear NF-κB P65 localization.  These parasites were unable to develop intracellularly and survive within macrophages.  IL-12 expression levels in macrophages infected with cruzain-deficient T. cruzi were comparable to LPS activated controls.  Thus cruzain hinders macrophage activation during the early (<60 min) stages of infection, by interruption of the NF-κB P65 mediated signaling pathway.  These early events allow T. cruzi survival and replication, and may lead to the spread of infection in acute Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA2EglOwxBsLVg90H21EOLACvtfcHk0lh8200xWNU6Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1altLnM&md5=bb2b90a2ef673596cca188faa96fa5b0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002139%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DY.%2BM.%26aulast%3DHsieh%26aufirst%3DI.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Trypanosoma%2520cruzi%2520Protease%2520Cruzain%2520Mediates%2520Immune%2520Evasion%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26doi%3D10.1371%2Fjournal.ppat.1002139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Peptide-fluoromethyl Ketones Arrest Intracellular Replication and Intercellular Transmission of <i>Trypanosoma cruzi</i></span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/0166-6851(93)90086-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2F0166-6851%2893%2990086-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=8459830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=17-24&author=G.+Harthauthor=N.+Andrewsauthor=A.+A.+Millsauthor=J.+C.+Engelauthor=R.+Smithauthor=J.+H.+McKerrow&title=Peptide-fluoromethyl+Ketones+Arrest+Intracellular+Replication+and+Intercellular+Transmission+of+Trypanosoma+cruzi&doi=10.1016%2F0166-6851%2893%2990086-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-fluoromethyl ketones arrest intracellular replication and intercllular transmission of Trypanosoma cruzi</span></div><div class="casAuthors">Harth, Guenter; Andrews, Norma; Mills, Alea A.; Engel, Juan C.; Smith, Robert; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    </div><div class="casAbstract">The major proteolytic activity of T. cruzi is a cathepsin L-like cysteine protease expressed in all stages of the parasite.  As an initial step in identifying possible functions of this enzyme in the life cycle of T. cruzi, and examg. its potential as a target for rational drug design, two fluoromethyl ketone-derivatized cysteine protease inhibitors were studied for their effects on T. cruzi infection of mammalian cells.  Both inhibitors are irreversible substrate analogs with high specificity for cysteine proteases and minimal toxicity to mammalian cells.  While micromolar concns. of inhibitors had some effect on replication of all parasite stages, the most dramatic arrest replication occurred at the transformation of trypomastigote to amastigote, and also from amastigote to trypomastigote.  It is therefore proposed that the enzyme functions not only in intracellular protein degrdn. in some stages of T. cruzi, but also in remodeling of the parasite during transformation between stages.  Concns. of inhibitors necessary to interrupt the parasite life cycle had no observable toxicity to macrophages, fibroblasts or epithelial cells in culture.  Differential susceptibility of T. cruzi vs. host cysteine proteases to fluoromethyl ketone protease inhibitors suggests that inhibition of the T. cruzi cysteine protease is a potential lead for new chemotherapy of Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AvI4UpyaabVg90H21EOLACvtfcHk0ljtbX2ptsspIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Cqu7o%253D&md5=f967250f17785c1aa95dca30743df744</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0166-6851%2893%2990086-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0166-6851%252893%252990086-D%26sid%3Dliteratum%253Aachs%26aulast%3DHarth%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DN.%26aulast%3DMills%26aufirst%3DA.%2BA.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DPeptide-fluoromethyl%2520Ketones%2520Arrest%2520Intracellular%2520Replication%2520and%2520Intercellular%2520Transmission%2520of%2520Trypanosoma%2520cruzi%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1993%26volume%3D58%26spage%3D17%26epage%3D24%26doi%3D10.1016%2F0166-6851%2893%2990086-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">A Cysteine Protease Inhibitor Cures Chagas Disease in an Immunodeficient-Mouse Model of Infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3932</span>– <span class="NLM_lpage">3939</span>, <span class="refDoi"> DOI: 10.1128/AAC.00436-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.00436-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=17698625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3932-3939&author=P.+S.+Doyleauthor=Y.+M.+Zhouauthor=J.+C.+Engelauthor=J.+H.+McKerrow&title=A+Cysteine+Protease+Inhibitor+Cures+Chagas+Disease+in+an+Immunodeficient-Mouse+Model+of+Infection&doi=10.1128%2FAAC.00436-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection</span></div><div class="casAuthors">Doyle, Patricia S.; Zhou, Yuan M.; Engel, Juan C.; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3932-3939</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chagas' disease, caused by the parasite Trypanosoma cruzi, remains the leading cause of cardiopathy in Latin America with about 12 million people infected.  Classic clin. manifestations derive from infection of muscle cells leading to progressive cardiomyopathy, while some patients develop megacolon or megaesophagus.  A very aggressive clin. course including fulminant meningoencephalitis has been reported in patients who contract Chagas' disease in the background of immunodeficiency.  This includes patients with human immunodeficiency virus infection as well as patients receiving immunosuppressive therapy for organ transplant.  Currently, only two drugs are approved for the treatment of Chagas' disease, nifurtimox and benznidazole.  Both have significant limitations due to common and serious side effects as well as limited availability.  A promising group of new drug leads for Chagas' disease is cysteine protease inhibitors targeting cruzain, the major protease of T. cruzi.  The inhibitor N-methyl-Pip-F-homoF-vinyl sulfonyl Ph (N-methyl-Pip-F-hF-VSφ) is in late-stage preclin. development.  Therefore, the question arose as to whether protease inhibitors targeting cruzain would have efficacy in Chagas' disease occurring in the background of immunodeficiency.  To address this question, we studied the course of infection in recombinase-deficient (Rag1-/-) and normal mice infected with T. cruzi.  Infections localized to heart and skeletal muscle in untreated normal animals, while untreated Rag1-/- mice showed severe infection in all organs and predominantly in liver and spleen.  Treatment with the dipeptide N-methyl-Pip-F-hF-VSφ rescued immunodeficient animals from lethal Chagas' infection.  The majority (60 to 100%) of inhibitor-treated Rag1-/- mice had increased survival, neg. PCR, and normal tissues by histopathol. examn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruii0nk3W_xbVg90H21EOLACvtfcHk0ljtbX2ptsspIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtL%252FL&md5=f692870a11fca60f359edbad28145788</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.00436-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00436-07%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DY.%2BM.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Cysteine%2520Protease%2520Inhibitor%2520Cures%2520Chagas%2520Disease%2520in%2520an%2520Immunodeficient-Mouse%2520Model%2520of%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3932%26epage%3D3939%26doi%3D10.1128%2FAAC.00436-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal Effect of Cysteine Protease Inhibitors <i>in vitro</i> and <i>in vivo</i> in Experimental Chagas Disease</span>. <i>Medicina</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10668260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BD3c7jtlCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=171-175&author=J.+C.+Engelauthor=P.+S.+Doyleauthor=J.+H.+McKerrow&title=Trypanocidal+Effect+of+Cysteine+Protease+Inhibitors+in+vitro+and+in+vivo+in+Experimental+Chagas+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal effect of cysteine protease inhibitors in vitro and in vivo in experimental Chagas disease</span></div><div class="casAuthors">Engel J C; Doyle P S; McKerrow J H</div><div class="citationInfo"><span class="NLM_cas:title">Medicina</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-5</span>
        ISSN:<span class="NLM_cas:issn">0025-7680</span>.
    </div><div class="casAbstract">Endemic in most American countries, Chagas' disease causes high morbidity and mortality.  Recent experimental and clinical evidence shows the importance of chemotherapy in both the acute and chronic phases of this disease.  However, treatment is yet limited by the toxicity associated to available drugs.  This review describes the design, evolution, and selection of dipeptides that interrupt the intracellular cycle of T. cruzi and cure acute experimental infections in laboratory animals.  Peptido-mimetic inhibitors specifically bind cruzain, a T. cruzi cystein protease.  The inhibitors cause alterations in the Golgi complex and ER, accumulation of unprocessed enzyme within Golgi cisternae, and decrease of mature cruzain within lysosomes.  The most effective compound, N-Pip-F-hF-VS phi, cured an acute lethal infection in experimental animals.  Myocardial lesions, lymphocyte infiltration and intracellular amastigote clusers were absent in treated animals.  Preliminary toxicology and pharmacokinetic analyses suggest the lack of toxicity associated to high doses and prolonged treatment regimes.  Protease inhibitors may soon become good chemotherapeutic alternatives for acute and chronic Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO9qHJyma4n3T4ugvCDgnZfW6udTcc2eZ68lgpglh3S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7jtlCguw%253D%253D&md5=fa8ae41479921dcfcc4415ce5e06ccf5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DTrypanocidal%2520Effect%2520of%2520Cysteine%2520Protease%2520Inhibitors%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520Experimental%2520Chagas%2520Disease%26jtitle%3DMedicina%26date%3D1999%26volume%3D59%26spage%3D171%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cysteine Protease Inhibitors Cure an Experimental <i>Trypanosoma cruzi</i> Infection</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1084/jem.188.4.725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1084%2Fjem.188.4.725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=9705954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1998&pages=725-734&author=J.+C.+Engelauthor=P.+S.+Doyleauthor=I.+Hsiehauthor=J.+H.+McKerrow&title=Cysteine+Protease+Inhibitors+Cure+an+Experimental+Trypanosoma+cruzi+Infection&doi=10.1084%2Fjem.188.4.725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection</span></div><div class="casAuthors">Engel, Juan C.; Doyle, Patricia S.; Hsieh, Ivy; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">725-734</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Trypanosoma cruzi is the causative agent of Chagas' disease.  The major protease, cruzain, is a target for the development of new chemotherapy.  We report the first successful treatment of an animal model of Chagas' disease with inhibitors designed to inactivate cruzain.  Treatment with fluoromethyl ketone-derivatized pseudopeptides rescued mice from lethal infection.  The optimal pseudopeptide scaffold was phenylalanine-homophenylalanine.  To achieve cure of infection, this pseudopeptide scaffold was incorporated in a less toxic vinyl sulfone deriv.  N-Me piperazine-Phe-homoPhe-vinyl sulfone Ph also rescued mice from a lethal infection.  Six of the treated mice survived over nine months, three without further treatment.  Three mice that had entered the chronic stage of infection were retreated with a 20-d regimen.  At the conclusion of the expts., five of the six mice had repeated neg. hemacultures, indicative of parasitol. cure.  Studies of the effect of inhibitors on the intracellular amastigote form suggest that the life cycle is interrupted because of inhibitor arrest of normal autoproteolytic cruzain processing at the level of the Golgi complex.  Parasites recovered from the hearts of treated mice showed the same abnormalities as those treated in vitro.  No abnormalities were noted in the Golgi complex of host cells.  This study provides proof of concept that cysteine protease inhibitors can be given at therapeutic doses to animals to selectively arrest a parasitic infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3b1RC4nplbVg90H21EOLACvtfcHk0ljViJaCETJ4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFClsbw%253D&md5=045e4e5dcf81aa7b44f1b9db96e7c5a8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1084%2Fjem.188.4.725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.188.4.725%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DHsieh%26aufirst%3DI.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DCysteine%2520Protease%2520Inhibitors%2520Cure%2520an%2520Experimental%2520Trypanosoma%2520cruzi%2520Infection%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D188%26spage%3D725%26epage%3D734%26doi%3D10.1084%2Fjem.188.4.725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span> <span> </span><span class="NLM_article-title">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25697</span>– <span class="NLM_lpage">25703</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+Sulfones+as+Antiparasitic+Agents+and+a+Structural+Basis+for+Drug+Design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0ljViJaCETJ4kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520Sulfones%2520as%2520Antiparasitic%2520Agents%2520and%2520a%2520Structural%2520Basis%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> Studies of the Trypanocidal Properties of WRR-483 against <i>Trypanosoma cruzi</i></span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e825</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pntd.0000825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=20856868" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&author=Y.+T.+Chenauthor=L.+S.+Brinenauthor=I.+D.+Kerrauthor=E.+Hansellauthor=P.+S.+Doyleauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=In+vitro+and+in+vivo+Studies+of+the+Trypanocidal+Properties+of+WRR-483+against+Trypanosoma+cruzi&doi=10.1371%2Fjournal.pntd.0000825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Studies%2520of%2520the%2520Trypanocidal%2520Properties%2520of%2520WRR-483%2520against%2520Trypanosoma%2520cruzi%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26doi%3D10.1371%2Fjournal.pntd.0000825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, K. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1021/jm901069a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901069a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=52-60&author=B.+T.+Mottauthor=R.+S.+Ferreiraauthor=A.+Simeonovauthor=A.+Jadhavauthor=K.+K.+H.+Angauthor=W.+Leisterauthor=M.+Shenauthor=J.+T.+Silveiraauthor=P.+S.+Doyleauthor=M.+R.+Arkinauthor=J.+H.+McKerrowauthor=J.+Ingleseauthor=C.+P.+Austinauthor=C.+J.+Thomasauthor=B.+K.+Shoichetauthor=D.+J.+Maloney&title=Identification+and+Optimization+of+Inhibitors+of+Trypanosomal+Cysteine+Proteases%3A+Cruzain%2C+Rhodesain%2C+and+TbCatB&doi=10.1021%2Fjm901069a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB</span></div><div class="casAuthors">Mott, Bryan T.; Ferreira, Rafaela S.; Simeonov, Anton; Jadhav, Ajit; Ang, Kenny Kean-Hooi; Leister, William; Shen, Min; Silveira, Julia T.; Doyle, Patricia S.; Arkin, Michelle R.; McKerrow, James H.; Inglese, James; Austin, Christopher P.; Thomas, Craig J.; Shoichet, Brian K.; Maloney, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas' disease and African sleeping sickness, resp.  Both parasites rely on essential cysteine proteases for survival: cruzain for T. cruzi and TbCatB/rhodesain for T. brucei.  A recent quant. high-throughput screen of cruzain identified triazine nitriles, which are known inhibitors of other cysteine proteases, as reversible inhibitors of the enzyme.  Structural modifications detailed herein, including core scaffold modification from triazine to purine, improved the in vitro potency against both cruzain and rhodesain by 350-fold, while also gaining activity against T. brucei parasites.  Selected compds. were screened against a panel of human cysteine and serine proteases to det. selectivity, and a co-crystal was obtained of our most potent analog bound to cruzain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooBt9aofNhebVg90H21EOLACvtfcHk0liIgSG4kfx6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FM&md5=473bade6311d998f7a4521a0c93b9fce</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901069a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901069a%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DFerreira%26aufirst%3DR.%2BS.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DAng%26aufirst%3DK.%2BK.%2BH.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DSilveira%26aufirst%3DJ.%2BT.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520Inhibitors%2520of%2520Trypanosomal%2520Cysteine%2520Proteases%253A%2520Cruzain%252C%2520Rhodesain%252C%2520and%2520TbCatB%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D52%26epage%3D60%26doi%3D10.1021%2Fjm901069a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Two Approaches to Discovering and Developing New Drugs for Chagas Disease</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1590/S0074-02762009000900034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1590%2FS0074-02762009000900034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=19753483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFegtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=263-269&author=J.+H.+McKerrowauthor=P.+S.+Doyleauthor=J.+C.+Engelauthor=L.+M.+Podustauthor=S.+A.+Robertsonauthor=R.+Ferreiraauthor=T.+Saxtonauthor=M.+Arkinauthor=I.+D.+Kerrauthor=L.+S.+Brinenauthor=C.+S.+Craik&title=Two+Approaches+to+Discovering+and+Developing+New+Drugs+for+Chagas+Disease&doi=10.1590%2FS0074-02762009000900034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Two approaches to discovering and developing new drugs for Chagas disease</span></div><div class="casAuthors">McKerrow, J. H.; Doyle, P. S.; Engel, J. C.; Podust, L. M.; Robertson, S. A.; Ferreira, R.; Saxton, T.; Arkin, M.; Kerr, I. D.; Brinen, L. S.; Craik, C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">263-269</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">This review will focus on two general approaches carried out at the Sandier Center, University of California, San Francisco, to address the challenge of developing new drugs for the treatment of Chagas disease.  The first approach is target-based drug discovery, and two specific targets, cytochrome P 450 CYP51 and cruzain (aka cruzipain), are discussed.  A "proof of concept" mol., the vinyl sulfone inhibitor K777, is now a clin. candidate.  The preclin. assessment compliance for filing as an Investigational New Drug with the United States Food and Drug Administration (FDA) is presented, and an outline of potential clin. trials is given.  The second approach to identifying new drug leads is parasite phenotypic screens in culture.  The development of an assay allowing high throughput screening of Trypanosoma cruzi amastigotes in skeletal muscle cells is presented.  This screen has the advantage of not requiring specific strains of parasites, so it could be used with field isolates, drug resistant strains or lab. strains.  It is optimized for robotic liq. handling and has been validated through a screen of a library of FDA-approved drugs identifying 65 hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPiQLGneYh2LVg90H21EOLACvtfcHk0liIgSG4kfx6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFegtLfO&md5=6d2fa84e594bf0d0f205ea0ad4f1b824</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762009000900034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762009000900034%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRobertson%26aufirst%3DS.%2BA.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSaxton%26aufirst%3DT.%26aulast%3DArkin%26aufirst%3DM.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DTwo%2520Approaches%2520to%2520Discovering%2520and%2520Developing%2520New%2520Drugs%2520for%2520Chagas%2520Disease%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2009%26volume%3D104%26spage%3D263%26epage%3D269%26doi%3D10.1590%2FS0074-02762009000900034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Update on Drug Development Targeting Parasite Cysteine Proteases</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0005850</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pntd.0005850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=30138309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslejsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&author=J.+H.+McKerrow&title=Update+on+Drug+Development+Targeting+Parasite+Cysteine+Proteases&doi=10.1371%2Fjournal.pntd.0005850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Update on drug development targeting parasite cysteine proteases</span></div><div class="casAuthors">Mckerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0005850/1-e0005850/4</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbmwZ-Qos3LrVg90H21EOLACvtfcHk0liIgSG4kfx6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslejsbzJ&md5=a3c2e59416b2a86a6a79a66c56886ccb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005850%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DUpdate%2520on%2520Drug%2520Development%2520Targeting%2520Parasite%2520Cysteine%2520Proteases%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2018%26volume%3D12%26doi%3D10.1371%2Fjournal.pntd.0005850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paavilainen, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loughhead, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Prolonged and Tunable Residence Time Using Reversible Covalent Kinase Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+Tunable+Residence+Time+Using+Reversible+Covalent+Kinase+Inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0ljYTujH8z-Qpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520Tunable%2520Residence%2520Time%2520Using%2520Reversible%2520Covalent%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">12624</span>– <span class="NLM_lpage">12630</span>, <span class="refDoi"> DOI: 10.1021/ja505194w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505194w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=12624-12630&author=S.+Krishnanauthor=R.+M.+Millerauthor=B.+Tianauthor=R.+D.+Mullinsauthor=M.+P.+Jacobsonauthor=J.+Taunton&title=Design+of+Reversible%2C+Cysteine-Targeted+Michael+Acceptors+Guided+by+Kinetic+and+Computational+Analysis&doi=10.1021%2Fja505194w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis</span></div><div class="casAuthors">Krishnan, Shyam; Miller, Rand M.; Tian, Boxue; Mullins, R. Dyche; Jacobson, Matthew P.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12624-12630</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacol. potency and selectivity.  Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood.  Here, we report a novel class of acrylonitrile-based Michael acceptors, activated by aryl or heteroaryl electron-withdrawing groups.  We demonstrate that thiol adducts of these acrylonitriles undergo β-elimination at rates that span more than 3 orders of magnitude.  These rates correlate inversely with the computed proton affinity of the corresponding carbanions, enabling the intrinsic reversibility of the thiol-Michael reaction to be tuned in a predictable manner.  We apply these principles to the design of new reversible covalent kinase inhibitors with improved properties.  A cocrystal structure of one such inhibitor reveals specific noncovalent interactions between the 1,2,4-triazole activating group and the kinase.  Our exptl. and computational study enables the design of new Michael acceptors, expanding the palette of reversible, cysteine-targeted electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHXljSEecz5LVg90H21EOLACvtfcHk0ljYTujH8z-Qpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbvK&md5=de052bac07c8920cb807c05f71f4f95d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja505194w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505194w%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DMullins%26aufirst%3DR.%2BD.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520Reversible%252C%2520Cysteine-Targeted%2520Michael%2520Acceptors%2520Guided%2520by%2520Kinetic%2520and%2520Computational%2520Analysis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D12624%26epage%3D12630%26doi%3D10.1021%2Fja505194w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug–Target Residence Time and its Implications for Lead Optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%80%93Target+Residence+Time+and+its+Implications+for+Lead+Optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0ljYTujH8z-Qpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2580%2593Target%2520Residence%2520Time%2520and%2520its%2520Implications%2520for%2520Lead%2520Optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornreic, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">A Cysteine Protease Inhibitor Protects Dogs from Cardiac Damage during Infection by <i>Trypanosoma cruzi</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5160</span>– <span class="NLM_lpage">5161</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.12.5160-5161.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.49.12.5160-5161.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16304193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=5160-5161&author=S.+C.+Barrauthor=K.+L.+Warnerauthor=B.+G.+Kornreicauthor=J.+Piscitelliauthor=A.+Wolfeauthor=L.+Benetauthor=J.+H.+McKerrow&title=A+Cysteine+Protease+Inhibitor+Protects+Dogs+from+Cardiac+Damage+during+Infection+by+Trypanosoma+cruzi&doi=10.1128%2FAAC.49.12.5160-5161.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi</span></div><div class="casAuthors">Barr, S. C.; Warner, K. L.; Kornreic, B. G.; Piscitelli, J.; Wolfe, A.; Benet, L.; McKerrow, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5160-5161</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cruzain is an essential cysteine protease of Trypanosoma cruzi and a therapeutic target for Chagas' disease.  Eight dogs were infected with T. cruzi; three were treated with an inhibitor of cruzain, K777, for 14 days.  Treatment with K777 abrogated myocardial damage by T. cruzi, as documented by histopathol. lesion scores and serum troponin I levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5fG-3KRPL2rVg90H21EOLACvtfcHk0lgEB3Zak3DPJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrvM&md5=21093940c91e59e0b312abd58f018032</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.12.5160-5161.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.12.5160-5161.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DS.%2BC.%26aulast%3DWarner%26aufirst%3DK.%2BL.%26aulast%3DKornreic%26aufirst%3DB.%2BG.%26aulast%3DPiscitelli%26aufirst%3DJ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DBenet%26aufirst%3DL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Cysteine%2520Protease%2520Inhibitor%2520Protects%2520Dogs%2520from%2520Cardiac%2520Damage%2520during%2520Infection%2520by%2520Trypanosoma%2520cruzi%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D5160%26epage%3D5161%26doi%3D10.1128%2FAAC.49.12.5160-5161.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3176</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=3176-3190&author=X.+Zhaiauthor=T.+D.+Meek&title=Catalytic+Mechanism+of+Cruzain+from+Trypanosoma+cruzi+As+Determined+from+Solvent+Kinetic+Isotope+Effects+of+Steady-State+and+Pre-Steady-State+Kinetics&doi=10.1021%2Facs.biochem.7b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span></div><div class="casAuthors">Zhai, Xiang; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3176-3190</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an important drug target for Chagas disease, is a member of Clan CA of the cysteine proteases.  Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors.  To this end, we have performed pH-rate profiles for substrates and affinity agents, and have detd. solvent kinetic isotope effects in pre-steady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC and Cbz-Arg-Ala-AMC.  The pH-rate profile of kcat/Km for Cbz-Arg-Arg-AMC indicated groups of pK1 = 6.6 (unprotonated) and pK2 ∼ 9.6 (protonated) required for catalysis.  The temp. dependence of the group of pK = 6.2 - 6.6 exhibited a values of ΔHion = 8.4 kcal/mol, typical of histidine.  The pH-rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a pKa of 9.8.  Normal solvent kinetic isotope effects were obsd. for both D2Okcat = 1.6 - 2.1 and D2Okcat/Km = 1.1 - 1.4 for all three substrates.  Pre-steady-state kinetics revealed exponential bursts of AMC prodn. for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC.  The overall solvent isotope effect on kcat is attributable to the solvent isotope effect on the deacylation step.  Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine are neutral in charge in the free enzyme.  The generation of the active thiolate of the catalytic cysteine is likely proceeded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad to close proximity in order to effect proton transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNPkhmnRHYbVg90H21EOLACvtfcHk0lgEB3Zak3DPJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D&md5=c9905e633b50aab71fe3450428aa4c84</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01250%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DCatalytic%2520Mechanism%2520of%2520Cruzain%2520from%2520Trypanosoma%2520cruzi%2520As%2520Determined%2520from%2520Solvent%2520Kinetic%2520Isotope%2520Effects%2520of%2520Steady-State%2520and%2520Pre-Steady-State%2520Kinetics%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D3176%26epage%3D3190%26doi%3D10.1021%2Facs.biochem.7b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Enzyme Inactivators</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span>; <span class="NLM_string-name">Brand, L.</span></span>, Eds; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">1995</span>; pp  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">283</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=240-283&author=R.+B.+Silvermanauthor=M.+L.+Johnson&author=L.+Brand&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMechanism-Based%2520Enzyme%2520Inactivators%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26pub%3DAcademic%2520Press%26date%3D1995%26spage%3D240%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeles, R. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Chymotrypsin by Peptidyl Trifluoromethyl Ketones: Determinants of Slow-Binding Kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">7608</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/bi00485a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00485a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFersLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=7608-7617&author=K.+Bradyauthor=R.+H.+Abeles&title=Inhibition+of+Chymotrypsin+by+Peptidyl+Trifluoromethyl+Ketones%3A+Determinants+of+Slow-Binding+Kinetics&doi=10.1021%2Fbi00485a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones:  determinants of slow-binding kinetics</span></div><div class="casAuthors">Brady, Kenneth; Abeles, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7608-17</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A series of 7 peptidyl trifluoromethyl ketone (TFK) inhibitors of chymotrypsin were prepd. which differ at the P1 and P2 subsites.  Inhibition equil. and kinetics of assocn. and dissocn. with chymotrypsin were measured.  The assocn. rate of Ac-Phe-CF3 was measured at enzyme concns. between 8 nM and 117 μM in order to examine the relation between the ketone/hydrate equil. of trifluoromethyl ketones and the slow binding by these inhibitors.  The assocn. rate decreased at high enzyme concns., indicating that TFK ketone is the reactive species and that conversion of TFK hydrate to TFK ketone becomes rate limiting under these conditions.  Inhibitors with hydrophobic side-chains at P2 bound more tightly but more slowly to chymotrypsin, indicating that formation of van der Waals contacts between the P2 side-chain and the histidine-57 and isoleucine-99 side-chains of chymotrypsin is a relatively slow process.  Inhibitor properties were compared to the Michaelis-Menten kinetic consts. of a homologous series of peptide Me ester and peptide amide substrates.  Plots of log Ki vs. log(kcat/Km) were linear with slopes of 0.65, indicating that these inhibitors are able to utilize 65% of the total binding energy between chymotrypsin and its hydrolytic transition state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsw7Ry7tBM7Vg90H21EOLACvtfcHk0lgEB3Zak3DPJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFersLo%253D&md5=0306c95a2b3a801007197e848b3934cb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00485a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00485a010%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520Chymotrypsin%2520by%2520Peptidyl%2520Trifluoromethyl%2520Ketones%253A%2520Determinants%2520of%2520Slow-Binding%2520Kinetics%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D7608%26epage%3D7617%26doi%3D10.1021%2Fbi00485a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubach, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thrall, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7551</span>– <span class="NLM_lpage">7568</span>, <span class="refDoi"> DOI: 10.1021/bi300719b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300719b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kms7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7551-7568&author=J.+K.+Rubachauthor=G.+Cuiauthor=J.+L.+Schneckauthor=A.+N.+Taylorauthor=B.+Zhaoauthor=A.+Smallwoodauthor=N.+Nevinsauthor=D.+Wisnoskiauthor=S.+H.+Thrallauthor=T.+D.+Meek&title=The+Amino-Acid+Substituents+of+Dipeptide+Substrates+of+Cathepsin+C+Can+Determine+the+Rate-Limiting+Steps+of+Catalysis&doi=10.1021%2Fbi300719b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis</span></div><div class="casAuthors">Rubach, Jon K.; Cui, Guanglei; Schneck, Jessica L.; Taylor, Amy N.; Zhao, Baoguang; Smallwood, Angela; Nevins, Neysa; Wisnoski, David; Thrall, Sara H.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7551-7568</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We examd. the cathepsin C-catalyzed hydrolysis of dipeptide substrates of the form Yaa-Xaa-AMC, using steady-state and pre-steady-state kinetic methods.  The substrates group into three kinetic profiles based upon the broad range obsd. for kcat/Ka and kcat values, pre-steady-state time courses, and solvent kinetic isotope effects (sKIEs).  The dipeptide substrate Gly-Arg-AMC displayed large values for kcat/Ka (1.6±0.09 μM-1 s-1) and kcat (255±6 s-1), an inverse sKIE on kcat/Ka (D(kcat/Ka) = 0.6±0.15), a modest, normal sKIE on kcat (Dkcat = 1.6±0.2), and immeasurable pre-steady-state kinetics, indicating an extremely fast pre-steady-state rate (>400 s-1).  (Errors on fitted values are omitted in the text for clarity but may be found in Table 2.).  These results conformed to a kinetic model where the acylation (kac) and deacylation (kdac) half-reactions are very fast and similar in value.  The second substrate type, Gly-Tyr-AMC and Ser-Tyr-AMC, the latter the subject of a comprehensive kinetic study (Schneck et al. (2008) Biochem. 47, 8697-8710), were found to be less active substrates compared to Gly-Arg-AMC, with resp. kcat/Ka values of 0.49±0.07 μM-1 s-1 and 5.3±0.5 μM-1 s-1, and kcat values of 28±1 s-1 and 25±0.5 s-1.  Solvent kinetic isotope effects for Ser-Tyr-AMC were found to be inverse for kcat/Ka (D(kcat/Ka) = 0.74±0.05) and normal for kcat (Dkcat = 2.3±0.1) but unlike Gly-Arg-AMC, pre-steady-state kinetics of Gly-Tyr-AMC and Ser-Tyr-AMC were measurable and characterized by a single-exponential burst, with fast transient rates (490 s-1 and 390 s-1, resp.), from which it was detd. that kac » kdac ∼ kcat.  The third substrate type, Gly-Ile-AMC, gave very low values of kcat/Ka (0.0015±0.0001 μM-1 s-1) and kcat (0.33±0.02 s-1), no sKIEs, (D(kcat/Ka) = 1.05±0.5 and Dkcat = 1.06±0.4), and pre-steady-state kinetics exhibited a discernible, but negligible, transient phase.  For this third class of substrate, kinetic modeling was consistent with a mechanism in which kdac > kac ∼ kcat, and for which an isotope-insensitive step in the acylation half-reaction is the slowest.  The combined results of these studies suggested that the identity of the amino acid at the P1 position of the substrate is the main determinant of catalysis.  On the basis of these kinetic data, together with crystallog. studies of substrate analogs and mol. dynamics anal. with models of acyl-enzyme intermediates, we present a catalytic model derived from the relative rates of the acylation vs. deacylation half-reactions of cathepsin C.  The chem. steps of catalysis are proposed to be dependent upon the conformational freedom of the amino acid substituents for optimal alignment for thiolation (acylation) or hydrolysis (deacylation).  These studies suggest ideas for inhibitor design for papain-family cysteine proteases and strategies to progress drug discovery for other classes of disease-relevant cysteine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9GBPYB2_wXbVg90H21EOLACvtfcHk0ljL5_btJO3zKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kms7zM&md5=e7527b6a5f5913e9cbff9fdce62dfc56</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi300719b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300719b%26sid%3Dliteratum%253Aachs%26aulast%3DRubach%26aufirst%3DJ.%2BK.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DTaylor%26aufirst%3DA.%2BN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DThrall%26aufirst%3DS.%2BH.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DThe%2520Amino-Acid%2520Substituents%2520of%2520Dipeptide%2520Substrates%2520of%2520Cathepsin%2520C%2520Can%2520Determine%2520the%2520Rate-Limiting%2520Steps%2520of%2520Catalysis%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7551%26epage%3D7568%26doi%3D10.1021%2Fbi300719b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljL5_btJO3zKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+2.+Enrichment+Factors+in+Database+Screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0ljL5_btJO3zKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25202.%2520Enrichment%2520Factors%2520in%2520Database%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein–Ligand Complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein%E2%80%93Ligand+Complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0ljfETlBBZyjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein%25E2%2580%2593Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span> <span> </span><span class="NLM_article-title">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1021/ci500118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1932-1940&author=K.+Zhuauthor=K.+W.+Borrelliauthor=J.+R.+Greenwoodauthor=T.+Dayauthor=R.+Abelauthor=R.+S.+Faridauthor=E.+Harder&title=Docking+Covalent+Inhibitors%3A+A+Parameter+Free+Approach+To+Pose+Prediction+and+Scoring&doi=10.1021%2Fci500118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span></div><div class="casAuthors">Zhu, Kai; Borrelli, Kenneth W.; Greenwood, Jeremy R.; Day, Tyler; Abel, Robert; Farid, Ramy S.; Harder, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although many popular docking programs include a facility to account for covalent ligands, large-scale systematic docking validation studies of covalent inhibitors have been sparse.  In this paper, we present the development and validation of a novel approach for docking and scoring covalent inhibitors, which consists of conventional noncovalent docking, heuristic formation of the covalent attachment point, and structural refinement of the protein-ligand complex.  This approach combines the strengths of the docking program Glide and the protein structure modeling program Prime and does not require any parameter fitting for the study of addnl. covalent reaction types.  We first test this method by predicting the native binding geometry of 38 covalently bound complexes.  The av. RMSD of the predicted poses is 1.52 Å, and 76% of test set inhibitors have an RMSD of less than 2.0 Å.  In addn., the apparent affinity score constructed herein is tested on a virtual screening study and the characterization of the SAR properties of two different series of congeneric compds. with satisfactory success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbtjEb3EqzQ7Vg90H21EOLACvtfcHk0ljfETlBBZyjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D&md5=3633c29fa5dc29817b178fd10a4c7b15</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci500118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500118s%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DBorrelli%26aufirst%3DK.%2BW.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFarid%26aufirst%3DR.%2BS.%26aulast%3DHarder%26aufirst%3DE.%26atitle%3DDocking%2520Covalent%2520Inhibitors%253A%2520A%2520Parameter%2520Free%2520Approach%2520To%2520Pose%2520Prediction%2520and%2520Scoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1932%26epage%3D1940%26doi%3D10.1021%2Fci500118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöllkopf, U.</span></span> <span> </span><span class="NLM_article-title">Über Triphenyl-phosphin-methylene als Olefinbildende Reagenzien I. Mitteil</span>. <i>Chem. Ber.</i> <span class="NLM_year" style="font-weight: bold;">1954</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1002/cber.19540870919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2Fcber.19540870919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1954&pages=1318-1330&author=G.+Wittigauthor=U.+Sch%C3%B6llkopf&title=%C3%9Cber+Triphenyl-phosphin-methylene+als+Olefinbildende+Reagenzien+I.+Mitteil&doi=10.1002%2Fcber.19540870919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fcber.19540870919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19540870919%26sid%3Dliteratum%253Aachs%26aulast%3DWittig%26aufirst%3DG.%26aulast%3DSch%25C3%25B6llkopf%26aufirst%3DU.%26atitle%3D%25C3%259Cber%2520Triphenyl-phosphin-methylene%2520als%2520Olefinbildende%2520Reagenzien%2520I.%2520Mitteil%26jtitle%3DChem.%2520Ber.%26date%3D1954%26volume%3D87%26spage%3D1318%26epage%3D1330%26doi%3D10.1002%2Fcber.19540870919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, W. D.</span></span> <span> </span><span class="NLM_article-title">The Utility of Phosphonate Carbanions in Olefin Synthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1733</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1021/ja01468a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01468a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaF3MXpvFWrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1961&pages=1733-1738&author=W.+S.+Wadsworthauthor=W.+D.+Emmons&title=The+Utility+of+Phosphonate+Carbanions+in+Olefin+Synthesis&doi=10.1021%2Fja01468a042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The utility of phosphonate carbanions in olefin synthesis</span></div><div class="casAuthors">Wadsworth, William S., Jr.; Emmons, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1733-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The reaction of phosphonate carbanions contg. electron-withdrawing groups with aldehydes or ketones in an aprotic solvent, a useful olefin synthesis, was studied.  These reagents were, in general, more reactive than the analogous triarylphosphoranes (Wittig reagents) and had a no. of special features which enhanced their usefulness.  (EtO)2P(O)CH2Bz (11.4 g.) added dropwise with stirring to 2.4 g. 50% NaH in 100 cc. dry (MeOCH2)2 at 20°, stirred 1 hr. at room temp., treated below 25° dropwise with 5.3 g. BzH, stirred 1 hr. at room temp., and refluxed 0.5 hr. gave 6.3 g. PhCH:CHBz, m. 52-3°.  EtO2CCH2P(O)(OEt)2 (I) added dropwise at 20° to 2.4 g. 50% NaH in 100 cc. dry (MeOCH2)2, stirred 1 hr. at room temp., treated dropwise below 30° with 4.9 g. cyclohexanone, and stirred 15 min. at room temp. yielded 5.8 g. Et cyclohexylideneacetate, b10 88-90°, n25D 1.4704.  I (11.2 g.), 2.4 g. 50% NaH in 100 cc. (CH2OMe)2, and 7.2 g. AcCH2CH2CO2Et gave in the usual manner at 50-60° during 1 hr. 7.1 g. EtO2CCH:CMeCH2CH2CO2Et, b0.25 78-80°, n25D 1.4506.  PhCH2P(O)(OEt)2 (11.4 g.), 2.4 g. 50% NaH, 5.3 g. BzH, and 100 cc. (MeOCH2)2 refluxed 0.5 hr. gave 5.6 g. trans-stilbene, m. 124.5°.  p-[(EtO)2P(O)CH2]2C6H4 (II) (9.45 g.), 1.2 g. 50% NaH, 2.65 g. BzH, and 100 cc. (MeOCH2)2 refluxed 0.5 hr. yielded 4.5 g. (p-PhCH:CH)2C6H4, m. 259-60°. II (9.45 g.), 2.4 g. 50% NaH, 7.6 g. PhCH:CHCHO, and 100 cc. (MeOCH2)2 heated 0.5 hr. at 85° gave 3.0 g. p-(PhCH: CHCH:CH)2C6H4, m. 290-1°.  CH2[P(O)(OEt)2]2 (5.3 g.) added dropwise at room temp. to 0.971 g. 50% NaH and 100 cc. (MeOCH2)2, stirred 1 hr., and treated dropwise with stirring with 2.14 g. BzH yielded 2.4 g. PhCH:CHP(O) (OEt)2, b0.35, 116-18°, n25D 1.5208.  Di-Et fluorenylphosphonate (III) (7.55 g.), 1.3 g. 50% NaH, 100 cc. dry (MeOCH2)2, and 0.8 g. paraformaldehyde in (MeOCH2)2, processed in the usual manner at 30°, dild. with H2O, and extd. with Et2O gave a soln. of 9-methylenefluorene which with Br-CCl4 gave a cryst. ppt., m. 144°; the bulk of the Et2O soln. evapd. yielded 30.5 g. polymerized product which was insol. in all common solvents. I (86 g.) added dropwise with stirring at room temp. to 18.4 g. 50% NaH in 100 cc. (MeOCH2)2, the mixt. heated 1 hr. at 50° with 52.6 g. BuBr, cooled to 10°, treated with 18.4 g. 50% NaH, stirred 1 hr. at room temp., treated with 12.1 g. paraformaldehyde in 50 cc. (MeOCH2)2 at 20° during 1 hr., and stirred 1 hr. yielded 38.4 g. CH2:CBuCO2Et, b100 68-9°, n25D 1.4254.  I (22.4 g.) added dropwise at 20° to 4.8 g. 50% NaH in 100 cc. (MeOCH2)2, stirred 1 hr., treated dropwise below 25° with 16 g. Br, warmed briefly at 40°, cooled to 10°, treated with 4.5 g. 50% NaH and then below 30° with 7.3 g. iso-PrCHO, and worked up gave 14.5 g. Me2CHCH:CBrCO2Et, b10 76-8°, n25D 1.4649.  I (11.2 g.) added at 25° dropwise to 2.4 g. 50% NaH in 100 cc. (MeOCH2)2, stirred 1 hr., treated dropwise with 12.7 g. iodine in the min. (MeOCH2)2, stirred 1 hr. at room temp., treated at 10° with 4.8 g. 50% NaH and then at 25° dropwise with 5.3 g. BzH, and heated slowly to 40° gave 5.1 g. PhC≡CCO2Et, b0.1 78-80°, n25D 1.5800.  I (11.2 g.), 2.5 g. 50% NaH in 100 cc. (MeOCH2)2, and 7.3 g. EtPhC:C:O gave at 50° 3.5 g. EtPhC:C:CHCO2Et, b0.1 89-90°, n25D 1.5490.  (EtO)2P(O)CH2Ph (IV) with BzPh gave similarly 78% Ph2C:CHPh, m. 67°.  IV with PhCH:CHCHO yielded 58% (PhCH:CH)2, m. 151°.  I with BzH gave 84% PhCH:CHCO2Et, b0.1 70°, n25D 1.5562.  I with iso-PrCHO yielded 74% iso-PrCH:CHCO2Et, b15 65°, n25D 1.4284.  III with BzH gave 80% 9-benzylidenefluorene, m. 74-5°.  (EtO)2P(O)CH2CN and BzH gave 66% PhCH:CHCN, b10 130°, n25D 1.5828.  I with CCl3CHO yielded 50% CCl3CH:CHCO2Et, b10 86°, n25D 1.4798. (MeO)2P(O)CH2CO2Et and Me2CO yielded 70% Me2C:CHCO2Et, b760 150°, n25D 1.4331.  (EtO)2P(O)CH(CO2Et)CH2CO2Et [prepd. by treating mono-Et maleate with (EtO)3P] with BzH gave 61% PhCH:C(CO2Et)CH2CO2Et, b0.1 119°, n25D 1.5068.  I (22.4 g.) added dropwise with stirring at 25° to 5.0 g. 50% NaH in 100 cc. dry (MeOCH2)2, stirred 1 hr., refluxed 4 hrs. with 12.0 g. styrene oxide, cooled to room temp., dild. with H2O, and extd. with Et2O gave 8.0 g. PhCH.CH2.CHCO2Et, b0.5 100-2°, n25D 1.5121.  I with EtCH.CH2.O gave similarly 21% EtCH.CH2.CHCO2Et, b15 55°, n25D 1.4215.  (EtO)2P(O)CH2CN with styrene oxide yielded 51% PhCH.CH2.CHCN, b0.2 80°, m. 26-7°, n25D 1.5226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6k-5lLhgGfbVg90H21EOLACvtfcHk0ljfETlBBZyjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXpvFWrsg%253D%253D&md5=abd1cfb148b71698851eaec7fc939943</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fja01468a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01468a042%26sid%3Dliteratum%253Aachs%26aulast%3DWadsworth%26aufirst%3DW.%2BS.%26aulast%3DEmmons%26aufirst%3DW.%2BD.%26atitle%3DThe%2520Utility%2520of%2520Phosphonate%2520Carbanions%2520in%2520Olefin%2520Synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1961%26volume%3D83%26spage%3D1733%26epage%3D1738%26doi%3D10.1021%2Fja01468a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nahm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinreb, S. M.</span></span> <span> </span><span class="NLM_article-title">N-methoxy-N-Methylamides as Effective Acylating Agents</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3815</span>– <span class="NLM_lpage">3818</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)91316-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0040-4039%2801%2991316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=3815-3818&author=S.+Nahmauthor=S.+M.+Weinreb&title=N-methoxy-N-Methylamides+as+Effective+Acylating+Agents&doi=10.1016%2FS0040-4039%2801%2991316-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methoxy-N-methylamides as effective acylating agents</span></div><div class="casAuthors">Nahm, Steven; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3815-18</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">N-Methoxy-N-methylamides couple readily with both Grignard and organolithium reagents in THF to give ketones; tertiary alcs. were not formed even in the presence of large excesses of the organometallic compd.  E.g., treatment of Me(CH2)16CONMeOMe (I), prepd. from Me(CH2)16COCl and HNMeOMe.HCl (pyridine/CHCl3, room temp., 1 h), with 2 equiv MeMgBr (THF, 0°, 1 h) gave 94% Me(CH2)16COMe.  Hydride redn. of the N-methoxy-N-methylamides gave the corresponding aldehydes, together with small amts. of the primary alc.  E.g., I with excess LiAlH4 (THF, -78°, 5 min) gave 50% Me(CH2)16CHO and 25% Me(CH2)17OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzB8ss9N34rVg90H21EOLACvtfcHk0lgQf-5V3MQFCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D&md5=ce1dc3bf2af883db320d90c4ff32616c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2991316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252991316-4%26sid%3Dliteratum%253Aachs%26aulast%3DNahm%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DN-methoxy-N-Methylamides%2520as%2520Effective%2520Acylating%2520Agents%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D22%26spage%3D3815%26epage%3D3818%26doi%3D10.1016%2FS0040-4039%2801%2991316-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, J. L.</span>; <span class="NLM_string-name">Palmer, J. T.</span>; <span class="NLM_string-name">Rasnick, D.</span></span> <span> </span><span class="NLM_article-title">Irreversible Cysteine Protease Inhibitors Containing Vinyl Groups Conjugated to Electron Withdrawing Groups</span>. U.S. Patent <span class="NLM_patent">6,287,840</span>, <span class="NLM_year">2001</span><b>.</b></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+L.+Klaus&author=J.+T.+Palmer&author=D.+Rasnick&title=Irreversible+Cysteine+Protease+Inhibitors+Containing+Vinyl+Groups+Conjugated+to+Electron+Withdrawing+Groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26atitle%3DIrreversible%2520Cysteine%2520Protease%2520Inhibitors%2520Containing%2520Vinyl%2520Groups%2520Conjugated%2520to%2520Electron%2520Withdrawing%2520Groups%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">The Behavior and Significance of Slow-Binding Enzyme Inhibitors</span>. <i>Adv. Enzymol. Relat. Areas Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1002/9780470123072.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+Behavior+and+Significance+of+Slow-Binding+Enzyme+Inhibitors&doi=10.1002%2F9780470123072.ch5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0lgQf-5V3MQFCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520Behavior%2520and%2520Significance%2520of%2520Slow-Binding%2520Enzyme%2520Inhibitors%26jtitle%3DAdv.%2520Enzymol.%2520Relat.%2520Areas%2520Mol.%2520Biol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301%26doi%3D10.1002%2F9780470123072.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tochowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=77-82&author=B.+D.+Jonesauthor=A.+Tochowiczauthor=Y.+Tangauthor=M.+D.+Cameronauthor=L.+I.+McCallauthor=K.+Hirataauthor=J.+L.+Siqueira-Netoauthor=S.+L.+Reedauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=Synthesis+and+Evaluation+of+Oxyguanidine+Analogues+of+the+Cysteine+Protease+Inhibitor+WRR-483+against+Cruzain&doi=10.1021%2Facsmedchemlett.5b00336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00336%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DB.%2BD.%26aulast%3DTochowicz%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcCall%26aufirst%3DL.%2BI.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DReed%26aufirst%3DS.%2BL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Oxyguanidine%2520Analogues%2520of%2520the%2520Cysteine%2520Protease%2520Inhibitor%2520WRR-483%2520against%2520Cruzain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D7%26spage%3D77%26epage%3D82%26doi%3D10.1021%2Facsmedchemlett.5b00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isabel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Camargo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath-Chowdhury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Methot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span> <span> </span><span class="NLM_article-title">Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1128/AAC.01855-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.01855-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=24323474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVOkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1167-1178&author=M.+Ndaoauthor=C.+Beaulieuauthor=W.+C.+Blackauthor=E.+Isabelauthor=F.+Vasquez-Camargoauthor=M.+Nath-Chowdhuryauthor=F.+Mass%C3%A9author=C.+Mellonauthor=N.+Methotauthor=D.+A.+Nicoll-Griffith&title=Reversible+Cysteine+Protease+Inhibitors+Show+Promise+for+a+Chagas+Disease+Cure&doi=10.1128%2FAAC.01855-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible cysteine protease inhibitors show promise for a Chagas disease cure</span></div><div class="casAuthors">Ndao, Momar; Beaulieu, Christian; Black, W. Cameron; Isabel, Elise; Vasquez-Camargo, Fabio; Nath-Chowdhury, Milli; Masse, Frederic; Mellon, Christophe; Methot, Nathalie; Nicoll-Griffith, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1167-1178, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The cysteine protease cruzipain is essential for the viability, infectivity and virulence of Trypanosoma cruzi, the causative agent of Chagas disease.  Thus, inhibitors of cruzipain are considered promising anti-T. cruzi chemotherapeutic agents.  Reversible cruzipain inhibitors contg. a nitrile "warhead" were prepd. and demonstrated 50% inhibitory concns. (IC50s) as potent as 1 nM in baculovirus-generated cruzipain enzyme assays.  In epimastigote and intracellular amastigote in vitro assays, the most potent compds. demonstrated antiparasitic behavior in the 5 to 10 μM IC50 range; however, trypomastigote prodn. from the amastigote form was ∼90 to 95 % inhibited at 2 μM.  Two key compds., Cz007 and Cz008, with IC50s of 1.1 and 1.8 nM, resp., against the recombinant enzyme were tested in a murine model of acute T. cruzi infection, with oral dosing in chow for 28 days at doses from 3 to 50 mg/kg of body wt.  At 3 mg/kg of Cz007 and 3 mg/kg of Cz008, the blood parasitemia areas under the concn.-time curves were 16% and 25% of the untreated group, resp.  At sacrifice, 24 days after immunosuppression with cyclophosphamide, parasite presence in blood, heart and esophagus was evaluated.  Based on neg. quant. PCR results in all three tissues, cure rates in surviving animals were 90% for Cz007 at 3 mg/kg, 78% for Cz008 at 3 mg/kg and 71% for benznidazole, the control compd., at 50 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOw-04Qv6G7Vg90H21EOLACvtfcHk0lj0YjqJzKpQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVOkur8%253D&md5=dc7bade0d9b3b04d2c49817e7b2a8035</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.01855-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01855-13%26sid%3Dliteratum%253Aachs%26aulast%3DNdao%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DIsabel%26aufirst%3DE.%26aulast%3DVasquez-Camargo%26aufirst%3DF.%26aulast%3DNath-Chowdhury%26aufirst%3DM.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DMethot%26aufirst%3DN.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26atitle%3DReversible%2520Cysteine%2520Protease%2520Inhibitors%2520Show%2520Promise%2520for%2520a%2520Chagas%2520Disease%2520Cure%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D1167%26epage%3D1178%26doi%3D10.1128%2FAAC.01855-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudreau, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaliti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hook, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and <i>Trypanosoma cruzi</i> Cruzain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9026</span>– <span class="NLM_lpage">9044</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00294</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVantL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9026-9044&author=P.+D.+Boudreauauthor=B.+W.+Millerauthor=L.+I.+McCallauthor=J.+Almalitiauthor=R.+Reherauthor=K.+Hirataauthor=T.+Leauthor=J.+L.+Siqueira-Netoauthor=V.+Hookauthor=W.+H.+Gerwick&title=Design+of+Gallinamide+A+Analogs+as+Potent+Inhibitors+of+the+Cysteine+Proteases+Human+Cathepsin+L+and+Trypanosoma+cruzi+Cruzain&doi=10.1021%2Facs.jmedchem.9b00294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain</span></div><div class="casAuthors">Boudreau, Paul D.; Miller, Bailey W.; McCall, Laura-Isobel; Almaliti, Jehad; Reher, Raphael; Hirata, Ken; Le, Thu; Siqueira-Neto, Jair L.; Hook, Vivian; Gerwick, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9026-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallinamide A, originally isolated with modest antimalarial activity, was subsequently re-isolated and characterized as a potent, selective, and irreversible inhibitor of the human cysteine protease cathepsin L.  Mol. docking identified potential modifications to improve binding, which were synthesized as a suite of analogs., Resultingly, this current study produced the most potent gallinamide analog yet tested against cathepsin L (10, Ki = 0.0937 ± 0.01 nM and kinact /Ki = 8,730,000).  From a protein structure and substrate preference perspective, cruzain, an essential Trypanosoma cruzi cysteine protease, is a highly homologous.  Our investigations revealed that gallimamide and its analogs potently inhibit cruzain and are exquisitely toxic towards T. cruzi in the intracellular amastigote stage.  The most active compd., 5, had an IC50 = 5.1 ± 1.4 nM, but was relatively inactive to both the epimastigote (insect stage) and the host cell, and thus represents a new candidate for treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsSQ1NB_10NrVg90H21EOLACvtfcHk0lgwfMc7eWabSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVantL3L&md5=24aeede597be1438e77cff58283044dc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00294%26sid%3Dliteratum%253Aachs%26aulast%3DBoudreau%26aufirst%3DP.%2BD.%26aulast%3DMiller%26aufirst%3DB.%2BW.%26aulast%3DMcCall%26aufirst%3DL.%2BI.%26aulast%3DAlmaliti%26aufirst%3DJ.%26aulast%3DReher%26aufirst%3DR.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DHook%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DDesign%2520of%2520Gallinamide%2520A%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Cysteine%2520Proteases%2520Human%2520Cathepsin%2520L%2520and%2520Trypanosoma%2520cruzi%2520Cruzain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9026%26epage%3D9044%26doi%3D10.1021%2Facs.jmedchem.9b00294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">Progress with Covalent Small-Molecule Kinase Inhibitors</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.drudis.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=29337202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslShurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=727-735&author=Z.+Zhaoauthor=P.+E.+Bourne&title=Progress+with+Covalent+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.drudis.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Progress with covalent small-molecule kinase inhibitors</span></div><div class="casAuthors">Zhao, Zheng; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-735</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">With reduced risk of toxicity and high selectivity, covalent small-mol. kinase inhibitors (CSKIs) have emerged rapidly.  Through the lens of structural system pharmacol., here we review this rapid progress by considering design strategies and the challenges and opportunities offered by current CSKIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog6l6qMAopYLVg90H21EOLACvtfcHk0ljYEvb7Q65LeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslShurg%253D&md5=f97a19f53a72044812a778ee9351fe94</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DProgress%2520with%2520Covalent%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2018%26volume%3D23%26spage%3D727%26epage%3D735%26doi%3D10.1016%2Fj.drudis.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkemgu, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span> <span> </span><span class="NLM_article-title">Improved Trypanocidal Activities of Cathepsin L Inhibitors</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0924-8579(03)00096-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0924-8579%2803%2900096-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=12927956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVKitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=155-159&author=N.+J.+Nkemguauthor=R.+Grandeauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+R.+Caffreyauthor=D.+Steverding&title=Improved+Trypanocidal+Activities+of+Cathepsin+L+Inhibitors&doi=10.1016%2FS0924-8579%2803%2900096-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Improved trypanocidal activities of cathepsin L inhibitors</span></div><div class="casAuthors">Nkemgu, Njinkeng Joseph; Grande, Rachel; Hansell, Elizabeth; McKerrow, James H.; Caffrey, Conor R.; Steverding, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-159</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The major lysosomal cysteine proteinase of African trypanosomes is a candidate target for novel chemotherapy of sleeping sickness.  This cathepsin L-like enzyme is termed rhodesain and brucipain in Trypanosoma brucei rhodesiense and Trypanosoma brucei brucei, resp.  Three potent and selective dipeptidyl cathepsin L inhibitors have been investigated for their trypanocidal activities in vitro using culture-adapted bloodstream forms of T. b. brucei.  Compared with general cysteine proteinase inhibitors used previously by ourselves and others, the present inhibitors had improved selectivity indexes and, importantly, anti-trypanosomal activities comparable with those of com. anti-sleeping sickness drugs.  Using purified recombinant rhodesain, potent kinact/Ki values of up to 2.3 × 106 M-1 s-1 were recorded with the inhibitors. Also, all inhibitors blocked proteinolysis in the lysosome consistent with the inhibition of rhodesain/brucipain.  In conclusion, the data support the potential of cathepsin L inhibitors for rational anti-trypanosomal drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok7BWl-MwexbVg90H21EOLACvtfcHk0ljYEvb7Q65LeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVKitbk%253D&md5=b6054b4f683fca6010134cd28ab41eaa</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2803%2900096-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252803%252900096-7%26sid%3Dliteratum%253Aachs%26aulast%3DNkemgu%26aufirst%3DN.%2BJ.%26aulast%3DGrande%26aufirst%3DR.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DImproved%2520Trypanocidal%2520Activities%2520of%2520Cathepsin%2520L%2520Inhibitors%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2003%26volume%3D22%26spage%3D155%26epage%3D159%26doi%3D10.1016%2FS0924-8579%2803%2900096-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">Proteomic Profiling and Potential Cellular Target Identification of K11777, a Clinical Cysteine Protease Inhibitor, in <i>Trypanosoma brucei</i></span>. <i>Chem. Commun</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1039/C1CC16178D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1039%2FC1CC16178D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22124229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=835-837&author=P.+Y.+Yangauthor=M.+Wangauthor=C.+Y.+Heauthor=S.+Q.+Yao&title=Proteomic+Profiling+and+Potential+Cellular+Target+Identification+of+K11777%2C+a+Clinical+Cysteine+Protease+Inhibitor%2C+in+Trypanosoma+brucei&doi=10.1039%2FC1CC16178D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic profiling and potential cellular target identification of K11777, a clinical cysteine protease inhibitor, in Trypanosoma brucei</span></div><div class="casAuthors">Yang, Peng-Yu; Wang, Min; He, Cynthia Y.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">835-837</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report herein the design, synthesis and application of K11777-derived activity-based probes (ABPs) allowing in situ profiling and identification of potential cellular targets of K11777 in Trypanosoma brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpetQP69l11g7Vg90H21EOLACvtfcHk0ljYEvb7Q65LeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersbbK&md5=4e0d4c6fd674fddcf0950dd62041abd0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC1CC16178D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1CC16178D%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.%2BY.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DProteomic%2520Profiling%2520and%2520Potential%2520Cellular%2520Target%2520Identification%2520of%2520K11777%252C%2520a%2520Clinical%2520Cysteine%2520Protease%2520Inhibitor%252C%2520in%2520Trypanosoma%2520brucei%26jtitle%3DChem.%2520Commun%26date%3D2012%26volume%3D48%26spage%3D835%26epage%3D837%26doi%3D10.1039%2FC1CC16178D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balouch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Mapping Inhibitor Binding Modes on an Active Cysteine Protease via Nuclear Magnetic Resonance Spectroscopy</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">10087</span>– <span class="NLM_lpage">10098</span>, <span class="refDoi"> DOI: 10.1021/bi301305k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301305k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslagu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=10087-10098&author=G.+M.+Leeauthor=E.+Balouchauthor=D.+H.+Goetzauthor=A.+Lazicauthor=J.+H.+McKerrowauthor=C.+S.+Craik&title=Mapping+Inhibitor+Binding+Modes+on+an+Active+Cysteine+Protease+via+Nuclear+Magnetic+Resonance+Spectroscopy&doi=10.1021%2Fbi301305k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping Inhibitor Binding Modes on an Active Cysteine Protease via Nuclear Magnetic Resonance Spectroscopy</span></div><div class="casAuthors">Lee, Gregory M.; Balouch, Eaman; Goetz, David H.; Lazic, Ana; McKerrow, James H.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">10087-10098</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain is a member of the papain/cathepsin L family of cysteine proteases, and the major cysteine protease of the protozoan Trypanosoma cruzi, the causative agent of Chagas disease.  We report an autoinduction methodol. that provides sol. cruzain in high yields (>30 mg/L in minimal medium).  These increased yields provide sufficient quantities of active enzyme for use in NMR-based ligand mapping.  Using CD and NMR spectroscopy, we also examd. the soln.-state structural dynamics of the enzyme in complex with a covalently bound vinyl sulfone inhibitor (K777).  We report the backbone amide and side chain carbon chem. shift assignments of cruzain in complex with K777.  These resonance assignments were used to identify and map residues located in the substrate binding pocket, including the catalytic Cys25 and His162.  Selective [15N]Cys, [15N]His, and [13C]Met labeling was performed to quickly assess cruzain-ligand interactions for a set of eight low-mol. wt. compds. exhibiting micromolar binding or inhibition.  Chem. shift perturbation mapping verified that six of the eight compds. bind to cruzain at the active site.  Three different binding modes were delineated for the compds., namely, covalent, noncovalent, and noninteracting.  These results provide examples of how NMR spectroscopy can be used to screen compds. for fast evaluation of enzyme-inhibitor interactions to facilitate lead compd. identification and subsequent structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCHS1f3hKGrVg90H21EOLACvtfcHk0lhYrw6qmFIp5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslagu7fJ&md5=c0484e0f3f4d4c9c830746e4507cc4c0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi301305k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301305k%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BM.%26aulast%3DBalouch%26aufirst%3DE.%26aulast%3DGoetz%26aufirst%3DD.%2BH.%26aulast%3DLazic%26aufirst%3DA.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DMapping%2520Inhibitor%2520Binding%2520Modes%2520on%2520an%2520Active%2520Cysteine%2520Protease%2520via%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D10087%26epage%3D10098%26doi%3D10.1021%2Fbi301305k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wei-Guo Jia, Xue-Ting Zhi, Xiao-Dong Li, Jun-Peng Zhou, Rui Zhong, Haibo Yu, <span class="NLM_string-name hlFld-ContribAuthor">Richmond Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Postsynthetic Modification of Half-Sandwich Ruthenium Complexes by Mechanochemical Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (7)
                                     , 4313-4321. <a href="https://doi.org/10.1021/acs.inorgchem.1c00059" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.1c00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.1c00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.1c00059%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DPostsynthetic%252BModification%252Bof%252BHalf-Sandwich%252BRuthenium%252BComplexes%252Bby%252BMechanochemical%252BSynthesis%26aulast%3DJia%26aufirst%3DWei-Guo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08012021%26date%3D24032021%26volume%3D60%26issue%3D7%26spage%3D4313%26epage%3D4321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jose Guadalupe Rosas-Jimenez, Marco A. Garcia-Revilla, Abraham Madariaga-Mazon, <span class="NLM_string-name hlFld-ContribAuthor">Karina Martinez-Mayorga</span>. </span><span class="cited-content_cbyCitation_article-title">Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (10)
                                     , 6722-6735. <a href="https://doi.org/10.1021/acsomega.0c05645" title="DOI URL">https://doi.org/10.1021/acsomega.0c05645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c05645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c05645%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPredictive%252BGlobal%252BModels%252Bof%252BCruzain%252BInhibitors%252Bwith%252BLarge%252BChemical%252BCoverage%26aulast%3DRosas-Jimenez%26aufirst%3DJose%2BGuadalupe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20112020%26date%3D11022021%26date%3D05032021%26volume%3D6%26issue%3D10%26spage%3D6722%26epage%3D6735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amar R. Mohite, Ravindra S. Phatake, Pooja Dubey, Mohamed Agbaria, Alexander I. Shames, N. Gabriel Lemcoff, <span class="NLM_string-name hlFld-ContribAuthor">Ofer Reany</span>. </span><span class="cited-content_cbyCitation_article-title">Thiourea-Mediated Halogenation of Alcohols. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (20)
                                     , 12901-12911. <a href="https://doi.org/10.1021/acs.joc.0c01431" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01431%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThiourea-Mediated%252BHalogenation%252Bof%252BAlcohols%26aulast%3DMohite%26aufirst%3DAmar%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D01102020%26date%3D17092020%26volume%3D85%26issue%3D20%26spage%3D12901%26epage%3D12911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex R.  Medeiros</span>, <span class="hlFld-ContribAuthor ">Leonardo L. G.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Mariana L.  de Souza</span>, <span class="hlFld-ContribAuthor ">Celso  de Oliveira Rezende Junior</span>, <span class="hlFld-ContribAuthor ">Rocío Marisol  Espinoza-Chávez</span>, <span class="hlFld-ContribAuthor ">Luiz Carlos  Dias</span>, <span class="hlFld-ContribAuthor ">Adriano D.  Andricopulo</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 579. <a href="https://doi.org/10.3390/biom11040579" title="DOI URL">https://doi.org/10.3390/biom11040579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040579%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DChemoinformatics%252BStudies%252Bon%252Ba%252BSeries%252Bof%252BImidazoles%252Bas%252BCruzain%252BInhibitors%26aulast%3DMedeiros%26aufirst%3DAlex%2BR.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. E.  Ali</span>, <span class="hlFld-ContribAuthor ">M. A.  Assiri</span>, <span class="hlFld-ContribAuthor ">I. S.  Yahia</span>, <span class="hlFld-ContribAuthor ">H. Y.  Zahran</span>, <span class="hlFld-ContribAuthor ">M. H.  Meselhy</span>, <span class="hlFld-ContribAuthor ">M. S. A.  Hussien</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Novel Functionalized
				Pyrano[2′,3′:4,5]pyrimido[1,6-b][1,2,4,5]triazaphosphepines. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>57 </em>
                                    (1)
                                     , 79-84. <a href="https://doi.org/10.1134/S1070428021010115" title="DOI URL">https://doi.org/10.1134/S1070428021010115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428021010115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428021010115%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252BNovel%252BFunctionalized%252BPyrano%25255B2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A4%25252C5%25255Dpyrimido%25255B1%25252C6-b%25255D%25255B1%25252C2%25252C4%25252C5%25255Dtriazaphosphepines%26aulast%3DAli%26aufirst%3DT.%2BE.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D1%26spage%3D79%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>K11777</b>, <b>GSK2793660</b>, and Cbz-Phe-Phe-vinyl-2Pyrmd <b>7</b> with thia-Michael addition of Cys<sub>25</sub> to the vinyl groups in these compounds, including the putative adduct <b>7a</b>, which reverts to the fully conjugated <b>7</b> upon the reverse of adduct formation. The common bioisosteric atoms of <b>K11777</b>, <b>GSK2793660</b>, and <b>7</b> are highlighted in red. X is an electron-donating or electron-withdrawing substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Molecular models of compound <b>9</b> bound to cruzain. (A) <b>K11777</b> (gray) is superimposed with a binding pose (green) in which a covalent bond is formed between the β-carbon of the vinyl group of <b>9</b>. (B) Binding pose (cyan) of <b>9</b> in which no covalent bond is formed with Cys<sub>25</sub>. Yellow and white dashed lines represent hydrogen bonds with surrounding residues for <b>9</b> and <b>K11777</b>, respectively. Red dashed lines are measurements between the catalytic dyad and the vinyl moiety of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route to PVHIs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Conditions and reagents (General Procedures are detailed in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>): GP1, <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride, T3P, DIPEA, DCM, and 0 °C; GP2, LAH, THF, and −10 °C; GP3, (1) NaBH<sub>4</sub>, EtOH, and 0 °C and (2) SOCl<sub>2</sub> and DCM; GP4, PPh<sub>3</sub>, benzene, and reflux; GP5, P(OEt)<sub>3</sub> and 150 °C; GP6, LHMDS, THF, −70 to 0 °C; GP7, LHMDS, THF, −70 to 0 °C; GP8, (1) TFA, DCM, and 0 °C and (2) R<sub>1</sub>-Xaa-OH, T3P, DIPEA, DCM, and 0 °C; GP9, MeI, MeCN, and reflux; GP10, (1) LiOH and H<sub>2</sub>O and (2)ClCOOEt and NH<sub>4</sub>Cl.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time courses of depletion of 0.5 mM <b>K11777</b> (red circles), compound <b>12</b> (blue circles), and compound <b>15</b> (black circles) upon formation of adducts (red, blue, and black squares, respectively) with 1 mM glutathione. Lines drawn through the curves for substrate depletion and adduct formation were respectively [substrate] = (0.5 mM – A)(1 – exp(−<i>k</i> ×<i>t</i>)) + <i>C</i> and [adduct] = A × (1 – exp(−<i>k</i> × <i>t</i>)) + <i>C</i>, with resulting kinetic parameters found in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf" class="ext-link">Table S2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent inhibition of cruzain by <b>15</b>. (A) Reaction initiated by addition of cruzain (100 pM) with Cbz-Phe-Arg-AMC (10 μM) and 0–20 μM <b>15</b> (pH 7.5). Lines drawn through the experimental data points were from fitting of each inhibitor concentration to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>, from which the replot of <i>k</i><sub>obs</sub> vs [<b>15</b>] is shown in the inset (fitting to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>: <i>K</i><sub>i</sub> = 2.00 ± 0.9 μM, <i>k</i><sub>3</sub> = 0.004 ± 0.001 s<sup>–1</sup>, and <i>k</i><sub>4</sub> ≈ 0). (B) Following 1 h of preincubation of cruzain (100 pM) with 0–6 μM <b>15</b>, the reaction was initiated by addition of Cbz-Phe-Arg-AMC (10 μM). (C) Fitting of cruzain inhibition by compound <b>15</b> for <i>v</i><sub>i</sub>/<i>v</i><sub>0</sub> (black) and <i>v</i><sub>s</sub>/<i>v</i><sub>0</sub> (red) using <a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a> with results of this found in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Kinetic Depiction of Inhibition and Inactivation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A–F) Effects of cruzain inhibitors on growth of <i>T. cruzi</i>-infected murine cardiomyoblasts in which growth of inhibition of <i>T. cruzi</i> (red) is superimposed with the viability of the cardiomyoblasts (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/medium/jm9b02078_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell growth inhibition of <i>T. b. brucei</i>. (A) Inhibition of bloodstream forms by <b>15</b>. (B) Inhibition of bloodstream forms by <b>7</b>. (C) Inhibition of procyclic forms by <b>15</b>. (D) Correlation plot of values of EC<sub>50</sub> for trypanocidal activity versus <i>T. b. brucei</i> BSFs (closed circles, <i>r</i><sup>2</sup> = 0.979, slope = 0.80) and <i>T. cruzi</i> in murine cardiomyoblasts (open circles).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-6/acs.jmedchem.9b02078/20200323/images/large/jm9b02078_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02078&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Saravia, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallukat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimke, I.</span></span> <span> </span><span class="NLM_article-title">Chronic Chagas’ Heart Disease: a Disease on its Way to Becoming a Worldwide Health Problem: Epidemiology, Etiopathology, Treatment, Pathogenesis and Laboratory Medicine</span>. <i>Heart Fail. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1007/s10741-010-9211-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2Fs10741-010-9211-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=21165698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fps1yquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=45-64&author=S.+G.+Mu%C3%B1oz-Saraviaauthor=A.+Haberlandauthor=G.+Wallukatauthor=I.+Schimke&title=Chronic+Chagas%E2%80%99+Heart+Disease%3A+a+Disease+on+its+Way+to+Becoming+a+Worldwide+Health+Problem%3A+Epidemiology%2C+Etiopathology%2C+Treatment%2C+Pathogenesis+and+Laboratory+Medicine&doi=10.1007%2Fs10741-010-9211-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine</span></div><div class="casAuthors">Munoz-Saravia Silvia Gilka; Haberland Annekathrin; Wallukat Gerd; Schimke Ingolf</div><div class="citationInfo"><span class="NLM_cas:title">Heart failure reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas' disease, caused by Trypanosoma cruzi infection, is ranked as the most serious parasitic disease in Latin America.  Nearly 30% of infected patients develop life-threatening complications, and with a latency of 10-30 years, mostly Chagas' heart disease which is currently the major cause of morbidity and mortality in Latin America, enormously burdening economic resources and dramatically affecting patients' social and labor situations.  Because of increasing migration, international tourism and parasite transfer by blood contact, intrauterine transfer and organ transplantation, Chagas' heart disease could potentially become a worldwide problem.  To raise awareness of this problem, we reflect on the epidemiology and etiopathology of Chagas' disease, particularly Chagas' heart disease.  To counteract Chagas' heart disease, in addition to the general interruption of the infection cycle and chemotherapeutic elimination of the infection agent, early and effective causal or symptomatic therapies would be indispensable.  Prerequisites for this are improved knowledge of the pathogenesis and optimized patient management.  From economic and logistics viewpoints, this last prerequisite should be performed using laboratory medicine tools.  Consequently, we first summarize the mechanisms that have been suggested as driving Chagas' heart disease, mainly those associated with the presence of autoantibodies against G-protein-coupled receptors; secondly, we indicate new treatment strategies involving autoantibody apheresis and in vivo autoantibody neutralization; thirdly, we present laboratory medicine tools such as autoantibody estimation and heart marker measurement, proposed for diagnosis, risk assessment and patient guidance and lastly, we critically reflect upon the increase in inflammation and oxidative stress markers in Chagas' heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4A6JSV6MuoE2yPDyEFiigfW6udTcc2ebx78j_kZxzg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fps1yquw%253D%253D&md5=2b9715cca8da00f753fac995ae459777</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs10741-010-9211-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10741-010-9211-5%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Saravia%26aufirst%3DS.%2BG.%26aulast%3DHaberland%26aufirst%3DA.%26aulast%3DWallukat%26aufirst%3DG.%26aulast%3DSchimke%26aufirst%3DI.%26atitle%3DChronic%2520Chagas%25E2%2580%2599%2520Heart%2520Disease%253A%2520a%2520Disease%2520on%2520its%2520Way%2520to%2520Becoming%2520a%2520Worldwide%2520Health%2520Problem%253A%2520Epidemiology%252C%2520Etiopathology%252C%2520Treatment%252C%2520Pathogenesis%2520and%2520Laboratory%2520Medicine%26jtitle%3DHeart%2520Fail.%2520Rev.%26date%3D2012%26volume%3D17%26spage%3D45%26epage%3D64%26doi%3D10.1007%2Fs10741-010-9211-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <i>Centers for Disease Control and Prevention</i>.  (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Centers+for+Disease+Control+and+Prevention.+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coura, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viñas, P. A.</span></span> <span> </span><span class="NLM_article-title">Chagas Disease: a New Worldwide Challenge</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>465</i></span>,  <span class="NLM_fpage">S6</span>– <span class="NLM_lpage">S7</span>, <span class="refDoi"> DOI: 10.1038/nature09221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnature09221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=20571554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotleiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=S6-S7&author=J.+R.+Couraauthor=P.+A.+Vi%C3%B1as&title=Chagas+Disease%3A+a+New+Worldwide+Challenge&doi=10.1038%2Fnature09221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas disease: a new worldwide challenge</span></div><div class="casAuthors">Coura, Jose Rodrigues; Vinas, Pedro Albajar</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7301</span>),
    <span class="NLM_cas:pages">S6-S7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1sTY-jAEB7Vg90H21EOLACvtfcHk0liFRacpDtCSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotleiu7o%253D&md5=c4fe0c1df4366c775bbd40af6cdca437</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09221%26sid%3Dliteratum%253Aachs%26aulast%3DCoura%26aufirst%3DJ.%2BR.%26aulast%3DVi%25C3%25B1as%26aufirst%3DP.%2BA.%26atitle%3DChagas%2520Disease%253A%2520a%2520New%2520Worldwide%2520Challenge%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3DS6%26epage%3DS7%26doi%3D10.1038%2Fnature09221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, R.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of Chagas Disease in the USA: High-Risk Patient Populations for Screening</span>. <i>Curr. Trop. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/s40475-019-0169-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2Fs40475-019-0169-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=8-12&author=Y.+Castroauthor=R.+Marcus&title=Epidemiology+of+Chagas+Disease+in+the+USA%3A+High-Risk+Patient+Populations+for+Screening&doi=10.1007%2Fs40475-019-0169-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40475-019-0169-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40475-019-0169-7%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DY.%26aulast%3DMarcus%26aufirst%3DR.%26atitle%3DEpidemiology%2520of%2520Chagas%2520Disease%2520in%2520the%2520USA%253A%2520High-Risk%2520Patient%2520Populations%2520for%2520Screening%26jtitle%3DCurr.%2520Trop.%2520Med.%2520Rep.%26date%3D2019%26volume%3D6%26spage%3D8%26epage%3D12%26doi%3D10.1007%2Fs40475-019-0169-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialek, S. R.</span></span> <span> </span><span class="NLM_article-title">What Do We Know About Chagas Disease in the United States?</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1227</span>, <span class="refDoi"> DOI: 10.4269/ajtmh.16-0213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.4269%2Fajtmh.16-0213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=27402515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ptFGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=1225-1227&author=S.+P.+Montgomeryauthor=M.+E.+Pariseauthor=E.+M.+Dotsonauthor=S.+R.+Bialek&title=What+Do+We+Know+About+Chagas+Disease+in+the+United+States%3F&doi=10.4269%2Fajtmh.16-0213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">What Do We Know About Chagas Disease in the United States?</span></div><div class="casAuthors">Montgomery Susan P; Parise Monica E; Dotson Ellen M; Bialek Stephanie R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of tropical medicine and hygiene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1225-1227</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, caused by the parasite Trypanosoma cruzi, affects more than 5 million people worldwide leading to serious heart and gastrointestinal disease in a proportion of chronically infected patients.  Important modes of transmission include vector-borne, congenital, and via blood transfusion or organ transplant from an infected donor.  Vector-borne transmission of Chagas disease occurs in the Americas, including the southern half of North America, where the specific vector insects (triatomines), T. cruzi, and infected reservoir mammalian hosts are found.  In the United States, there are estimated to be at least 300,000 cases of chronic Chagas disease among people originally from countries of Latin America where Chagas disease is endemic.  Fewer than 30 cases of locally acquired infection have been documented in the United States, although a sylvatic transmission cycle has been known to exist in this country for at least a century.  Studies defining risks for locally acquired infection and effective prevention strategies are needed to help prevent domestic transmission of T. cruzi To help address Chagas disease in the United States, improved health-care provider awareness and knowledge, better tools for screening and diagnosing patients, and wider availability of treatment drugs are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdnJB8GcYb4L9KldV63DuefW6udTcc2ea3CarxlJxqJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ptFGhtA%253D%253D&md5=e1a514f5cf7872365b0715403e5e0ed0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.16-0213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.16-0213%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DS.%2BP.%26aulast%3DParise%26aufirst%3DM.%2BE.%26aulast%3DDotson%26aufirst%3DE.%2BM.%26aulast%3DBialek%26aufirst%3DS.%2BR.%26atitle%3DWhat%2520Do%2520We%2520Know%2520About%2520Chagas%2520Disease%2520in%2520the%2520United%2520States%253F%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2016%26volume%3D95%26spage%3D1225%26epage%3D1227%26doi%3D10.4269%2Fajtmh.16-0213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcondes de Rezende, J.</span></span> <span> </span><span class="NLM_article-title">American Trypanosomiasis (Chagas Disease)</span>. <i>Infect. Dis. Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.idc.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.idc.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22632639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=275-291&author=A.+Rassiauthor=A.+Rassiauthor=J.+Marcondes+de+Rezende&title=American+Trypanosomiasis+%28Chagas+Disease%29&doi=10.1016%2Fj.idc.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">American trypanosomiasis (Chagas disease)</span></div><div class="casAuthors">Rassi Anis Jr; Rassi Anis; Marcondes de Rezende Joffre</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease, also known as American trypanosomiasis, is a chronic infection caused by Trypanosoma cruzi, a protozoan parasite.  It is transmitted to human beings mainly through the feces of infected triatomine bugs.  The disease affects an estimated 8 to 10 million people in the Americas, putting them at risk of developing life-threatening cardiac and gastrointestinal complications.  This article provides a brief update on the epidemiology, clinical manifestations, diagnosis, and treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJzahk2B7NOeRS7coPn-RtfW6udTcc2eZLh5fas6P49Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nmtlOltA%253D%253D&md5=ef2274a813974a0cf8a7995a06ef1b71</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DMarcondes%2Bde%2BRezende%26aufirst%3DJ.%26atitle%3DAmerican%2520Trypanosomiasis%2520%2528Chagas%2520Disease%2529%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D275%26epage%3D291%26doi%3D10.1016%2Fj.idc.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lejon, V.</span>; <span class="NLM_string-name">Bentivoglio, M.</span>; <span class="NLM_string-name">Franco, J. R.</span></span> <span> </span><span class="NLM_article-title">Human African Trypanosomiasis</span>. In  <i>Handbook of Clinical Neurology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, H. H.</span>; <span class="NLM_string-name">Tanowitz, H. B.</span>; <span class="NLM_string-name">Del Brutto, O. H.</span></span>, Eds; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">181</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=169-181&author=V.+Lejon&author=M.+Bentivoglio&author=J.+R.+Francoauthor=H.+H.+Garcia&author=H.+B.+Tanowitz&author=O.+H.+Del+Brutto&title=Handbook+of+Clinical+Neurology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLejon%26aufirst%3DV.%26atitle%3DHuman%2520African%2520Trypanosomiasis%26btitle%3DHandbook%2520of%2520Clinical%2520Neurology%26aulast%3DGarcia%26aufirst%3DH.%2BH.%26pub%3DElsevier%26date%3D2013%26spage%3D169%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">World
Health Organization</span>.  <i>Trypanosomiasis,
human African (sleeping
sickness)</i><a href="https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness" class="extLink">https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness</a>) (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World%0AHealth+Organization.+Trypanosomiasis%2C%0Ahuman+African+%28sleeping%0Asickness%29https%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Ftrypanosomiasis-human-african-%28sleeping-sickness%29+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DTrypanosomiasis%252C%250Ahuman%2520African%2520%2528sleeping%250Asickness%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span> <i>Drugs for Neglected Diseases
initiative</i>. <a href="https://www.dndi.org/wp-content/uploads/2019/09/Factsheet2019_SleepingSickness.pdf" class="extLink">https://www.dndi.org/wp-content/uploads/2019/09/Factsheet2019_SleepingSickness.pdf</a> (Accessed October 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Drugs+for+Neglected+Diseases%0Ainitiative.+https%3A%2F%2Fwww.dndi.org%2Fwp-content%2Fuploads%2F2019%2F09%2FFactsheet2019_SleepingSickness.pdf+%28Accessed+October+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520for%2520Neglected%2520Diseases%250Ainitiative" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simarro, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jannin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattand, P.</span></span> <span> </span><span class="NLM_article-title">Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?</span>. <i>PLOS Medicine</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e55</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0050055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pmed.0050055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=18303943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ksFGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&author=P.+P.+Simarroauthor=J.+Janninauthor=P.+Cattand&title=Eliminating+Human+African+Trypanosomiasis%3A+Where+Do+We+Stand+and+What+Comes+Next%3F&doi=10.1371%2Fjournal.pmed.0050055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating human African trypanosomiasis: where do we stand and what comes next?</span></div><div class="casAuthors">Simarro Pere P; Jannin Jean; Cattand Pierre</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e55</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnJHeJ_kKhEUkUaC_kzhvyfW6udTcc2eZLh5fas6P49Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ksFGjsA%253D%253D&md5=540cbe2cec177b8d6b0d629f33187d59</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0050055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0050055%26sid%3Dliteratum%253Aachs%26aulast%3DSimarro%26aufirst%3DP.%2BP.%26aulast%3DJannin%26aufirst%3DJ.%26aulast%3DCattand%26aufirst%3DP.%26atitle%3DEliminating%2520Human%2520African%2520Trypanosomiasis%253A%2520Where%2520Do%2520We%2520Stand%2520and%2520What%2520Comes%2520Next%253F%26jtitle%3DPLOS%2520Medicine%26date%3D2008%26volume%3D5%26doi%3D10.1371%2Fjournal.pmed.0050055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, P. G. E.</span></span> <span> </span><span class="NLM_article-title">Clinical Features, Diagnosis, and Treatment of Human African Trypanosomiasis (Sleeping Sickness)</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(12)70296-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS1474-4422%2812%2970296-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=23260189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=186-194&author=P.+G.+E.+Kennedy&title=Clinical+Features%2C+Diagnosis%2C+and+Treatment+of+Human+African+Trypanosomiasis+%28Sleeping+Sickness%29&doi=10.1016%2FS1474-4422%2812%2970296-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span></div><div class="casAuthors">Kennedy Peter Ge</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis, or sleeping sickness, is caused by infection with parasites of the genus Trypanosoma, transmitted by the tsetse fly.  The disease has two forms, Trypanosoma brucei (T b) rhodesiense and T b gambiense; and is almost always fatal if untreated.  Despite a recent reduction in the number of reported cases, patients with African trypanosomiasis continue to present major challenges to clinicians.  Because treatment for CNS-stage disease can be very toxic, diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic.  Melarsoprol is the only available treatment for late-stage T b rhodesiense infection, but can be lethal to 5% of patients owing to post-treatment reactive encephalopathy.  Eflornithine combined with nifurtimox is the first-line treatment for late-stage T b gambiense.  New drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDi0PRo3CXkCEJCPKhJPuqfW6udTcc2eYmIVP2mpfMBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D&md5=c9ac342f345240d413300c17cd1ae80f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970296-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970296-X%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DP.%2BG.%2BE.%26atitle%3DClinical%2520Features%252C%2520Diagnosis%252C%2520and%2520Treatment%2520of%2520Human%2520African%2520Trypanosomiasis%2520%2528Sleeping%2520Sickness%2529%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D186%26epage%3D194%26doi%3D10.1016%2FS1474-4422%2812%2970296-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, C. J.</span></span> <span> </span><span class="NLM_article-title">First Century of Chagas’ Disease: An Overview on Novel Approaches to Nifurtimox and Benznidazole Delivery Systems</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">894</span>, <span class="refDoi"> DOI: 10.1002/jps.23010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2Fjps.23010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22161779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Snsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=888-894&author=C.+J.+Salomon&title=First+Century+of+Chagas%E2%80%99+Disease%3A+An+Overview+on+Novel+Approaches+to+Nifurtimox+and+Benznidazole+Delivery+Systems&doi=10.1002%2Fjps.23010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">First century of Chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems</span></div><div class="casAuthors">Salomon, Claudio J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">888-894</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Hundred years after the discovery of Chagas' disease, there is a lack of effective treatment to control this neglected disease caused by the parasite Trypanosoma cruzi.  The transmission is primarily through vector-borne blood transfusion or during pregnancy, producing high mortality and morbidity among poor people in many countries of Latin America.  In the last decades, the efforts have been focused mainly on the elimination of vectors.  At the same time, screening of blood donors in order to avoid transfusional transmission has been improved all over the world.  However, Chagas' disease is still a major public health problem, with ests. of nearly 90 million people at risk of infection and more than eight million infected in 18 endemic countries.  Despite the high incidence in endemic regions and the dissemination of neglected diseases in North America and Europe, to date, there are only two drugs developed and prescribed for the treatment of Chagas' disease, nifurtimox (tablets of 120 mg) and benznidazole (tablets of 100 mg).  In this review, different approaches carried out in the last decades for developing novel pharmaceutical formulations for the delivery of nifurtimox and benznidazole are discussed. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdTQqKE_luKLVg90H21EOLACvtfcHk0lik8npYAoX4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Snsr%252FO&md5=98f783103b6d7e247d85784bee746eb6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fjps.23010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23010%26sid%3Dliteratum%253Aachs%26aulast%3DSalomon%26aufirst%3DC.%2BJ.%26atitle%3DFirst%2520Century%2520of%2520Chagas%25E2%2580%2599%2520Disease%253A%2520An%2520Overview%2520on%2520Novel%2520Approaches%2520to%2520Nifurtimox%2520and%2520Benznidazole%2520Delivery%2520Systems%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D888%26epage%3D894%26doi%3D10.1002%2Fjps.23010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10497</span>– <span class="NLM_lpage">10525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00683</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00683" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGkur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10497-10525&author=L.+Cianniauthor=C.+W.+Feldmannauthor=E.+Gilbergauthor=M.+G%C3%BCtschowauthor=L.+Julianoauthor=A.+Leit%C3%A3oauthor=J.+Bajorathauthor=C.+A.+Montanari&title=Can+Cysteine+Protease+Cross-Class+Inhibitors+Achieve+Selectivity%3F&doi=10.1021%2Facs.jmedchem.9b00683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?</span></div><div class="casAuthors">Cianni, Lorenzo; Feldmann, Christian Wolfgang; Gilberg, Erik; Gutschow, Michael; Juliano, Luiz; Leitao, Andrei; Bajorath, Jurgen; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10497-10525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cysteine proteases are important targets for the discovery of novel therapeutics for many human diseases.  From parasitic diseases to cancer, cysteine proteases follow a common mechanism, the formation of an encounter complex with subsequent nucleophilic reactivity of the catalytic cysteine thiol group toward the carbonyl carbon of a peptide bond or an electrophilic group of an inhibitor.  Modulation of target enzymes occurs preferably by covalent modification, which imposes challenges in balancing cross-reactivity and selectivity.  Given the resurgence of irreversible covalent inhibitors, can they impair off-target effects or are reversible covalent inhibitors a better route to selectivity.  This Perspective addresses how small mol. inhibitors may achieve selectivity for different cathepsins, cruzain, rhodesain, and falcipain-2.  We discuss target- and ligand-based designs emphasizing repurposing inhibitors from one cysteine protease to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr75s_t-OU9gbVg90H21EOLACvtfcHk0lik8npYAoX4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGkur7I&md5=49fc0900174dfad403d33e906498ae28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00683%26sid%3Dliteratum%253Aachs%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DFeldmann%26aufirst%3DC.%2BW.%26aulast%3DGilberg%26aufirst%3DE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DCan%2520Cysteine%2520Protease%2520Cross-Class%2520Inhibitors%2520Achieve%2520Selectivity%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10497%26epage%3D10525%26doi%3D10.1021%2Facs.jmedchem.9b00683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brömme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span>. <i>J Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">12824</span>– <span class="NLM_lpage">12832</span>, <span class="refDoi"> DOI: 10.1074/jbc.M513331200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M513331200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16520377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12824-12832&author=Y.+Choeauthor=F.+Leonettiauthor=D.+C.+Greenbaumauthor=F.+Lecailleauthor=M.+Bogyoauthor=D.+Br%C3%B6mmeauthor=J.+A.+Ellmanauthor=C.+S.+Craik&title=Substrate+Profiling+of+Cysteine+Proteases+Using+a+Combinatorial+Peptide+Library+Identifies+Functionally+Unique+Specificities&doi=10.1074%2Fjbc.M513331200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities</span></div><div class="casAuthors">Choe, Youngchool; Leonetti, Francesco; Greenbaum, Doron C.; Lecaille, Fabien; Bogyo, Matthew; Broemme, Dieter; Ellman, Jonathan A.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12824-12832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The substrate specificities of papain-like cysteine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and five proteases of parasitic origin were studied using a completely diversified positional scanning synthetic combinatorial library.  A bifunctional coumarin fluorophore was used that facilitated synthesis of the library and individual peptide substrates.  The library has a total of 160,000 tetrapeptide substrate sequences completely randomizing each of the P1, P2, P3, and P4 positions with 20 amino acids.  A microtiter plate assay format permitted a rapid detn. of the specificity profile of each enzyme.  Individual peptide substrates were then synthesized and tested for a quant. detn. of the specificity of the human cathepsins.  Despite the conserved three-dimensional structure and similar substrate specificity of the enzymes studied, distinct amino acid preferences that differentiate each enzyme were identified.  The specificities of cathepsins K and S partially match the cleavage site sequences in their physiol. substrates.  Capitalizing on its unique preference for proline and glycine at the P2 and P3 positions, resp., selective substrates and a substrate-based inhibitor were developed for cathepsin K.  A cluster anal. of the proteases based on the complete specificity profile provided a functional characterization distinct from std. sequence anal.  This approach provides useful information for developing selective chem. probes to study protease-related pathologies and physiologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-Na7PpDSPLVg90H21EOLACvtfcHk0lik8npYAoX4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKktLY%253D&md5=8a90a92e810ac59436a9ea3a12536f27</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M513331200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M513331200%26sid%3Dliteratum%253Aachs%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DBr%25C3%25B6mme%26aufirst%3DD.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DSubstrate%2520Profiling%2520of%2520Cysteine%2520Proteases%2520Using%2520a%2520Combinatorial%2520Peptide%2520Library%2520Identifies%2520Functionally%2520Unique%2520Specificities%26jtitle%3DJ%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12824%26epage%3D12832%26doi%3D10.1074%2Fjbc.M513331200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lecaille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Authié, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serveau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span> <span> </span><span class="NLM_article-title">Subsite Specificity of Trypanosomal Cathepsin L-Like Cysteine Proteases</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">2733</span>– <span class="NLM_lpage">2741</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.02172.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1046%2Fj.1432-1327.2001.02172.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=11322895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVyht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2733-2741&author=F.+Lecailleauthor=E.+Authi%C3%A9author=T.+Moreauauthor=C.+Serveauauthor=F.+Gauthierauthor=G.+Lalmanach&title=Subsite+Specificity+of+Trypanosomal+Cathepsin+L-Like+Cysteine+Proteases&doi=10.1046%2Fj.1432-1327.2001.02172.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids</span></div><div class="casAuthors">Lecaille, Fabien; Authie, Edith; Moreau, Thierry; Serveau, Carole; Gauthier, Francis; Lalmanach, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2733-2741</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The S2 subsite of mammalian cysteine proteinases of the papain family is essential for specificity.  Among natural amino acids, all these enzymes prefer bulky hydrophobic residues such as phenylalanine at P2.  This holds true for their trypanosomal counterparts: cruzain from Trypanosoma cruzi and congopain from T. congolense.  A detailed anal. of the S2 specificity of parasitic proteases was performed to gain information that might be of interest for the design of more selective pseudopeptidyl inhibitors.  Nonproteogenic phenylalanyl analogs (Xaa) have been introduced into position P2 of fluorogenic substrates dansyl-Xaa-Arg-Ala-Pro-Trp, and their kinetic consts. (Km, kcat/Km) have been detd. with congopain and cruzain, and related host cathepsins B and L.  Trypanosomal cysteine proteases are poorly stereoselective towards D/L-Phe, the inversion of chirality modifying the efficiency of the reaction but not the Km.  Congopain binds cyclohexylalanine better than arom. Phe derivs.  Another characteristic feature of congopain compared to cruzain and cathepsins B and L was that it could accommodate a phenylglycyl residue (kcat/Km = 1300 mM-1·s-1), while lengthening of the side chain by a methylene group only slightly impaired the specificity const. towards trypanosomal cysteine proteases.  Mono- and di-halogenation or nitration of Phe did not affect Km for cathepsin L-like enzymes, but the presence of constrained Phe derivs. prevented a correct fitting into the S2 subsite.  A model of congopain has been built to study the fit of Phe analogs within the S2 pocket.  Phe analogs adopted a positioning within the S2 pocket similar to that of the Tyr of the cruzain/Z-Tyr-Ala-fluoromethylketone complex.  However, cyclohexylalanine has an energetically favorable chair-like conformation and can penetrate deeper into the subsite.  Fitting of modeled Phe analogs were in good agreement with kinetic parameters.  Furthermore, a linear relationship could be established with logP, supporting the suggestion that fitting into the S2 pocket of trypanosomal cysteine proteases depends on the hydrophobicity of Phe analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZKMvltPtELVg90H21EOLACvtfcHk0lgPAl3QKnh60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVyht7Y%253D&md5=5c1e95dfd70e2a77634bc76795076e70</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02172.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02172.x%26sid%3Dliteratum%253Aachs%26aulast%3DLecaille%26aufirst%3DF.%26aulast%3DAuthi%25C3%25A9%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DT.%26aulast%3DServeau%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DLalmanach%26aufirst%3DG.%26atitle%3DSubsite%2520Specificity%2520of%2520Trypanosomal%2520Cathepsin%2520L-Like%2520Cysteine%2520Proteases%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2733%26epage%3D2741%26doi%3D10.1046%2Fj.1432-1327.2001.02172.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sudhan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemann, D. W.</span></span> <span> </span><span class="NLM_article-title">Cathepsin L Targeting in Cancer Treatment</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.pharmthera.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=26299995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2015&pages=105-116&author=D.+R.+Sudhanauthor=D.+W.+Siemann&title=Cathepsin+L+Targeting+in+Cancer+Treatment&doi=10.1016%2Fj.pharmthera.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin L targeting in cancer treatment</span></div><div class="casAuthors">Sudhan, Dhivya R.; Siemann, Dietmar W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-116</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Proteolytic enzymes may serve as promising targets for novel therapeutic treatment strategies seeking to impede cancer progression and metastasis.  One such enzyme is cathepsin L (CTSL), a lysosomal cysteine protease.  CTSL upregulation, a common occurrence in a variety of human cancers, has been widely correlated with metastatic aggressiveness and poor patient prognosis.  In addn., CTSL has been implicated to contribute to cancer-assocd. osteolysis, a debilitating morbidity affecting both life expectancy and the quality of life.  In this review, we highlight the mechanisms by which CTSL contributes to tumor progression and dissemination and discuss the therapeutic utility of CTSL intervention strategies aimed at impeding metastatic progression and bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrea3FRSr1_j7Vg90H21EOLACvtfcHk0lgPAl3QKnh60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jL&md5=84201f3d9494d7a1ef52a0610e1d038d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSudhan%26aufirst%3DD.%2BR.%26aulast%3DSiemann%26aufirst%3DD.%2BW.%26atitle%3DCathepsin%2520L%2520Targeting%2520in%2520Cancer%2520Treatment%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D155%26spage%3D105%26epage%3D116%26doi%3D10.1016%2Fj.pharmthera.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span> <span> </span><span class="NLM_article-title">Epithelial Desquamation Observed in a Phase I Study of an Oral Cathepsin C Inhibitor (GSK2793660)</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1111/bcp.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1111%2Fbcp.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=28800383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=2813-2820&author=B.+E.+Millerauthor=R.+J.+Mayerauthor=N.+Goyalauthor=J.+Balauthor=N.+Dallowauthor=M.+Boyceauthor=D.+Carpenterauthor=A.+Churchillauthor=T.+Heslopauthor=A.+L.+Lazaar&title=Epithelial+Desquamation+Observed+in+a+Phase+I+Study+of+an+Oral+Cathepsin+C+Inhibitor+%28GSK2793660%29&doi=10.1111%2Fbcp.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span></div><div class="casAuthors">Miller, Bruce E.; Mayer, Ruth J.; Goyal, Navin; Bal, Joanne; Dallow, Nigel; Boyce, Malcolm; Carpenter, Donald; Churchill, Alison; Heslop, Teresa; Lazaar, Aili L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2813-2820</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Cathepsin C (CTSC) is necessary for the activation of several serine proteases including neutrophil elastase (NE), cathepsin G and proteinase 3.  GSK2793660 is an oral, irreversible inhibitor of CTSC that is hypothesized to provide an alternative route to achieve NE inhibition and was tested in a Phase I study.  Methods : Single escalating oral doses of GSK2793660 from 0.5 to 20 mg or placebo were administered in a randomized crossover design to healthy male subjects; a sep. cohort received once daily doses of 12 mg or placebo for 21 days.  Data were collected on safety, pharmacokinetics, CTSC enzyme inhibition and blood biomarkers.  Results : Single, oral doses of GSK2793660 were able to dose-dependently inhibit whole blood CTSC activity.  Once daily dosing of 12 mg GSK2793660 for 21 days achieved ≥90% inhibition (95% CI: 56, 130) of CTSC within 3 h on day 1.  Only modest redns. of whole blood enzyme activity of approx. 20% were obsd. for NE, cathepsin G and proteinase 3.  Seven of 10 subjects receiving repeat doses of GSK2793660 manifested epidermal desquamation on palmar and plantar surfaces beginning 7-10 days after dosing commencement.  There were no other clin. important safety findings.  Conclusions : GSK2793660 inhibited CTSC activity but not the activity of downstream neutrophil serine proteases.  The palmar-plantar epidermal desquamation suggests a previously unidentified role for CTSC or one of its target proteins in the maintenance and integrity of the epidermis at these sites, with some similarities to the phenotype of CTSC-deficient humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzbhfHPivxrVg90H21EOLACvtfcHk0lgPAl3QKnh60Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM&md5=7adcac6bc9dc5a24bffda1afd89e1f88</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13398%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BE.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DGoyal%26aufirst%3DN.%26aulast%3DBal%26aufirst%3DJ.%26aulast%3DDallow%26aufirst%3DN.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DChurchill%26aufirst%3DA.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26atitle%3DEpithelial%2520Desquamation%2520Observed%2520in%2520a%2520Phase%2520I%2520Study%2520of%2520an%2520Oral%2520Cathepsin%2520C%2520Inhibitor%2520%2528GSK2793660%2529%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D83%26spage%3D2813%26epage%3D2820%26doi%3D10.1111%2Fbcp.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burden, R. E.</span></span> <span> </span><span class="NLM_article-title">Cathepsin S: Therapeutic, Diagnostic, and Prognostic Potential</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1515%2Fhsz-2015-0114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=25872877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSrtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2015&pages=867-882&author=R.+D.+A.+Wilkinsonauthor=R.+Williamsauthor=C.+J.+Scottauthor=R.+E.+Burden&title=Cathepsin+S%3A+Therapeutic%2C+Diagnostic%2C+and+Prognostic+Potential&doi=10.1515%2Fhsz-2015-0114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin S: therapeutic, diagnostic, and prognostic potential</span></div><div class="casAuthors">Wilkinson, Richard D. A.; Williams, Rich; Scott, Christopher J.; Burden, Roberta E.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-882</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Cathepsin S is a member of the cysteine cathepsin protease family.  It is a lysosomal protease which can promote degrdn. of damaged or unwanted proteins in the endo-lysosomal pathway.  Addnl., it has more specific roles such as MHC class II antigen presentation, where it is important in the degrdn. of the invariant chain.  Unsurprisingly, mis-regulation has implicated cathepsin S in a variety of pathol. processes including arthritis, cancer, and cardiovascular disease, where it becomes secreted and can act on extracellular substrates.  In comparison to many other cysteine cathepsin family members, cathepsin S has uniquely restricted tissue expression and is more stable at a neutral pH, which supports its involvement and importance in localised disease microenvironments.  In this review, we examine the known involvement of cathepsin S in disease, particularly with respect to recent work indicating its role in mediating pain, diabetes, and cystic fibrosis.  We provide an overview of current literature with regards cathepsin S as a therapeutic target, as well as its role and potential as a predictive diagnostic and/or prognostic marker in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ9-OsCJWtTLVg90H21EOLACvtfcHk0ljyjNGIGBNZOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSrtLbK&md5=1e8637a0213779c1c5105756c0c978d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0114%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DR.%2BD.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DBurden%26aufirst%3DR.%2BE.%26atitle%3DCathepsin%2520S%253A%2520Therapeutic%252C%2520Diagnostic%252C%2520and%2520Prognostic%2520Potential%26jtitle%3DBiol.%2520Chem.%26date%3D2015%26volume%3D396%26spage%3D867%26epage%3D882%26doi%3D10.1515%2Fhsz-2015-0114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drake, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oursler, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khosla, S.</span></span> <span> </span><span class="NLM_article-title">Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1210/er.2015-1114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1210%2Fer.2015-1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=28651365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BC1cjhvFCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=325-350&author=M.+T.+Drakeauthor=B.+L.+Clarkeauthor=M.+J.+Ourslerauthor=S.+Khosla&title=Cathepsin+K+Inhibitors+for+Osteoporosis%3A+Biology%2C+Potential+Clinical+Utility%2C+and+Lessons+Learned&doi=10.1210%2Fer.2015-1114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned</span></div><div class="casAuthors">Drake Matthew T; Clarke Bart L; Oursler Merry Jo; Khosla Sundeep</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-350</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cathepsin K is a cysteine protease member of the cathepsin lysosomal protease family.  Although cathepsin K is highly expressed in osteoclasts, lower levels of cathepsin K are also found in a variety of other tissues.  Secretion of cathepsin K from the osteoclast into the sealed osteoclast-bone cell interface results in efficient degradation of type I collagen.  The absence of cathepsin K activity in humans results in pycnodysostosis, characterized by increased bone mineral density and fractures.  Pharmacologic cathepsin K inhibition leads to continuous increases in bone mineral density for ≤5 years of treatment and improves bone strength at the spine and hip.  Compared with other antiresorptive agents, cathepsin K inhibition is nearly equally efficacious for reducing biochemical markers of bone resorption but comparatively less active for reducing bone formation markers.  Despite multiple efforts to develop cathepsin K inhibitors, potential concerns related to off-target effects of the inhibitors against other cathepsins and cathepsin K inhibition at nonbone sites, including skin and perhaps cardiovascular and cerebrovascular sites, prolonged the regulatory approval process.  A large multinational randomized, double-blind phase III study of odanacatib in postmenopausal women with osteoporosis was recently completed.  Although that study demonstrated clinically relevant reductions in fractures at multiple sites, odanacatib was ultimately withdrawn from the regulatory approval process after it was found to be associated with an increased risk of cerebrovascular accidents.  Nonetheless, the underlying biology and clinical effects of cathepsin K inhibition remain of considerable interest and could guide future therapeutic approaches for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYsuGMEuOzAyXXDYhVZBdlfW6udTcc2eaY1xWS0GklsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjhvFCrsw%253D%253D&md5=e57986276b10974f6636e86351903c10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1210%2Fer.2015-1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2015-1114%26sid%3Dliteratum%253Aachs%26aulast%3DDrake%26aufirst%3DM.%2BT.%26aulast%3DClarke%26aufirst%3DB.%2BL.%26aulast%3DOursler%26aufirst%3DM.%2BJ.%26aulast%3DKhosla%26aufirst%3DS.%26atitle%3DCathepsin%2520K%2520Inhibitors%2520for%2520Osteoporosis%253A%2520Biology%252C%2520Potential%2520Clinical%2520Utility%252C%2520and%2520Lessons%2520Learned%26jtitle%3DEndocr.%2520Rev.%26date%3D2017%26volume%3D38%26spage%3D325%26epage%3D350%26doi%3D10.1210%2Fer.2015-1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span>; <span class="NLM_string-name">Robertson, S. A.</span>; <span class="NLM_string-name">Brinen, L. S.</span>; <span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cruzain</span>. In  <i>Cysteine Proteases of Pathogenic Organisms</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, M. W.</span>; <span class="NLM_string-name">Dalton, J. P.</span></span>, Eds; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">115</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1007%2F978-1-4419-8414-2_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=100-115&author=M.+Sajid&author=S.+A.+Robertson&author=L.+S.+Brinen&author=J.+H.+McKerrowauthor=M.+W.+Robinson&author=J.+P.+Dalton&title=Cysteine+Proteases+of+Pathogenic+Organisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-8414-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-8414-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DSajid%26aufirst%3DM.%26atitle%3DCruzain%26btitle%3DCysteine%2520Proteases%2520of%2520Pathogenic%2520Organisms%26aulast%3DRobinson%26aufirst%3DM.%2BW.%26pub%3DSpringer%26date%3D2011%26spage%3D100%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eakin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">The Sequence, Organization, and Expression of the Major Cysteine Protease (Cruzain) from <i>Trypanosoma cruzi</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">7411</span>– <span class="NLM_lpage">7420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1559982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3sXitVygtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=7411-7420&author=A.+E.+Eakinauthor=A.+A.+Millsauthor=G.+Harthauthor=J.+H.+McKerrowauthor=C.+S.+Craik&title=The+Sequence%2C+Organization%2C+and+Expression+of+the+Major+Cysteine+Protease+%28Cruzain%29+from+Trypanosoma+cruzi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi</span></div><div class="casAuthors">Eakin, Ann E.; Mills, Alea A.; Harth, Guenter; McKerrow, James H.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7411-20</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The complete sequence of the gene encoding the major cysteine protease from T. cruzi is reported.  The amino acid sequence predicted from the gene sequence aligns well with members of the papain family of cysteine proteases, suggesting the name cruzain.  The sequence is most closely related to the cysteine protease of Trypanosoma brucei (59.3%) and the murine cathepsin L (42.2%).  At least six copies of the gene are present in the genome and are organized in a tandem array of copies which are identical in all restriction endonucleases sites tested.  The gene appears to be expressed in all developmental stages of T. cruzi with mRNA levels approx. 2-fold higher in the intracellular amastigote form.  The T. cruzi gene was expressed in bacteria as an inactive, insol. fusion polypeptide to approx. 5% of the total cell protein.  The fusion protein was readily purified, solubilized in urea, and successfully refolded to produce a polyprotein which processed autocatalytically to yield active protease.  The processed form of the recombinant protease has an N-terminal sequence identical to that of the mature form of the protease purified from T. cruzi (Murta, A. C. M., et al., 1990; Cazzulo, J. J., et al., 1989).  This suggests that the recombinant protease possesses the requisite specificity and activity to correctly process the proform of the protease in vitro.  Kinetic assays with peptide substrates demonstrate that the substrate specificity and kinetic parameters for the recombinant protease are consistent with those of the endogenous protease.  The proteolytic activity of the recombinant protease is enhanced by dithiothreitol, inhibited by leupeptin, Nα-p-tosyl-L-lysine chloromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) but is unaffected by phenylmethylsulfonyl fluoride, pepstatin, and 1,10-phenanthroline.  More specifically, the recombinant enzyme was inhibited by benzyloxycarbonyl-Phe-Arg-fluoromethyl ketone, which inhibits replication and differentiation of T. cruzi within mammalian cells in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaeq71ROrbVg90H21EOLACvtfcHk0lipMX9S_xsdZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVygtr0%253D&md5=7606ae983cdbd4ea0fca4711502d980d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEakin%26aufirst%3DA.%2BE.%26aulast%3DMills%26aufirst%3DA.%2BA.%26aulast%3DHarth%26aufirst%3DG.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DThe%2520Sequence%252C%2520Organization%252C%2520and%2520Expression%2520of%2520the%2520Major%2520Cysteine%2520Protease%2520%2528Cruzain%2529%2520from%2520Trypanosoma%2520cruzi%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D7411%26epage%3D7420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eakin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletterick, R. J.</span></span> <span> </span><span class="NLM_article-title">The Crystal Structure of Cruzain: A Therapeutic Target for Chagas’ Disease</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1994.0137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1006%2Fjmbi.1994.0137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=7707373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK2MXkvV2ku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1995&pages=251-259&author=M.+E.+McGrathauthor=A.+E.+Eakinauthor=J.+C.+Engelauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=R.+J.+Fletterick&title=The+Crystal+Structure+of+Cruzain%3A+A+Therapeutic+Target+for+Chagas%E2%80%99+Disease&doi=10.1006%2Fjmbi.1994.0137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of cruzain: a therapeutic target for Chagas' disease</span></div><div class="casAuthors">McGrath, Mary E.; Eakin, Ann E.; Engel, Juan C.; McKerrow, James H.; Craik, Charles C.; Fletterick, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-9</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Trypanosoma cruzi, a protozoan parasite, is the etiol. agent of American trypanosomiasis or Chagas' disease.  Chagas disease afflicts >24 million individuals in South and Central America producing a debilitating life-long disease.  It is the leading cause of heart failure in many Latin American countries.  Currently, there is no satisfactory treatment for this parasitic infection.  Cruzain (also known as cruzipain; gp 57/51), the major cysteine protease present in T. cruzi, is crit. for the development and survival of the parasite within the host cells, making this enzyme a target for potential trypanocidal drugs.  Here, the x-ray crystal structure of cruzain complexed with the potent inhibitor, Z-Phe-Ala-fluoromethyl ketone, is reported.  The structure was detd. at 2.35 Å (Rcryst = 0.15) by mol. replacement using a modified papain as the search model.  The refined structure was compared to papain.  Features which distinguish cruzain from papain were discussed since they may aid in the design of specificity inhibitors.  Fluorescence microscopy showed that a biotinylated form of the bound inhibitor did not effectively reach the host protease in their lysosomal compartment, but was selectively taken up by the parasite.  The inhibitor greatly reduced parasitemia in a cell culture system, without adverse effects to mammalian cells.  This biol. selectivity could be exploited, in conjunction with unique active site features revealed by the crystal structure, to develop chemotherapy for Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosPcmJ9Y_oG7Vg90H21EOLACvtfcHk0lipMX9S_xsdZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvV2ku7c%253D&md5=9107eb6e0a3982fac7bb8bf636b154b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1994.0137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1994.0137%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DEakin%26aufirst%3DA.%2BE.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Crystal%2520Structure%2520of%2520Cruzain%253A%2520A%2520Therapeutic%2520Target%2520for%2520Chagas%25E2%2580%2599%2520Disease%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D247%26spage%3D251%26epage%3D259%26doi%3D10.1006%2Fjmbi.1994.0137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stierhof, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Active Site Mapping, Biochemical Properties and Subcellular Localization of Rhodesain, the Major Cysteine Protease of <i>Trypanosoma brucei rhodesiense</i></span>. <i>Mol. Biochem. Parasitol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/S0166-6851(01)00368-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0166-6851%2801%2900368-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=11704274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2001&pages=61-73&author=C.+R.+Caffreyauthor=E.+Hansellauthor=K.+D.+Lucasauthor=L.+S.+Brinenauthor=A.+A.+Hernandezauthor=J.+Chengauthor=S.+L.+Gwaltneyauthor=W.+R.+Roushauthor=Y.+D.+Stierhofauthor=M.+Bogyoauthor=D.+Steverdingauthor=J.+H.+McKerrow&title=Active+Site+Mapping%2C+Biochemical+Properties+and+Subcellular+Localization+of+Rhodesain%2C+the+Major+Cysteine+Protease+of+Trypanosoma+brucei+rhodesiense&doi=10.1016%2FS0166-6851%2801%2900368-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Caffrey, Conor R.; Hansell, Elizabeth; Lucas, Kimberley D.; Brinen, Linda S.; Alvarez Hernandez, Alejandro; Cheng, Jiamning; Gwaltney, Stephen L., II; Roush, William R.; Stierhof, York-Dieter; Bogyo, Matthew; Steverding, Dietmar; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-73</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Cysteine protease activity of African trypanosome parasites is a target for new chemotherapy using synthetic protease inhibitors.  To support this effort and further characterize the enzyme, we expressed and purified rhodesain, the target protease of Trypanosoma brucei rhodesiense (MVAT4 strain), in reagent quantities from Pichia pastoris.  Rhodesain was secreted as an active, mature protease.  Site-directed mutagenesis of a cryptic glycosylation motif not previously identified allowed prodn. of rhodesain suitable for crystn.  An invariable ER(A/V)FNAA motif in the pro-peptide sequence of rhodesain was identified as being unique to the genus Trypanosoma.  Antibodies to rhodesain localized the protease in the lysosome and identified a 40-kDa protein in long slender forms of T. b. rhodesiense and all life-cycle stages of T. b. brucei.  With the latter parasite, protease expression was five times greater in short stumpy trypanosomes than in the other stages.  Radiolabeled active site-directed inhibitors identified brucipain as the major cysteine protease in T. b. brucei.  Peptidomimetic vinyl sulfone and epoxide inhibitors designed to interact with the S2, S1 and S' subsites of the active site cleft revealed differences between rhodesain and the related trypanosome protease cruzain.  Using fluorogenic dipeptidyl substrates, rhodesain and cruzain had acid pH optima, but unlike some mammalian cathepsins retained significant activity and stability up to pH 8.0, consistent with a possible extracellular function.  S2 subsite mapping of rhodesain and cruzain with fluorogenic peptidyl substrates demonstrates that the presence of alanine rather than glutamate at S2 prevents rhodesain from cleaving substrates in which P2 is arginine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJfvYdkg17bVg90H21EOLACvtfcHk0lipMX9S_xsdZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFSqsrk%253D&md5=756484ab3694e015c7aef9591eb2bb7c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0166-6851%2801%2900368-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-6851%252801%252900368-1%26sid%3Dliteratum%253Aachs%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DLucas%26aufirst%3DK.%2BD.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DHernandez%26aufirst%3DA.%2BA.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DStierhof%26aufirst%3DY.%2BD.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DActive%2520Site%2520Mapping%252C%2520Biochemical%2520Properties%2520and%2520Subcellular%2520Localization%2520of%2520Rhodesain%252C%2520the%2520Major%2520Cysteine%2520Protease%2520of%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DMol.%2520Biochem.%2520Parasitol%26date%3D2001%26volume%3D118%26spage%3D61%26epage%3D73%26doi%3D10.1016%2FS0166-6851%2801%2900368-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span> <span> </span><span class="NLM_article-title"><i>Trypanosoma brucei:</i> Chemical Evidence that Cathepsin L is Essential for Survival and a Relevant Drug Target</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1016/j.ijpara.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.ijpara.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22549023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=481-488&author=D.+Steverdingauthor=D.+W.+Sextonauthor=X.+Wangauthor=S.+S.+Gehrkeauthor=G.+K.+Wagnerauthor=C.+R.+Caffrey&title=Trypanosoma+brucei%3A+Chemical+Evidence+that+Cathepsin+L+is+Essential+for+Survival+and+a+Relevant+Drug+Target&doi=10.1016%2Fj.ijpara.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosoma brucei: Chemical evidence that cathepsin L is essential for survival and a relevant drug target</span></div><div class="casAuthors">Steverding, Dietmar; Sexton, Darren W.; Wang, Xia; Gehrke, Sebastian S.; Wagner, Gerd K.; Caffrey, Conor R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal for Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">481-488</span>CODEN:
                <span class="NLM_cas:coden">IJPYBT</span>;
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protozoan parasite causing human African trypanosomiasis, Trypanosoma brucei, displays cysteine peptidase activity, the chem. inhibition of which is lethal to the parasite.  This activity comprises a cathepsin B (TbCATB) and a cathepsin L (TbCATL).  Previous RNA interference (RNAi) data suggest that TbCATB rather than TbCATL is essential to survival even though silencing of the latter was incomplete.  Also, chem. evidence supporting the essentiality of either enzyme which would facilitate a target-based drug development program is lacking.  Using specific peptidyl inhibitors and substrates, we quantified the contributions of TbCATB and TbCATL to the survival of T. brucei.  At 100 μM, the minimal inhibitory concn. that kills all parasites in culture, the non-specific cathepsin inhibitors, benzyloxycarbonyl-phenylalanyl-arginyl-diazomethyl ketone (Z-FA-diazomethyl ketone) and (l-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l-proline Me ester (CA-074Me) inhibited TbCATL and TbCATB by >99%.  The cathepsin L (CATL)-specific inhibitor, ((2S,3S)-oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide}) (CAA0225), killed parasites with >99% inhibition of TbCATL but only 70% inhibition of TbCATB.  Conversely, the cathepsin B (CATB)-specific inhibitor, (l-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l-proline (CA-074), did not affect survival even though TbCATB inhibition at >95% was statistically indistinguishable from the complete inhibition by Z-FA-diazomethyl ketone and CA-074Me.  The obsd. inhibition of TbCATL by CA-074 and CA-074Me was shown to be facilitated by the reducing intracellular environment.  All inhibitors, except the CATB-specific inhibitor, CA-074, blockaded lysosomal hydrolysis prior to death.  The results suggest that TbCATL, rather than TbCATB, is essential to the survival of T. brucei and an appropriate drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr675aPCwLVBbVg90H21EOLACvtfcHk0ljFUKyToErrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWht7Y%253D&md5=c90f0f98b9727b92406f43d3a6a94bd8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpara.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpara.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DSexton%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGehrke%26aufirst%3DS.%2BS.%26aulast%3DWagner%26aufirst%3DG.%2BK.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26atitle%3DTrypanosoma%2520brucei%253A%2520Chemical%2520Evidence%2520that%2520Cathepsin%2520L%2520is%2520Essential%2520for%2520Survival%2520and%2520a%2520Relevant%2520Drug%2520Target%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2012%26volume%3D42%26spage%3D481%26epage%3D488%26doi%3D10.1016%2Fj.ijpara.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fetter, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span> <span> </span><span class="NLM_article-title">A Parasite Cysteine Protease is Key to Host Protein Degradation and Iron Acquisition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">28934</span>– <span class="NLM_lpage">28943</span>, <span class="refDoi"> DOI: 10.1074/jbc.M805824200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M805824200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=18701454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Glsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28934-28943&author=T.+C.+O%E2%80%99Brienauthor=Z.+B.+Mackeyauthor=R.+D.+Fetterauthor=Y.+Choeauthor=A.+J.+O%E2%80%99Donoghueauthor=M.+Zhouauthor=C.+S.+Craikauthor=C.+R.+Caffrey&title=A+Parasite+Cysteine+Protease+is+Key+to+Host+Protein+Degradation+and+Iron+Acquisition&doi=10.1074%2Fjbc.M805824200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Parasite Cysteine Protease Is Key to Host Protein Degradation and Iron Acquisition</span></div><div class="casAuthors">O'Brien, Theresa C.; Mackey, Zachary B.; Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.; Caffrey, Conor R.; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">28934-28943</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the Clan CA (papain) family are the predominant protease group in primitive invertebrates.  Cysteine protease inhibitors arrest infection by the protozoan parasite, Trypanosoma brucei.  RNA interference studies implicated a cathepsin B-like protease, tbcatB, as a key inhibitor target.  Utilizing parasites in which one of the two alleles of tbcatb has been deleted, the key role of this protease in degrdn. of endocytosed host proteins is delineated.  TbcatB deficiency results in a decreased growth rate and dysmorphism of the flagellar pocket and the subjacent endocytic compartment.  Western blot and microscopic anal. indicate that deficiency in tbcatB results in accumulation of both host and parasite proteins, including the lysosomal marker p67.  A crit. function for parasitism is the degrdn. of host transferrin, which is necessary for iron acquisition.  Substrate specificity anal. of recombinant tbcatB revealed the optimal peptide cleavage sequences for the enzyme and these were confirmed exptl. using FRET-based substrates.  Degrdn. of transferrin was validated by SDS-PAGE and the specific cleavage sites identified by N-terminal sequencing.  Because even a modest deficiency in tbcatB is lethal for the parasite, tbcatB is a logical target for the development of new anti-trypanosomal chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0xdbV3G4STbVg90H21EOLACvtfcHk0ljFUKyToErrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Glsb7I&md5=27c09cee7b81bf5991513010a65ee0ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M805824200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M805824200%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BC.%26aulast%3DMackey%26aufirst%3DZ.%2BB.%26aulast%3DFetter%26aufirst%3DR.%2BD.%26aulast%3DChoe%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26atitle%3DA%2520Parasite%2520Cysteine%2520Protease%2520is%2520Key%2520to%2520Host%2520Protein%2520Degradation%2520and%2520Iron%2520Acquisition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28934%26epage%3D28943%26doi%3D10.1074%2Fjbc.M805824200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenbaum, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span> <span> </span><span class="NLM_article-title">The <i>Trypanosoma cruzi</i> Protease Cruzain Mediates Immune Evasion</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1002139</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.ppat.1002139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=21909255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1altLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&author=P.+S.+Doyleauthor=Y.+M.+Zhouauthor=I.+Hsiehauthor=D.+C.+Greenbaumauthor=J.+H.+McKerrowauthor=J.+C.+Engel&title=The+Trypanosoma+cruzi+Protease+Cruzain+Mediates+Immune+Evasion&doi=10.1371%2Fjournal.ppat.1002139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Trypanosoma cruzi protease cruzain mediates immune evasion</span></div><div class="casAuthors">Doyle, Patricia S.; Zhou, Yuan M.; Hsieh, Ivy; Greenbaum, Doron C.; McKerrow, James H.; Engel, Juan C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002139</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Trypanosoma cruzi is the causative agent of Chagas' disease.  Novel chemotherapy with the drug K11777 targets the major cysteine protease cruzain and disrupts amastigote intracellular development.  Nevertheless, the biol. role of the protease in infection and pathogenesis remains unclear as cruzain gene knockout failed due to genetic redundancy.  A role for the T. cruzi cysteine protease cruzain in immune evasion was elucidated in a comparative study of parental wild type- and cruzain-deficient parasites.  Wild type T. cruzi did not activate host macrophages during early infection (<60 min) and no increase in ∼P iκB was detected.  The signaling factor NF-κB P65 colocalized with cruzain on the cell surface of intracellular wild type parasites, and was proteolytically cleaved.  No significant IL-12 expression occurred in macrophages infected with wild type T. cruzi and treated with LPS and BFA, confirming impairment of macrophage activation pathways.  In contrast, cruzain-deficient parasites induced macrophage activation, detectable iκB phosphorylation, and nuclear NF-κB P65 localization.  These parasites were unable to develop intracellularly and survive within macrophages.  IL-12 expression levels in macrophages infected with cruzain-deficient T. cruzi were comparable to LPS activated controls.  Thus cruzain hinders macrophage activation during the early (<60 min) stages of infection, by interruption of the NF-κB P65 mediated signaling pathway.  These early events allow T. cruzi survival and replication, and may lead to the spread of infection in acute Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA2EglOwxBsLVg90H21EOLACvtfcHk0ljFUKyToErrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1altLnM&md5=bb2b90a2ef673596cca188faa96fa5b0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002139%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DY.%2BM.%26aulast%3DHsieh%26aufirst%3DI.%26aulast%3DGreenbaum%26aufirst%3DD.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Trypanosoma%2520cruzi%2520Protease%2520Cruzain%2520Mediates%2520Immune%2520Evasion%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26doi%3D10.1371%2Fjournal.ppat.1002139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Peptide-fluoromethyl Ketones Arrest Intracellular Replication and Intercellular Transmission of <i>Trypanosoma cruzi</i></span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/0166-6851(93)90086-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2F0166-6851%2893%2990086-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=8459830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=17-24&author=G.+Harthauthor=N.+Andrewsauthor=A.+A.+Millsauthor=J.+C.+Engelauthor=R.+Smithauthor=J.+H.+McKerrow&title=Peptide-fluoromethyl+Ketones+Arrest+Intracellular+Replication+and+Intercellular+Transmission+of+Trypanosoma+cruzi&doi=10.1016%2F0166-6851%2893%2990086-D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-fluoromethyl ketones arrest intracellular replication and intercllular transmission of Trypanosoma cruzi</span></div><div class="casAuthors">Harth, Guenter; Andrews, Norma; Mills, Alea A.; Engel, Juan C.; Smith, Robert; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    </div><div class="casAbstract">The major proteolytic activity of T. cruzi is a cathepsin L-like cysteine protease expressed in all stages of the parasite.  As an initial step in identifying possible functions of this enzyme in the life cycle of T. cruzi, and examg. its potential as a target for rational drug design, two fluoromethyl ketone-derivatized cysteine protease inhibitors were studied for their effects on T. cruzi infection of mammalian cells.  Both inhibitors are irreversible substrate analogs with high specificity for cysteine proteases and minimal toxicity to mammalian cells.  While micromolar concns. of inhibitors had some effect on replication of all parasite stages, the most dramatic arrest replication occurred at the transformation of trypomastigote to amastigote, and also from amastigote to trypomastigote.  It is therefore proposed that the enzyme functions not only in intracellular protein degrdn. in some stages of T. cruzi, but also in remodeling of the parasite during transformation between stages.  Concns. of inhibitors necessary to interrupt the parasite life cycle had no observable toxicity to macrophages, fibroblasts or epithelial cells in culture.  Differential susceptibility of T. cruzi vs. host cysteine proteases to fluoromethyl ketone protease inhibitors suggests that inhibition of the T. cruzi cysteine protease is a potential lead for new chemotherapy of Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AvI4UpyaabVg90H21EOLACvtfcHk0ljFUKyToErrqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Cqu7o%253D&md5=f967250f17785c1aa95dca30743df744</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0166-6851%2893%2990086-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0166-6851%252893%252990086-D%26sid%3Dliteratum%253Aachs%26aulast%3DHarth%26aufirst%3DG.%26aulast%3DAndrews%26aufirst%3DN.%26aulast%3DMills%26aufirst%3DA.%2BA.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DPeptide-fluoromethyl%2520Ketones%2520Arrest%2520Intracellular%2520Replication%2520and%2520Intercellular%2520Transmission%2520of%2520Trypanosoma%2520cruzi%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D1993%26volume%3D58%26spage%3D17%26epage%3D24%26doi%3D10.1016%2F0166-6851%2893%2990086-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">A Cysteine Protease Inhibitor Cures Chagas Disease in an Immunodeficient-Mouse Model of Infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3932</span>– <span class="NLM_lpage">3939</span>, <span class="refDoi"> DOI: 10.1128/AAC.00436-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.00436-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=17698625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=3932-3939&author=P.+S.+Doyleauthor=Y.+M.+Zhouauthor=J.+C.+Engelauthor=J.+H.+McKerrow&title=A+Cysteine+Protease+Inhibitor+Cures+Chagas+Disease+in+an+Immunodeficient-Mouse+Model+of+Infection&doi=10.1128%2FAAC.00436-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection</span></div><div class="casAuthors">Doyle, Patricia S.; Zhou, Yuan M.; Engel, Juan C.; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3932-3939</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chagas' disease, caused by the parasite Trypanosoma cruzi, remains the leading cause of cardiopathy in Latin America with about 12 million people infected.  Classic clin. manifestations derive from infection of muscle cells leading to progressive cardiomyopathy, while some patients develop megacolon or megaesophagus.  A very aggressive clin. course including fulminant meningoencephalitis has been reported in patients who contract Chagas' disease in the background of immunodeficiency.  This includes patients with human immunodeficiency virus infection as well as patients receiving immunosuppressive therapy for organ transplant.  Currently, only two drugs are approved for the treatment of Chagas' disease, nifurtimox and benznidazole.  Both have significant limitations due to common and serious side effects as well as limited availability.  A promising group of new drug leads for Chagas' disease is cysteine protease inhibitors targeting cruzain, the major protease of T. cruzi.  The inhibitor N-methyl-Pip-F-homoF-vinyl sulfonyl Ph (N-methyl-Pip-F-hF-VSφ) is in late-stage preclin. development.  Therefore, the question arose as to whether protease inhibitors targeting cruzain would have efficacy in Chagas' disease occurring in the background of immunodeficiency.  To address this question, we studied the course of infection in recombinase-deficient (Rag1-/-) and normal mice infected with T. cruzi.  Infections localized to heart and skeletal muscle in untreated normal animals, while untreated Rag1-/- mice showed severe infection in all organs and predominantly in liver and spleen.  Treatment with the dipeptide N-methyl-Pip-F-hF-VSφ rescued immunodeficient animals from lethal Chagas' infection.  The majority (60 to 100%) of inhibitor-treated Rag1-/- mice had increased survival, neg. PCR, and normal tissues by histopathol. examn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruii0nk3W_xbVg90H21EOLACvtfcHk0lg2mb-VMkNFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtL%252FL&md5=f692870a11fca60f359edbad28145788</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.00436-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00436-07%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DY.%2BM.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Cysteine%2520Protease%2520Inhibitor%2520Cures%2520Chagas%2520Disease%2520in%2520an%2520Immunodeficient-Mouse%2520Model%2520of%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D3932%26epage%3D3939%26doi%3D10.1128%2FAAC.00436-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Trypanocidal Effect of Cysteine Protease Inhibitors <i>in vitro</i> and <i>in vivo</i> in Experimental Chagas Disease</span>. <i>Medicina</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10668260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A280%3ADC%252BD3c7jtlCguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=171-175&author=J.+C.+Engelauthor=P.+S.+Doyleauthor=J.+H.+McKerrow&title=Trypanocidal+Effect+of+Cysteine+Protease+Inhibitors+in+vitro+and+in+vivo+in+Experimental+Chagas+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanocidal effect of cysteine protease inhibitors in vitro and in vivo in experimental Chagas disease</span></div><div class="casAuthors">Engel J C; Doyle P S; McKerrow J H</div><div class="citationInfo"><span class="NLM_cas:title">Medicina</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-5</span>
        ISSN:<span class="NLM_cas:issn">0025-7680</span>.
    </div><div class="casAbstract">Endemic in most American countries, Chagas' disease causes high morbidity and mortality.  Recent experimental and clinical evidence shows the importance of chemotherapy in both the acute and chronic phases of this disease.  However, treatment is yet limited by the toxicity associated to available drugs.  This review describes the design, evolution, and selection of dipeptides that interrupt the intracellular cycle of T. cruzi and cure acute experimental infections in laboratory animals.  Peptido-mimetic inhibitors specifically bind cruzain, a T. cruzi cystein protease.  The inhibitors cause alterations in the Golgi complex and ER, accumulation of unprocessed enzyme within Golgi cisternae, and decrease of mature cruzain within lysosomes.  The most effective compound, N-Pip-F-hF-VS phi, cured an acute lethal infection in experimental animals.  Myocardial lesions, lymphocyte infiltration and intracellular amastigote clusers were absent in treated animals.  Preliminary toxicology and pharmacokinetic analyses suggest the lack of toxicity associated to high doses and prolonged treatment regimes.  Protease inhibitors may soon become good chemotherapeutic alternatives for acute and chronic Chagas' disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO9qHJyma4n3T4ugvCDgnZfW6udTcc2eaHd-ZD1oM9E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7jtlCguw%253D%253D&md5=fa8ae41479921dcfcc4415ce5e06ccf5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DTrypanocidal%2520Effect%2520of%2520Cysteine%2520Protease%2520Inhibitors%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520Experimental%2520Chagas%2520Disease%26jtitle%3DMedicina%26date%3D1999%26volume%3D59%26spage%3D171%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Cysteine Protease Inhibitors Cure an Experimental <i>Trypanosoma cruzi</i> Infection</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1084/jem.188.4.725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1084%2Fjem.188.4.725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=9705954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFClsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1998&pages=725-734&author=J.+C.+Engelauthor=P.+S.+Doyleauthor=I.+Hsiehauthor=J.+H.+McKerrow&title=Cysteine+Protease+Inhibitors+Cure+an+Experimental+Trypanosoma+cruzi+Infection&doi=10.1084%2Fjem.188.4.725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection</span></div><div class="casAuthors">Engel, Juan C.; Doyle, Patricia S.; Hsieh, Ivy; McKerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">725-734</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Trypanosoma cruzi is the causative agent of Chagas' disease.  The major protease, cruzain, is a target for the development of new chemotherapy.  We report the first successful treatment of an animal model of Chagas' disease with inhibitors designed to inactivate cruzain.  Treatment with fluoromethyl ketone-derivatized pseudopeptides rescued mice from lethal infection.  The optimal pseudopeptide scaffold was phenylalanine-homophenylalanine.  To achieve cure of infection, this pseudopeptide scaffold was incorporated in a less toxic vinyl sulfone deriv.  N-Me piperazine-Phe-homoPhe-vinyl sulfone Ph also rescued mice from a lethal infection.  Six of the treated mice survived over nine months, three without further treatment.  Three mice that had entered the chronic stage of infection were retreated with a 20-d regimen.  At the conclusion of the expts., five of the six mice had repeated neg. hemacultures, indicative of parasitol. cure.  Studies of the effect of inhibitors on the intracellular amastigote form suggest that the life cycle is interrupted because of inhibitor arrest of normal autoproteolytic cruzain processing at the level of the Golgi complex.  Parasites recovered from the hearts of treated mice showed the same abnormalities as those treated in vitro.  No abnormalities were noted in the Golgi complex of host cells.  This study provides proof of concept that cysteine protease inhibitors can be given at therapeutic doses to animals to selectively arrest a parasitic infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3b1RC4nplbVg90H21EOLACvtfcHk0lg2mb-VMkNFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFClsbw%253D&md5=045e4e5dcf81aa7b44f1b9db96e7c5a8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1084%2Fjem.188.4.725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.188.4.725%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DHsieh%26aufirst%3DI.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DCysteine%2520Protease%2520Inhibitors%2520Cure%2520an%2520Experimental%2520Trypanosoma%2520cruzi%2520Infection%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D188%26spage%3D725%26epage%3D734%26doi%3D10.1084%2Fjem.188.4.725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span> <span> </span><span class="NLM_article-title">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25697</span>– <span class="NLM_lpage">25703</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.014340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1074%2Fjbc.M109.014340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=19620707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25697-25703&author=I.+D.+Kerrauthor=J.+H.+Leeauthor=C.+J.+Faradyauthor=R.+Marionauthor=M.+Rickertauthor=M.+Sajidauthor=K.+C.+Pandeyauthor=C.+R.+Caffreyauthor=J.+Legacauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+S.+Craikauthor=P.+J.+Rosenthalauthor=L.+S.+Brinen&title=Vinyl+Sulfones+as+Antiparasitic+Agents+and+a+Structural+Basis+for+Drug+Design&doi=10.1074%2Fjbc.M109.014340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design</span></div><div class="casAuthors">Kerr, Iain D.; Lee, Ji H.; Farady, Christopher J.; Marion, Rachael; Rickert, Mathias; Sajid, Mohammed; Pandey, Kailash C.; Caffrey, Conor R.; Legac, Jennifer; Hansell, Elizabeth; McKerrow, James H.; Craik, Charles S.; Rosenthal, Philip J.; Brinen, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25697-25703</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cysteine proteases of the papain superfamily are implicated in a no. of cellular processes and are important virulence factors in the pathogenesis of parasitic disease.  These enzymes have therefore emerged as promising targets for antiparasitic drugs.  We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small mol., cysteine protease inhibitors, the vinyl sulfones.  These data, in conjunction with comparative inhibition kinetics, provide insight into the mol. mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolV0DUxF0YFbVg90H21EOLACvtfcHk0ljyv8Z0gZobpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhsbbK&md5=c0bed13d912846fdcb4c2ba7f31954cb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.014340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.014340%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DMarion%26aufirst%3DR.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DSajid%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DLegac%26aufirst%3DJ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26atitle%3DVinyl%2520Sulfones%2520as%2520Antiparasitic%2520Agents%2520and%2520a%2520Structural%2520Basis%2520for%2520Drug%2520Design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25697%26epage%3D25703%26doi%3D10.1074%2Fjbc.M109.014340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> Studies of the Trypanocidal Properties of WRR-483 against <i>Trypanosoma cruzi</i></span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e825</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0000825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pntd.0000825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=20856868" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&author=Y.+T.+Chenauthor=L.+S.+Brinenauthor=I.+D.+Kerrauthor=E.+Hansellauthor=P.+S.+Doyleauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=In+vitro+and+in+vivo+Studies+of+the+Trypanocidal+Properties+of+WRR-483+against+Trypanosoma+cruzi&doi=10.1371%2Fjournal.pntd.0000825"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Studies%2520of%2520the%2520Trypanocidal%2520Properties%2520of%2520WRR-483%2520against%2520Trypanosoma%2520cruzi%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26doi%3D10.1371%2Fjournal.pntd.0000825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, K. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1021/jm901069a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901069a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=52-60&author=B.+T.+Mottauthor=R.+S.+Ferreiraauthor=A.+Simeonovauthor=A.+Jadhavauthor=K.+K.+H.+Angauthor=W.+Leisterauthor=M.+Shenauthor=J.+T.+Silveiraauthor=P.+S.+Doyleauthor=M.+R.+Arkinauthor=J.+H.+McKerrowauthor=J.+Ingleseauthor=C.+P.+Austinauthor=C.+J.+Thomasauthor=B.+K.+Shoichetauthor=D.+J.+Maloney&title=Identification+and+Optimization+of+Inhibitors+of+Trypanosomal+Cysteine+Proteases%3A+Cruzain%2C+Rhodesain%2C+and+TbCatB&doi=10.1021%2Fjm901069a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB</span></div><div class="casAuthors">Mott, Bryan T.; Ferreira, Rafaela S.; Simeonov, Anton; Jadhav, Ajit; Ang, Kenny Kean-Hooi; Leister, William; Shen, Min; Silveira, Julia T.; Doyle, Patricia S.; Arkin, Michelle R.; McKerrow, James H.; Inglese, James; Austin, Christopher P.; Thomas, Craig J.; Shoichet, Brian K.; Maloney, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-60</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanosoma cruzi and Trypanosoma brucei are parasites that cause Chagas' disease and African sleeping sickness, resp.  Both parasites rely on essential cysteine proteases for survival: cruzain for T. cruzi and TbCatB/rhodesain for T. brucei.  A recent quant. high-throughput screen of cruzain identified triazine nitriles, which are known inhibitors of other cysteine proteases, as reversible inhibitors of the enzyme.  Structural modifications detailed herein, including core scaffold modification from triazine to purine, improved the in vitro potency against both cruzain and rhodesain by 350-fold, while also gaining activity against T. brucei parasites.  Selected compds. were screened against a panel of human cysteine and serine proteases to det. selectivity, and a co-crystal was obtained of our most potent analog bound to cruzain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooBt9aofNhebVg90H21EOLACvtfcHk0ljyv8Z0gZobpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FM&md5=473bade6311d998f7a4521a0c93b9fce</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901069a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901069a%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DFerreira%26aufirst%3DR.%2BS.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DAng%26aufirst%3DK.%2BK.%2BH.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DSilveira%26aufirst%3DJ.%2BT.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520and%2520Optimization%2520of%2520Inhibitors%2520of%2520Trypanosomal%2520Cysteine%2520Proteases%253A%2520Cruzain%252C%2520Rhodesain%252C%2520and%2520TbCatB%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D52%26epage%3D60%26doi%3D10.1021%2Fjm901069a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinen, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Two Approaches to Discovering and Developing New Drugs for Chagas Disease</span>. <i>Mem. Inst. Oswaldo Cruz</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1590/S0074-02762009000900034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1590%2FS0074-02762009000900034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=19753483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFegtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=263-269&author=J.+H.+McKerrowauthor=P.+S.+Doyleauthor=J.+C.+Engelauthor=L.+M.+Podustauthor=S.+A.+Robertsonauthor=R.+Ferreiraauthor=T.+Saxtonauthor=M.+Arkinauthor=I.+D.+Kerrauthor=L.+S.+Brinenauthor=C.+S.+Craik&title=Two+Approaches+to+Discovering+and+Developing+New+Drugs+for+Chagas+Disease&doi=10.1590%2FS0074-02762009000900034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Two approaches to discovering and developing new drugs for Chagas disease</span></div><div class="casAuthors">McKerrow, J. H.; Doyle, P. S.; Engel, J. C.; Podust, L. M.; Robertson, S. A.; Ferreira, R.; Saxton, T.; Arkin, M.; Kerr, I. D.; Brinen, L. S.; Craik, C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Memorias do Instituto Oswaldo Cruz</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">263-269</span>CODEN:
                <span class="NLM_cas:coden">MIOCAS</span>;
        ISSN:<span class="NLM_cas:issn">0074-0276</span>.
    
            (<span class="NLM_cas:orgname">Instituto Oswaldo Cruz</span>)
        </div><div class="casAbstract">This review will focus on two general approaches carried out at the Sandier Center, University of California, San Francisco, to address the challenge of developing new drugs for the treatment of Chagas disease.  The first approach is target-based drug discovery, and two specific targets, cytochrome P 450 CYP51 and cruzain (aka cruzipain), are discussed.  A "proof of concept" mol., the vinyl sulfone inhibitor K777, is now a clin. candidate.  The preclin. assessment compliance for filing as an Investigational New Drug with the United States Food and Drug Administration (FDA) is presented, and an outline of potential clin. trials is given.  The second approach to identifying new drug leads is parasite phenotypic screens in culture.  The development of an assay allowing high throughput screening of Trypanosoma cruzi amastigotes in skeletal muscle cells is presented.  This screen has the advantage of not requiring specific strains of parasites, so it could be used with field isolates, drug resistant strains or lab. strains.  It is optimized for robotic liq. handling and has been validated through a screen of a library of FDA-approved drugs identifying 65 hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPiQLGneYh2LVg90H21EOLACvtfcHk0liz8VG_WbZ83A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFegtLfO&md5=6d2fa84e594bf0d0f205ea0ad4f1b824</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1590%2FS0074-02762009000900034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0074-02762009000900034%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRobertson%26aufirst%3DS.%2BA.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSaxton%26aufirst%3DT.%26aulast%3DArkin%26aufirst%3DM.%26aulast%3DKerr%26aufirst%3DI.%2BD.%26aulast%3DBrinen%26aufirst%3DL.%2BS.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DTwo%2520Approaches%2520to%2520Discovering%2520and%2520Developing%2520New%2520Drugs%2520for%2520Chagas%2520Disease%26jtitle%3DMem.%2520Inst.%2520Oswaldo%2520Cruz%26date%3D2009%26volume%3D104%26spage%3D263%26epage%3D269%26doi%3D10.1590%2FS0074-02762009000900034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">Update on Drug Development Targeting Parasite Cysteine Proteases</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0005850</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1371%2Fjournal.pntd.0005850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=30138309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslejsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&author=J.+H.+McKerrow&title=Update+on+Drug+Development+Targeting+Parasite+Cysteine+Proteases&doi=10.1371%2Fjournal.pntd.0005850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Update on drug development targeting parasite cysteine proteases</span></div><div class="casAuthors">Mckerrow, James H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0005850/1-e0005850/4</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbmwZ-Qos3LrVg90H21EOLACvtfcHk0liz8VG_WbZ83A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslejsbzJ&md5=a3c2e59416b2a86a6a79a66c56886ccb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005850%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DUpdate%2520on%2520Drug%2520Development%2520Targeting%2520Parasite%2520Cysteine%2520Proteases%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2018%26volume%3D12%26doi%3D10.1371%2Fjournal.pntd.0005850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paavilainen, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisconte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loughhead, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Prolonged and Tunable Residence Time Using Reversible Covalent Kinase Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+Tunable+Residence+Time+Using+Reversible+Covalent+Kinase+Inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0liz8VG_WbZ83A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520Tunable%2520Residence%2520Time%2520Using%2520Reversible%2520Covalent%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span> <span> </span><span class="NLM_article-title">Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">12624</span>– <span class="NLM_lpage">12630</span>, <span class="refDoi"> DOI: 10.1021/ja505194w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja505194w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=12624-12630&author=S.+Krishnanauthor=R.+M.+Millerauthor=B.+Tianauthor=R.+D.+Mullinsauthor=M.+P.+Jacobsonauthor=J.+Taunton&title=Design+of+Reversible%2C+Cysteine-Targeted+Michael+Acceptors+Guided+by+Kinetic+and+Computational+Analysis&doi=10.1021%2Fja505194w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis</span></div><div class="casAuthors">Krishnan, Shyam; Miller, Rand M.; Tian, Boxue; Mullins, R. Dyche; Jacobson, Matthew P.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12624-12630</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Electrophilic probes that covalently modify a cysteine thiol often show enhanced pharmacol. potency and selectivity.  Although reversible Michael acceptors have been reported, the structural requirements for reversibility are poorly understood.  Here, we report a novel class of acrylonitrile-based Michael acceptors, activated by aryl or heteroaryl electron-withdrawing groups.  We demonstrate that thiol adducts of these acrylonitriles undergo β-elimination at rates that span more than 3 orders of magnitude.  These rates correlate inversely with the computed proton affinity of the corresponding carbanions, enabling the intrinsic reversibility of the thiol-Michael reaction to be tuned in a predictable manner.  We apply these principles to the design of new reversible covalent kinase inhibitors with improved properties.  A cocrystal structure of one such inhibitor reveals specific noncovalent interactions between the 1,2,4-triazole activating group and the kinase.  Our exptl. and computational study enables the design of new Michael acceptors, expanding the palette of reversible, cysteine-targeted electrophiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHXljSEecz5LVg90H21EOLACvtfcHk0liSpnfnoSZ2Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtbvK&md5=de052bac07c8920cb807c05f71f4f95d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fja505194w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja505194w%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DTian%26aufirst%3DB.%26aulast%3DMullins%26aufirst%3DR.%2BD.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520Reversible%252C%2520Cysteine-Targeted%2520Michael%2520Acceptors%2520Guided%2520by%2520Kinetic%2520and%2520Computational%2520Analysis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D12624%26epage%3D12630%26doi%3D10.1021%2Fja505194w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug–Target Residence Time and its Implications for Lead Optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%80%93Target+Residence+Time+and+its+Implications+for+Lead+Optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0liSpnfnoSZ2Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2580%2593Target%2520Residence%2520Time%2520and%2520its%2520Implications%2520for%2520Lead%2520Optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornreic, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">A Cysteine Protease Inhibitor Protects Dogs from Cardiac Damage during Infection by <i>Trypanosoma cruzi</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">5160</span>– <span class="NLM_lpage">5161</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.12.5160-5161.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.49.12.5160-5161.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=16304193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=5160-5161&author=S.+C.+Barrauthor=K.+L.+Warnerauthor=B.+G.+Kornreicauthor=J.+Piscitelliauthor=A.+Wolfeauthor=L.+Benetauthor=J.+H.+McKerrow&title=A+Cysteine+Protease+Inhibitor+Protects+Dogs+from+Cardiac+Damage+during+Infection+by+Trypanosoma+cruzi&doi=10.1128%2FAAC.49.12.5160-5161.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi</span></div><div class="casAuthors">Barr, S. C.; Warner, K. L.; Kornreic, B. G.; Piscitelli, J.; Wolfe, A.; Benet, L.; McKerrow, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5160-5161</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cruzain is an essential cysteine protease of Trypanosoma cruzi and a therapeutic target for Chagas' disease.  Eight dogs were infected with T. cruzi; three were treated with an inhibitor of cruzain, K777, for 14 days.  Treatment with K777 abrogated myocardial damage by T. cruzi, as documented by histopathol. lesion scores and serum troponin I levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5fG-3KRPL2rVg90H21EOLACvtfcHk0liSpnfnoSZ2Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrvM&md5=21093940c91e59e0b312abd58f018032</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.12.5160-5161.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.12.5160-5161.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DS.%2BC.%26aulast%3DWarner%26aufirst%3DK.%2BL.%26aulast%3DKornreic%26aufirst%3DB.%2BG.%26aulast%3DPiscitelli%26aufirst%3DJ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DBenet%26aufirst%3DL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Cysteine%2520Protease%2520Inhibitor%2520Protects%2520Dogs%2520from%2520Cardiac%2520Damage%2520during%2520Infection%2520by%2520Trypanosoma%2520cruzi%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D5160%26epage%3D5161%26doi%3D10.1128%2FAAC.49.12.5160-5161.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3176</span>– <span class="NLM_lpage">3190</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=3176-3190&author=X.+Zhaiauthor=T.+D.+Meek&title=Catalytic+Mechanism+of+Cruzain+from+Trypanosoma+cruzi+As+Determined+from+Solvent+Kinetic+Isotope+Effects+of+Steady-State+and+Pre-Steady-State+Kinetics&doi=10.1021%2Facs.biochem.7b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics</span></div><div class="casAuthors">Zhai, Xiang; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3176-3190</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain, an important drug target for Chagas disease, is a member of Clan CA of the cysteine proteases.  Understanding the catalytic mechanism of cruzain is vital to the design of new inhibitors.  To this end, we have performed pH-rate profiles for substrates and affinity agents, and have detd. solvent kinetic isotope effects in pre-steady-state and steady-state modes using three substrates: Cbz-Phe-Arg-AMC, Cbz-Arg-Arg-AMC and Cbz-Arg-Ala-AMC.  The pH-rate profile of kcat/Km for Cbz-Arg-Arg-AMC indicated groups of pK1 = 6.6 (unprotonated) and pK2 ∼ 9.6 (protonated) required for catalysis.  The temp. dependence of the group of pK = 6.2 - 6.6 exhibited a values of ΔHion = 8.4 kcal/mol, typical of histidine.  The pH-rate profile of inactivation by iodoacetamide confirmed that the catalytic cysteine possesses a pKa of 9.8.  Normal solvent kinetic isotope effects were obsd. for both D2Okcat = 1.6 - 2.1 and D2Okcat/Km = 1.1 - 1.4 for all three substrates.  Pre-steady-state kinetics revealed exponential bursts of AMC prodn. for Cbz-Phe-Arg-AMC and Cbz-Arg-Arg-AMC, but not for Cbz-Arg-Ala-AMC.  The overall solvent isotope effect on kcat is attributable to the solvent isotope effect on the deacylation step.  Our results suggest that cruzain is unique among papain-like cysteine proteases in that the catalytic cysteine and histidine are neutral in charge in the free enzyme.  The generation of the active thiolate of the catalytic cysteine is likely proceeded (and possibly triggered) by a ligand-induced conformational change, which could bring the catalytic dyad to close proximity in order to effect proton transfer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGNPkhmnRHYbVg90H21EOLACvtfcHk0ljXyIwrgn3HuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2nsw%253D%253D&md5=c9905e633b50aab71fe3450428aa4c84</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01250%26sid%3Dliteratum%253Aachs%26aulast%3DZhai%26aufirst%3DX.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DCatalytic%2520Mechanism%2520of%2520Cruzain%2520from%2520Trypanosoma%2520cruzi%2520As%2520Determined%2520from%2520Solvent%2520Kinetic%2520Isotope%2520Effects%2520of%2520Steady-State%2520and%2520Pre-Steady-State%2520Kinetics%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26spage%3D3176%26epage%3D3190%26doi%3D10.1021%2Facs.biochem.7b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Enzyme Inactivators</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span>; <span class="NLM_string-name">Brand, L.</span></span>, Eds; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>, <span class="NLM_year">1995</span>; pp  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">283</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=240-283&author=R.+B.+Silvermanauthor=M.+L.+Johnson&author=L.+Brand&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMechanism-Based%2520Enzyme%2520Inactivators%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26pub%3DAcademic%2520Press%26date%3D1995%26spage%3D240%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brady, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeles, R. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Chymotrypsin by Peptidyl Trifluoromethyl Ketones: Determinants of Slow-Binding Kinetics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">7608</span>– <span class="NLM_lpage">7617</span>, <span class="refDoi"> DOI: 10.1021/bi00485a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00485a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFersLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=7608-7617&author=K.+Bradyauthor=R.+H.+Abeles&title=Inhibition+of+Chymotrypsin+by+Peptidyl+Trifluoromethyl+Ketones%3A+Determinants+of+Slow-Binding+Kinetics&doi=10.1021%2Fbi00485a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones:  determinants of slow-binding kinetics</span></div><div class="casAuthors">Brady, Kenneth; Abeles, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7608-17</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A series of 7 peptidyl trifluoromethyl ketone (TFK) inhibitors of chymotrypsin were prepd. which differ at the P1 and P2 subsites.  Inhibition equil. and kinetics of assocn. and dissocn. with chymotrypsin were measured.  The assocn. rate of Ac-Phe-CF3 was measured at enzyme concns. between 8 nM and 117 μM in order to examine the relation between the ketone/hydrate equil. of trifluoromethyl ketones and the slow binding by these inhibitors.  The assocn. rate decreased at high enzyme concns., indicating that TFK ketone is the reactive species and that conversion of TFK hydrate to TFK ketone becomes rate limiting under these conditions.  Inhibitors with hydrophobic side-chains at P2 bound more tightly but more slowly to chymotrypsin, indicating that formation of van der Waals contacts between the P2 side-chain and the histidine-57 and isoleucine-99 side-chains of chymotrypsin is a relatively slow process.  Inhibitor properties were compared to the Michaelis-Menten kinetic consts. of a homologous series of peptide Me ester and peptide amide substrates.  Plots of log Ki vs. log(kcat/Km) were linear with slopes of 0.65, indicating that these inhibitors are able to utilize 65% of the total binding energy between chymotrypsin and its hydrolytic transition state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsw7Ry7tBM7Vg90H21EOLACvtfcHk0ljXyIwrgn3HuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFersLo%253D&md5=0306c95a2b3a801007197e848b3934cb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi00485a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00485a010%26sid%3Dliteratum%253Aachs%26aulast%3DBrady%26aufirst%3DK.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DInhibition%2520of%2520Chymotrypsin%2520by%2520Peptidyl%2520Trifluoromethyl%2520Ketones%253A%2520Determinants%2520of%2520Slow-Binding%2520Kinetics%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D7608%26epage%3D7617%26doi%3D10.1021%2Fbi00485a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubach, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thrall, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7551</span>– <span class="NLM_lpage">7568</span>, <span class="refDoi"> DOI: 10.1021/bi300719b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300719b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kms7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7551-7568&author=J.+K.+Rubachauthor=G.+Cuiauthor=J.+L.+Schneckauthor=A.+N.+Taylorauthor=B.+Zhaoauthor=A.+Smallwoodauthor=N.+Nevinsauthor=D.+Wisnoskiauthor=S.+H.+Thrallauthor=T.+D.+Meek&title=The+Amino-Acid+Substituents+of+Dipeptide+Substrates+of+Cathepsin+C+Can+Determine+the+Rate-Limiting+Steps+of+Catalysis&doi=10.1021%2Fbi300719b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Amino-Acid Substituents of Dipeptide Substrates of Cathepsin C Can Determine the Rate-Limiting Steps of Catalysis</span></div><div class="casAuthors">Rubach, Jon K.; Cui, Guanglei; Schneck, Jessica L.; Taylor, Amy N.; Zhao, Baoguang; Smallwood, Angela; Nevins, Neysa; Wisnoski, David; Thrall, Sara H.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7551-7568</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We examd. the cathepsin C-catalyzed hydrolysis of dipeptide substrates of the form Yaa-Xaa-AMC, using steady-state and pre-steady-state kinetic methods.  The substrates group into three kinetic profiles based upon the broad range obsd. for kcat/Ka and kcat values, pre-steady-state time courses, and solvent kinetic isotope effects (sKIEs).  The dipeptide substrate Gly-Arg-AMC displayed large values for kcat/Ka (1.6±0.09 μM-1 s-1) and kcat (255±6 s-1), an inverse sKIE on kcat/Ka (D(kcat/Ka) = 0.6±0.15), a modest, normal sKIE on kcat (Dkcat = 1.6±0.2), and immeasurable pre-steady-state kinetics, indicating an extremely fast pre-steady-state rate (>400 s-1).  (Errors on fitted values are omitted in the text for clarity but may be found in Table 2.).  These results conformed to a kinetic model where the acylation (kac) and deacylation (kdac) half-reactions are very fast and similar in value.  The second substrate type, Gly-Tyr-AMC and Ser-Tyr-AMC, the latter the subject of a comprehensive kinetic study (Schneck et al. (2008) Biochem. 47, 8697-8710), were found to be less active substrates compared to Gly-Arg-AMC, with resp. kcat/Ka values of 0.49±0.07 μM-1 s-1 and 5.3±0.5 μM-1 s-1, and kcat values of 28±1 s-1 and 25±0.5 s-1.  Solvent kinetic isotope effects for Ser-Tyr-AMC were found to be inverse for kcat/Ka (D(kcat/Ka) = 0.74±0.05) and normal for kcat (Dkcat = 2.3±0.1) but unlike Gly-Arg-AMC, pre-steady-state kinetics of Gly-Tyr-AMC and Ser-Tyr-AMC were measurable and characterized by a single-exponential burst, with fast transient rates (490 s-1 and 390 s-1, resp.), from which it was detd. that kac » kdac ∼ kcat.  The third substrate type, Gly-Ile-AMC, gave very low values of kcat/Ka (0.0015±0.0001 μM-1 s-1) and kcat (0.33±0.02 s-1), no sKIEs, (D(kcat/Ka) = 1.05±0.5 and Dkcat = 1.06±0.4), and pre-steady-state kinetics exhibited a discernible, but negligible, transient phase.  For this third class of substrate, kinetic modeling was consistent with a mechanism in which kdac > kac ∼ kcat, and for which an isotope-insensitive step in the acylation half-reaction is the slowest.  The combined results of these studies suggested that the identity of the amino acid at the P1 position of the substrate is the main determinant of catalysis.  On the basis of these kinetic data, together with crystallog. studies of substrate analogs and mol. dynamics anal. with models of acyl-enzyme intermediates, we present a catalytic model derived from the relative rates of the acylation vs. deacylation half-reactions of cathepsin C.  The chem. steps of catalysis are proposed to be dependent upon the conformational freedom of the amino acid substituents for optimal alignment for thiolation (acylation) or hydrolysis (deacylation).  These studies suggest ideas for inhibitor design for papain-family cysteine proteases and strategies to progress drug discovery for other classes of disease-relevant cysteine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9GBPYB2_wXbVg90H21EOLACvtfcHk0ljXyIwrgn3HuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kms7zM&md5=e7527b6a5f5913e9cbff9fdce62dfc56</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi300719b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300719b%26sid%3Dliteratum%253Aachs%26aulast%3DRubach%26aufirst%3DJ.%2BK.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DSchneck%26aufirst%3DJ.%2BL.%26aulast%3DTaylor%26aufirst%3DA.%2BN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DThrall%26aufirst%3DS.%2BH.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DThe%2520Amino-Acid%2520Substituents%2520of%2520Dipeptide%2520Substrates%2520of%2520Cathepsin%2520C%2520Can%2520Determine%2520the%2520Rate-Limiting%2520Steps%2520of%2520Catalysis%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7551%26epage%3D7568%26doi%3D10.1021%2Fbi300719b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lje750VP1O7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+2.+Enrichment+Factors+in+Database+Screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lje750VP1O7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25202.%2520Enrichment%2520Factors%2520in%2520Database%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein–Ligand Complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">6196</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-6196&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+Precision+Glide%3A+Docking+and+Scoring+Incorporating+a+Model+of+Hydrophobic+Enclosure+for+Protein%E2%80%93Ligand+Complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lje750VP1O7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520Precision%2520Glide%253A%2520Docking%2520and%2520Scoring%2520Incorporating%2520a%2520Model%2520of%2520Hydrophobic%2520Enclosure%2520for%2520Protein%25E2%2580%2593Ligand%2520Complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D6196%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span> <span> </span><span class="NLM_article-title">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1932</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1021/ci500118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=1932-1940&author=K.+Zhuauthor=K.+W.+Borrelliauthor=J.+R.+Greenwoodauthor=T.+Dayauthor=R.+Abelauthor=R.+S.+Faridauthor=E.+Harder&title=Docking+Covalent+Inhibitors%3A+A+Parameter+Free+Approach+To+Pose+Prediction+and+Scoring&doi=10.1021%2Fci500118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring</span></div><div class="casAuthors">Zhu, Kai; Borrelli, Kenneth W.; Greenwood, Jeremy R.; Day, Tyler; Abel, Robert; Farid, Ramy S.; Harder, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1932-1940</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although many popular docking programs include a facility to account for covalent ligands, large-scale systematic docking validation studies of covalent inhibitors have been sparse.  In this paper, we present the development and validation of a novel approach for docking and scoring covalent inhibitors, which consists of conventional noncovalent docking, heuristic formation of the covalent attachment point, and structural refinement of the protein-ligand complex.  This approach combines the strengths of the docking program Glide and the protein structure modeling program Prime and does not require any parameter fitting for the study of addnl. covalent reaction types.  We first test this method by predicting the native binding geometry of 38 covalently bound complexes.  The av. RMSD of the predicted poses is 1.52 Å, and 76% of test set inhibitors have an RMSD of less than 2.0 Å.  In addn., the apparent affinity score constructed herein is tested on a virtual screening study and the characterization of the SAR properties of two different series of congeneric compds. with satisfactory success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbtjEb3EqzQ7Vg90H21EOLACvtfcHk0lgfl566LnaHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVKksLs%253D&md5=3633c29fa5dc29817b178fd10a4c7b15</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci500118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500118s%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DBorrelli%26aufirst%3DK.%2BW.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFarid%26aufirst%3DR.%2BS.%26aulast%3DHarder%26aufirst%3DE.%26atitle%3DDocking%2520Covalent%2520Inhibitors%253A%2520A%2520Parameter%2520Free%2520Approach%2520To%2520Pose%2520Prediction%2520and%2520Scoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D1932%26epage%3D1940%26doi%3D10.1021%2Fci500118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöllkopf, U.</span></span> <span> </span><span class="NLM_article-title">Über Triphenyl-phosphin-methylene als Olefinbildende Reagenzien I. Mitteil</span>. <i>Chem. Ber.</i> <span class="NLM_year" style="font-weight: bold;">1954</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1318</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1002/cber.19540870919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2Fcber.19540870919" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1954&pages=1318-1330&author=G.+Wittigauthor=U.+Sch%C3%B6llkopf&title=%C3%9Cber+Triphenyl-phosphin-methylene+als+Olefinbildende+Reagenzien+I.+Mitteil&doi=10.1002%2Fcber.19540870919"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fcber.19540870919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19540870919%26sid%3Dliteratum%253Aachs%26aulast%3DWittig%26aufirst%3DG.%26aulast%3DSch%25C3%25B6llkopf%26aufirst%3DU.%26atitle%3D%25C3%259Cber%2520Triphenyl-phosphin-methylene%2520als%2520Olefinbildende%2520Reagenzien%2520I.%2520Mitteil%26jtitle%3DChem.%2520Ber.%26date%3D1954%26volume%3D87%26spage%3D1318%26epage%3D1330%26doi%3D10.1002%2Fcber.19540870919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmons, W. D.</span></span> <span> </span><span class="NLM_article-title">The Utility of Phosphonate Carbanions in Olefin Synthesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1733</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.1021/ja01468a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01468a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaF3MXpvFWrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1961&pages=1733-1738&author=W.+S.+Wadsworthauthor=W.+D.+Emmons&title=The+Utility+of+Phosphonate+Carbanions+in+Olefin+Synthesis&doi=10.1021%2Fja01468a042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The utility of phosphonate carbanions in olefin synthesis</span></div><div class="casAuthors">Wadsworth, William S., Jr.; Emmons, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1733-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The reaction of phosphonate carbanions contg. electron-withdrawing groups with aldehydes or ketones in an aprotic solvent, a useful olefin synthesis, was studied.  These reagents were, in general, more reactive than the analogous triarylphosphoranes (Wittig reagents) and had a no. of special features which enhanced their usefulness.  (EtO)2P(O)CH2Bz (11.4 g.) added dropwise with stirring to 2.4 g. 50% NaH in 100 cc. dry (MeOCH2)2 at 20°, stirred 1 hr. at room temp., treated below 25° dropwise with 5.3 g. BzH, stirred 1 hr. at room temp., and refluxed 0.5 hr. gave 6.3 g. PhCH:CHBz, m. 52-3°.  EtO2CCH2P(O)(OEt)2 (I) added dropwise at 20° to 2.4 g. 50% NaH in 100 cc. dry (MeOCH2)2, stirred 1 hr. at room temp., treated dropwise below 30° with 4.9 g. cyclohexanone, and stirred 15 min. at room temp. yielded 5.8 g. Et cyclohexylideneacetate, b10 88-90°, n25D 1.4704.  I (11.2 g.), 2.4 g. 50% NaH in 100 cc. (CH2OMe)2, and 7.2 g. AcCH2CH2CO2Et gave in the usual manner at 50-60° during 1 hr. 7.1 g. EtO2CCH:CMeCH2CH2CO2Et, b0.25 78-80°, n25D 1.4506.  PhCH2P(O)(OEt)2 (11.4 g.), 2.4 g. 50% NaH, 5.3 g. BzH, and 100 cc. (MeOCH2)2 refluxed 0.5 hr. gave 5.6 g. trans-stilbene, m. 124.5°.  p-[(EtO)2P(O)CH2]2C6H4 (II) (9.45 g.), 1.2 g. 50% NaH, 2.65 g. BzH, and 100 cc. (MeOCH2)2 refluxed 0.5 hr. yielded 4.5 g. (p-PhCH:CH)2C6H4, m. 259-60°. II (9.45 g.), 2.4 g. 50% NaH, 7.6 g. PhCH:CHCHO, and 100 cc. (MeOCH2)2 heated 0.5 hr. at 85° gave 3.0 g. p-(PhCH: CHCH:CH)2C6H4, m. 290-1°.  CH2[P(O)(OEt)2]2 (5.3 g.) added dropwise at room temp. to 0.971 g. 50% NaH and 100 cc. (MeOCH2)2, stirred 1 hr., and treated dropwise with stirring with 2.14 g. BzH yielded 2.4 g. PhCH:CHP(O) (OEt)2, b0.35, 116-18°, n25D 1.5208.  Di-Et fluorenylphosphonate (III) (7.55 g.), 1.3 g. 50% NaH, 100 cc. dry (MeOCH2)2, and 0.8 g. paraformaldehyde in (MeOCH2)2, processed in the usual manner at 30°, dild. with H2O, and extd. with Et2O gave a soln. of 9-methylenefluorene which with Br-CCl4 gave a cryst. ppt., m. 144°; the bulk of the Et2O soln. evapd. yielded 30.5 g. polymerized product which was insol. in all common solvents. I (86 g.) added dropwise with stirring at room temp. to 18.4 g. 50% NaH in 100 cc. (MeOCH2)2, the mixt. heated 1 hr. at 50° with 52.6 g. BuBr, cooled to 10°, treated with 18.4 g. 50% NaH, stirred 1 hr. at room temp., treated with 12.1 g. paraformaldehyde in 50 cc. (MeOCH2)2 at 20° during 1 hr., and stirred 1 hr. yielded 38.4 g. CH2:CBuCO2Et, b100 68-9°, n25D 1.4254.  I (22.4 g.) added dropwise at 20° to 4.8 g. 50% NaH in 100 cc. (MeOCH2)2, stirred 1 hr., treated dropwise below 25° with 16 g. Br, warmed briefly at 40°, cooled to 10°, treated with 4.5 g. 50% NaH and then below 30° with 7.3 g. iso-PrCHO, and worked up gave 14.5 g. Me2CHCH:CBrCO2Et, b10 76-8°, n25D 1.4649.  I (11.2 g.) added at 25° dropwise to 2.4 g. 50% NaH in 100 cc. (MeOCH2)2, stirred 1 hr., treated dropwise with 12.7 g. iodine in the min. (MeOCH2)2, stirred 1 hr. at room temp., treated at 10° with 4.8 g. 50% NaH and then at 25° dropwise with 5.3 g. BzH, and heated slowly to 40° gave 5.1 g. PhC≡CCO2Et, b0.1 78-80°, n25D 1.5800.  I (11.2 g.), 2.5 g. 50% NaH in 100 cc. (MeOCH2)2, and 7.3 g. EtPhC:C:O gave at 50° 3.5 g. EtPhC:C:CHCO2Et, b0.1 89-90°, n25D 1.5490.  (EtO)2P(O)CH2Ph (IV) with BzPh gave similarly 78% Ph2C:CHPh, m. 67°.  IV with PhCH:CHCHO yielded 58% (PhCH:CH)2, m. 151°.  I with BzH gave 84% PhCH:CHCO2Et, b0.1 70°, n25D 1.5562.  I with iso-PrCHO yielded 74% iso-PrCH:CHCO2Et, b15 65°, n25D 1.4284.  III with BzH gave 80% 9-benzylidenefluorene, m. 74-5°.  (EtO)2P(O)CH2CN and BzH gave 66% PhCH:CHCN, b10 130°, n25D 1.5828.  I with CCl3CHO yielded 50% CCl3CH:CHCO2Et, b10 86°, n25D 1.4798. (MeO)2P(O)CH2CO2Et and Me2CO yielded 70% Me2C:CHCO2Et, b760 150°, n25D 1.4331.  (EtO)2P(O)CH(CO2Et)CH2CO2Et [prepd. by treating mono-Et maleate with (EtO)3P] with BzH gave 61% PhCH:C(CO2Et)CH2CO2Et, b0.1 119°, n25D 1.5068.  I (22.4 g.) added dropwise with stirring at 25° to 5.0 g. 50% NaH in 100 cc. dry (MeOCH2)2, stirred 1 hr., refluxed 4 hrs. with 12.0 g. styrene oxide, cooled to room temp., dild. with H2O, and extd. with Et2O gave 8.0 g. PhCH.CH2.CHCO2Et, b0.5 100-2°, n25D 1.5121.  I with EtCH.CH2.O gave similarly 21% EtCH.CH2.CHCO2Et, b15 55°, n25D 1.4215.  (EtO)2P(O)CH2CN with styrene oxide yielded 51% PhCH.CH2.CHCN, b0.2 80°, m. 26-7°, n25D 1.5226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6k-5lLhgGfbVg90H21EOLACvtfcHk0lgfl566LnaHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXpvFWrsg%253D%253D&md5=abd1cfb148b71698851eaec7fc939943</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fja01468a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01468a042%26sid%3Dliteratum%253Aachs%26aulast%3DWadsworth%26aufirst%3DW.%2BS.%26aulast%3DEmmons%26aufirst%3DW.%2BD.%26atitle%3DThe%2520Utility%2520of%2520Phosphonate%2520Carbanions%2520in%2520Olefin%2520Synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1961%26volume%3D83%26spage%3D1733%26epage%3D1738%26doi%3D10.1021%2Fja01468a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nahm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinreb, S. M.</span></span> <span> </span><span class="NLM_article-title">N-methoxy-N-Methylamides as Effective Acylating Agents</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3815</span>– <span class="NLM_lpage">3818</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)91316-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0040-4039%2801%2991316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1981&pages=3815-3818&author=S.+Nahmauthor=S.+M.+Weinreb&title=N-methoxy-N-Methylamides+as+Effective+Acylating+Agents&doi=10.1016%2FS0040-4039%2801%2991316-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methoxy-N-methylamides as effective acylating agents</span></div><div class="casAuthors">Nahm, Steven; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3815-18</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">N-Methoxy-N-methylamides couple readily with both Grignard and organolithium reagents in THF to give ketones; tertiary alcs. were not formed even in the presence of large excesses of the organometallic compd.  E.g., treatment of Me(CH2)16CONMeOMe (I), prepd. from Me(CH2)16COCl and HNMeOMe.HCl (pyridine/CHCl3, room temp., 1 h), with 2 equiv MeMgBr (THF, 0°, 1 h) gave 94% Me(CH2)16COMe.  Hydride redn. of the N-methoxy-N-methylamides gave the corresponding aldehydes, together with small amts. of the primary alc.  E.g., I with excess LiAlH4 (THF, -78°, 5 min) gave 50% Me(CH2)16CHO and 25% Me(CH2)17OH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSzB8ss9N34rVg90H21EOLACvtfcHk0lgfl566LnaHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XosFSitg%253D%253D&md5=ce1dc3bf2af883db320d90c4ff32616c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2991316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252991316-4%26sid%3Dliteratum%253Aachs%26aulast%3DNahm%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DN-methoxy-N-Methylamides%2520as%2520Effective%2520Acylating%2520Agents%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D22%26spage%3D3815%26epage%3D3818%26doi%3D10.1016%2FS0040-4039%2801%2991316-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, J. L.</span>; <span class="NLM_string-name">Palmer, J. T.</span>; <span class="NLM_string-name">Rasnick, D.</span></span> <span> </span><span class="NLM_article-title">Irreversible Cysteine Protease Inhibitors Containing Vinyl Groups Conjugated to Electron Withdrawing Groups</span>. U.S. Patent <span class="NLM_patent">6,287,840</span>, <span class="NLM_year">2001</span><b>.</b></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+L.+Klaus&author=J.+T.+Palmer&author=D.+Rasnick&title=Irreversible+Cysteine+Protease+Inhibitors+Containing+Vinyl+Groups+Conjugated+to+Electron+Withdrawing+Groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26atitle%3DIrreversible%2520Cysteine%2520Protease%2520Inhibitors%2520Containing%2520Vinyl%2520Groups%2520Conjugated%2520to%2520Electron%2520Withdrawing%2520Groups%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">The Behavior and Significance of Slow-Binding Enzyme Inhibitors</span>. <i>Adv. Enzymol. Relat. Areas Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1002/9780470123072.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+Behavior+and+Significance+of+Slow-Binding+Enzyme+Inhibitors&doi=10.1002%2F9780470123072.ch5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0lh2I7TYzuAC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520Behavior%2520and%2520Significance%2520of%2520Slow-Binding%2520Enzyme%2520Inhibitors%26jtitle%3DAdv.%2520Enzymol.%2520Relat.%2520Areas%2520Mol.%2520Biol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301%26doi%3D10.1002%2F9780470123072.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tochowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=77-82&author=B.+D.+Jonesauthor=A.+Tochowiczauthor=Y.+Tangauthor=M.+D.+Cameronauthor=L.+I.+McCallauthor=K.+Hirataauthor=J.+L.+Siqueira-Netoauthor=S.+L.+Reedauthor=J.+H.+McKerrowauthor=W.+R.+Roush&title=Synthesis+and+Evaluation+of+Oxyguanidine+Analogues+of+the+Cysteine+Protease+Inhibitor+WRR-483+against+Cruzain&doi=10.1021%2Facsmedchemlett.5b00336"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00336%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DB.%2BD.%26aulast%3DTochowicz%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcCall%26aufirst%3DL.%2BI.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DReed%26aufirst%3DS.%2BL.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Oxyguanidine%2520Analogues%2520of%2520the%2520Cysteine%2520Protease%2520Inhibitor%2520WRR-483%2520against%2520Cruzain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D7%26spage%3D77%26epage%3D82%26doi%3D10.1021%2Facsmedchemlett.5b00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isabel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Camargo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath-Chowdhury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Methot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll-Griffith, D. A.</span></span> <span> </span><span class="NLM_article-title">Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1128/AAC.01855-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1128%2FAAC.01855-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=24323474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVOkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1167-1178&author=M.+Ndaoauthor=C.+Beaulieuauthor=W.+C.+Blackauthor=E.+Isabelauthor=F.+Vasquez-Camargoauthor=M.+Nath-Chowdhuryauthor=F.+Mass%C3%A9author=C.+Mellonauthor=N.+Methotauthor=D.+A.+Nicoll-Griffith&title=Reversible+Cysteine+Protease+Inhibitors+Show+Promise+for+a+Chagas+Disease+Cure&doi=10.1128%2FAAC.01855-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible cysteine protease inhibitors show promise for a Chagas disease cure</span></div><div class="casAuthors">Ndao, Momar; Beaulieu, Christian; Black, W. Cameron; Isabel, Elise; Vasquez-Camargo, Fabio; Nath-Chowdhury, Milli; Masse, Frederic; Mellon, Christophe; Methot, Nathalie; Nicoll-Griffith, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1167-1178, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The cysteine protease cruzipain is essential for the viability, infectivity and virulence of Trypanosoma cruzi, the causative agent of Chagas disease.  Thus, inhibitors of cruzipain are considered promising anti-T. cruzi chemotherapeutic agents.  Reversible cruzipain inhibitors contg. a nitrile "warhead" were prepd. and demonstrated 50% inhibitory concns. (IC50s) as potent as 1 nM in baculovirus-generated cruzipain enzyme assays.  In epimastigote and intracellular amastigote in vitro assays, the most potent compds. demonstrated antiparasitic behavior in the 5 to 10 μM IC50 range; however, trypomastigote prodn. from the amastigote form was ∼90 to 95 % inhibited at 2 μM.  Two key compds., Cz007 and Cz008, with IC50s of 1.1 and 1.8 nM, resp., against the recombinant enzyme were tested in a murine model of acute T. cruzi infection, with oral dosing in chow for 28 days at doses from 3 to 50 mg/kg of body wt.  At 3 mg/kg of Cz007 and 3 mg/kg of Cz008, the blood parasitemia areas under the concn.-time curves were 16% and 25% of the untreated group, resp.  At sacrifice, 24 days after immunosuppression with cyclophosphamide, parasite presence in blood, heart and esophagus was evaluated.  Based on neg. quant. PCR results in all three tissues, cure rates in surviving animals were 90% for Cz007 at 3 mg/kg, 78% for Cz008 at 3 mg/kg and 71% for benznidazole, the control compd., at 50 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOw-04Qv6G7Vg90H21EOLACvtfcHk0lh2I7TYzuAC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVOkur8%253D&md5=dc7bade0d9b3b04d2c49817e7b2a8035</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.01855-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01855-13%26sid%3Dliteratum%253Aachs%26aulast%3DNdao%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DIsabel%26aufirst%3DE.%26aulast%3DVasquez-Camargo%26aufirst%3DF.%26aulast%3DNath-Chowdhury%26aufirst%3DM.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DMethot%26aufirst%3DN.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26atitle%3DReversible%2520Cysteine%2520Protease%2520Inhibitors%2520Show%2520Promise%2520for%2520a%2520Chagas%2520Disease%2520Cure%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D1167%26epage%3D1178%26doi%3D10.1128%2FAAC.01855-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudreau, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaliti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hook, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwick, W. H.</span></span> <span> </span><span class="NLM_article-title">Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and <i>Trypanosoma cruzi</i> Cruzain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9026</span>– <span class="NLM_lpage">9044</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00294</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00294" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVantL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9026-9044&author=P.+D.+Boudreauauthor=B.+W.+Millerauthor=L.+I.+McCallauthor=J.+Almalitiauthor=R.+Reherauthor=K.+Hirataauthor=T.+Leauthor=J.+L.+Siqueira-Netoauthor=V.+Hookauthor=W.+H.+Gerwick&title=Design+of+Gallinamide+A+Analogs+as+Potent+Inhibitors+of+the+Cysteine+Proteases+Human+Cathepsin+L+and+Trypanosoma+cruzi+Cruzain&doi=10.1021%2Facs.jmedchem.9b00294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain</span></div><div class="casAuthors">Boudreau, Paul D.; Miller, Bailey W.; McCall, Laura-Isobel; Almaliti, Jehad; Reher, Raphael; Hirata, Ken; Le, Thu; Siqueira-Neto, Jair L.; Hook, Vivian; Gerwick, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9026-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallinamide A, originally isolated with modest antimalarial activity, was subsequently re-isolated and characterized as a potent, selective, and irreversible inhibitor of the human cysteine protease cathepsin L.  Mol. docking identified potential modifications to improve binding, which were synthesized as a suite of analogs., Resultingly, this current study produced the most potent gallinamide analog yet tested against cathepsin L (10, Ki = 0.0937 ± 0.01 nM and kinact /Ki = 8,730,000).  From a protein structure and substrate preference perspective, cruzain, an essential Trypanosoma cruzi cysteine protease, is a highly homologous.  Our investigations revealed that gallimamide and its analogs potently inhibit cruzain and are exquisitely toxic towards T. cruzi in the intracellular amastigote stage.  The most active compd., 5, had an IC50 = 5.1 ± 1.4 nM, but was relatively inactive to both the epimastigote (insect stage) and the host cell, and thus represents a new candidate for treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsSQ1NB_10NrVg90H21EOLACvtfcHk0lh2I7TYzuAC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVantL3L&md5=24aeede597be1438e77cff58283044dc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00294%26sid%3Dliteratum%253Aachs%26aulast%3DBoudreau%26aufirst%3DP.%2BD.%26aulast%3DMiller%26aufirst%3DB.%2BW.%26aulast%3DMcCall%26aufirst%3DL.%2BI.%26aulast%3DAlmaliti%26aufirst%3DJ.%26aulast%3DReher%26aufirst%3DR.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DHook%26aufirst%3DV.%26aulast%3DGerwick%26aufirst%3DW.%2BH.%26atitle%3DDesign%2520of%2520Gallinamide%2520A%2520Analogs%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Cysteine%2520Proteases%2520Human%2520Cathepsin%2520L%2520and%2520Trypanosoma%2520cruzi%2520Cruzain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9026%26epage%3D9044%26doi%3D10.1021%2Facs.jmedchem.9b00294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">Progress with Covalent Small-Molecule Kinase Inhibitors</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2Fj.drudis.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=29337202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslShurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=727-735&author=Z.+Zhaoauthor=P.+E.+Bourne&title=Progress+with+Covalent+Small-Molecule+Kinase+Inhibitors&doi=10.1016%2Fj.drudis.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Progress with covalent small-molecule kinase inhibitors</span></div><div class="casAuthors">Zhao, Zheng; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-735</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">With reduced risk of toxicity and high selectivity, covalent small-mol. kinase inhibitors (CSKIs) have emerged rapidly.  Through the lens of structural system pharmacol., here we review this rapid progress by considering design strategies and the challenges and opportunities offered by current CSKIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog6l6qMAopYLVg90H21EOLACvtfcHk0ligoYa-Xsg7FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslShurg%253D&md5=f97a19f53a72044812a778ee9351fe94</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DProgress%2520with%2520Covalent%2520Small-Molecule%2520Kinase%2520Inhibitors%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2018%26volume%3D23%26spage%3D727%26epage%3D735%26doi%3D10.1016%2Fj.drudis.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkemgu, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span> <span> </span><span class="NLM_article-title">Improved Trypanocidal Activities of Cathepsin L Inhibitors</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0924-8579(03)00096-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1016%2FS0924-8579%2803%2900096-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=12927956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVKitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=155-159&author=N.+J.+Nkemguauthor=R.+Grandeauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=C.+R.+Caffreyauthor=D.+Steverding&title=Improved+Trypanocidal+Activities+of+Cathepsin+L+Inhibitors&doi=10.1016%2FS0924-8579%2803%2900096-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Improved trypanocidal activities of cathepsin L inhibitors</span></div><div class="casAuthors">Nkemgu, Njinkeng Joseph; Grande, Rachel; Hansell, Elizabeth; McKerrow, James H.; Caffrey, Conor R.; Steverding, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-159</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The major lysosomal cysteine proteinase of African trypanosomes is a candidate target for novel chemotherapy of sleeping sickness.  This cathepsin L-like enzyme is termed rhodesain and brucipain in Trypanosoma brucei rhodesiense and Trypanosoma brucei brucei, resp.  Three potent and selective dipeptidyl cathepsin L inhibitors have been investigated for their trypanocidal activities in vitro using culture-adapted bloodstream forms of T. b. brucei.  Compared with general cysteine proteinase inhibitors used previously by ourselves and others, the present inhibitors had improved selectivity indexes and, importantly, anti-trypanosomal activities comparable with those of com. anti-sleeping sickness drugs.  Using purified recombinant rhodesain, potent kinact/Ki values of up to 2.3 × 106 M-1 s-1 were recorded with the inhibitors. Also, all inhibitors blocked proteinolysis in the lysosome consistent with the inhibition of rhodesain/brucipain.  In conclusion, the data support the potential of cathepsin L inhibitors for rational anti-trypanosomal drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok7BWl-MwexbVg90H21EOLACvtfcHk0ligoYa-Xsg7FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVKitbk%253D&md5=b6054b4f683fca6010134cd28ab41eaa</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2803%2900096-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252803%252900096-7%26sid%3Dliteratum%253Aachs%26aulast%3DNkemgu%26aufirst%3DN.%2BJ.%26aulast%3DGrande%26aufirst%3DR.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCaffrey%26aufirst%3DC.%2BR.%26aulast%3DSteverding%26aufirst%3DD.%26atitle%3DImproved%2520Trypanocidal%2520Activities%2520of%2520Cathepsin%2520L%2520Inhibitors%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2003%26volume%3D22%26spage%3D155%26epage%3D159%26doi%3D10.1016%2FS0924-8579%2803%2900096-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">Proteomic Profiling and Potential Cellular Target Identification of K11777, a Clinical Cysteine Protease Inhibitor, in <i>Trypanosoma brucei</i></span>. <i>Chem. Commun</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1039/C1CC16178D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=10.1039%2FC1CC16178D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=22124229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=835-837&author=P.+Y.+Yangauthor=M.+Wangauthor=C.+Y.+Heauthor=S.+Q.+Yao&title=Proteomic+Profiling+and+Potential+Cellular+Target+Identification+of+K11777%2C+a+Clinical+Cysteine+Protease+Inhibitor%2C+in+Trypanosoma+brucei&doi=10.1039%2FC1CC16178D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic profiling and potential cellular target identification of K11777, a clinical cysteine protease inhibitor, in Trypanosoma brucei</span></div><div class="casAuthors">Yang, Peng-Yu; Wang, Min; He, Cynthia Y.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">835-837</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report herein the design, synthesis and application of K11777-derived activity-based probes (ABPs) allowing in situ profiling and identification of potential cellular targets of K11777 in Trypanosoma brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpetQP69l11g7Vg90H21EOLACvtfcHk0ligoYa-Xsg7FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersbbK&md5=4e0d4c6fd674fddcf0950dd62041abd0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC1CC16178D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1CC16178D%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DC.%2BY.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DProteomic%2520Profiling%2520and%2520Potential%2520Cellular%2520Target%2520Identification%2520of%2520K11777%252C%2520a%2520Clinical%2520Cysteine%2520Protease%2520Inhibitor%252C%2520in%2520Trypanosoma%2520brucei%26jtitle%3DChem.%2520Commun%26date%3D2012%26volume%3D48%26spage%3D835%26epage%3D837%26doi%3D10.1039%2FC1CC16178D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balouch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span> <span> </span><span class="NLM_article-title">Mapping Inhibitor Binding Modes on an Active Cysteine Protease via Nuclear Magnetic Resonance Spectroscopy</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">10087</span>– <span class="NLM_lpage">10098</span>, <span class="refDoi"> DOI: 10.1021/bi301305k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301305k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslagu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=10087-10098&author=G.+M.+Leeauthor=E.+Balouchauthor=D.+H.+Goetzauthor=A.+Lazicauthor=J.+H.+McKerrowauthor=C.+S.+Craik&title=Mapping+Inhibitor+Binding+Modes+on+an+Active+Cysteine+Protease+via+Nuclear+Magnetic+Resonance+Spectroscopy&doi=10.1021%2Fbi301305k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping Inhibitor Binding Modes on an Active Cysteine Protease via Nuclear Magnetic Resonance Spectroscopy</span></div><div class="casAuthors">Lee, Gregory M.; Balouch, Eaman; Goetz, David H.; Lazic, Ana; McKerrow, James H.; Craik, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">10087-10098</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cruzain is a member of the papain/cathepsin L family of cysteine proteases, and the major cysteine protease of the protozoan Trypanosoma cruzi, the causative agent of Chagas disease.  We report an autoinduction methodol. that provides sol. cruzain in high yields (>30 mg/L in minimal medium).  These increased yields provide sufficient quantities of active enzyme for use in NMR-based ligand mapping.  Using CD and NMR spectroscopy, we also examd. the soln.-state structural dynamics of the enzyme in complex with a covalently bound vinyl sulfone inhibitor (K777).  We report the backbone amide and side chain carbon chem. shift assignments of cruzain in complex with K777.  These resonance assignments were used to identify and map residues located in the substrate binding pocket, including the catalytic Cys25 and His162.  Selective [15N]Cys, [15N]His, and [13C]Met labeling was performed to quickly assess cruzain-ligand interactions for a set of eight low-mol. wt. compds. exhibiting micromolar binding or inhibition.  Chem. shift perturbation mapping verified that six of the eight compds. bind to cruzain at the active site.  Three different binding modes were delineated for the compds., namely, covalent, noncovalent, and noninteracting.  These results provide examples of how NMR spectroscopy can be used to screen compds. for fast evaluation of enzyme-inhibitor interactions to facilitate lead compd. identification and subsequent structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCHS1f3hKGrVg90H21EOLACvtfcHk0li-mNTHuKJ-QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslagu7fJ&md5=c0484e0f3f4d4c9c830746e4507cc4c0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fbi301305k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301305k%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BM.%26aulast%3DBalouch%26aufirst%3DE.%26aulast%3DGoetz%26aufirst%3DD.%2BH.%26aulast%3DLazic%26aufirst%3DA.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26atitle%3DMapping%2520Inhibitor%2520Binding%2520Modes%2520on%2520an%2520Active%2520Cysteine%2520Protease%2520via%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D10087%26epage%3D10098%26doi%3D10.1021%2Fbi301305k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZ2','PDB','2OZ2'); return false;">PDB: 2OZ2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02078">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27038"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02078?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02078</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular modeling information, fitting of time-course inhibition data using KinTek Explorer, thiolation of cruzain inhibitors by glutathione, synthesis and characterization of AMC-peptide substrates, structures of PVHIs, HPLC traces and NMR spectra of synthesized substrates and inhibitors, and unpublished crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of S2–S5 and S7–S11 and compounds <b>1</b>−<b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_002.csv">CSV</a>)</p></li><li><p class="inline">Model coordinates for cruzain bound to 7, 9, 11–13, and 15 using CovDock module(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Model coordinates for cruzain bound to 7, 9, 11–13, and 15 using Glide module (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_001.pdf">jm9b02078_si_001.pdf (6.32 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_002.csv">jm9b02078_si_002.csv (4.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_003.pdb">jm9b02078_si_003.pdb (289.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02078/suppl_file/jm9b02078_si_004.pdb">jm9b02078_si_004.pdb (287.76 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02078&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02078%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02078" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b6b32ea6a3c5e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
